<html xmlns="http://www.w3.org/1999/xhtml" class=" js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage no-websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients no-cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths"><!--MODERNIZED PAGE--><head id="coid_website_head" profile="http://www.w3.org/2005/10/profile"><style type="text/css">@charset "UTF-8";[ng\:cloak],[ng-cloak],[data-ng-cloak],[x-ng-cloak],.ng-cloak,.x-ng-cloak,.ng-hide{display:none !important;}ng\:form{display:block;}.ng-animate-block-transitions{transition:0s all!important;-webkit-transition:0s all!important;}</style>
	<meta http-equiv="content-type" content="text/html; charset=UTF-8">
	<meta http-equiv="X-UA-Compatible" content="IE=edge">
	<meta name="description" content="View on Westlaw or start a FREE TRIAL today, Endo Pharmaceuticals Inc. v. Actavis, Inc., Cases">







<script>
	

	(function () {
		window['$$errors'] = [];

		//handle js errors (it will be overwritten in GlobalPageHandlers.js. And any error will be processed when this script is loaded on the page.)
		window.onerror = function() {
			window['$$errors'].push(arguments);
		}
	})();
</script>




	<title>Endo Pharmaceuticals Inc. v. Actavis, Inc. | Cases | Westlaw</title>

	
	



	
	
	



	




    
    <link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/utilities.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/core.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/components.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/features.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/document.css" type="text/css" rel="stylesheet">
<link href="https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/print.css" type="text/css" rel="stylesheet" media="print">
<!--[if gte IE 6]>
<link href='https://ca.next.westlaw.com/StaticContent_40.1.1015/css/v2/ie.css' type='text/css' rel='stylesheet' />
<![endif]-->


	<link rel="shortcut icon" type="image/vnd.microsoft.icon" href="https://ia.next.westlaw.com/favicon.ico">
	<link rel="apple-touch-icon" href="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/iphone-webclip-icon.png">
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.923c80f054c89ca796f84c4fbed803b0.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.e94d5ee75e94c1087b529e979a552bed.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.83634f9482d1ddf27e96c8f1d9498ac3.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/bundle.82967e6fecb235c1f97c6591de01f9f7.dll.js"></script><script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="//ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/js/Website/Views/Document/DocumentTabView.bootstrap.js"></script><link id="Markman_MarkmanDisplayState"><link id="Markman"></head>



<body class="co_t2Left co_docDisplay">
	<div id="co_pageContainer" class="co_bodyToolbar">
		<div id="co_mainContainer">
			











<div id="co_headerWrapper" class="wlnv2 ">
	<div id="co_newHeader"><div id="co_privacyPolicyContainer"> 
	<p id="co_privacyPolicy">
		<b>We've updated our Privacy Statement.</b> Before you continue, please read our new <a id="coid_website_privacyPolicyLinkOut" href="javascript:void(0)">Privacy Statement</a> and familiarize yourself with the terms.
		<button type="button" id="coid_website_privacyPolicyAcknowledged" title="Close message to acknowledge privacy statement" class="co_absolute">
			<span class="icon25 icon_close_x"></span>
		</button>
	</p>
</div>
		<div id="co_headerContainer">
			<div id="co_newHeader_top" class="headerContent" role="banner">
					<div class="skipButtonContainer"><a href="javascript:void(0);" data-jumpto="co_docHeaderTitle" class="co_tbButton skipButton">Skip to Document</a><a href="javascript:void(0);" data-jumpto="co_footerLinks" class="co_tbButton skipButton">Skip to Footer</a></div>
						<ul id="co_mainNav" class="co_inlineList" role="navigation">
							
														<li id="co_kmFirmNameContainer"></li>


	<li id="co_clientIdContainer" class="navigation_link co_menuListFirst"><div id="co_clientID_title_0" class="co_dropdownTabCollapsed"><span class="co_clientID_label" id="co_clientID_label_0">Client ID:</span><span></span></div><div id="co_clientID_list_0" class="co_clientID_list co_hideState" aria-hidden="true">

<div class="co_dropdownBoxExpanded">
	<div class="co_dropdownBoxHeader">
		<span></span>
	</div>
	<div class="co_dropdownBoxContent">
		<button id="co_clientID_close_0" class="co_overlayBox_closeButton" type="button">Close</button>
		<div class="co_dropdownBoxContentRight" id="co_clientID_content_0"></div>
	</div>
	<div class="co_dropdownBoxFooter">
		<span></span>
	</div>
</div></div></li>
									<li id="co_recentHistoryContainer"><div id="tabIndicator" class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel"><span class="icon"></span>History</a><button class="co_hasTooltip co_dropdownArrowCollapsed" title="Recent History Menu"><span class="th_simple_icon icon_down_arrow reversed"></span><span class="co_accessibilityLabel" aria-hidden="true" id="coid_dropdownAriaLabel_1">History Menu</span> </button></div></div><div class="co_dropdownBoxCollapsed" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_1"><span class="co_accessibilityLabel">Beginning of history window.</span><div class="co_dropdownBoxContent"><div class="co_recentResearch iac-a11y-header-redesign" id="co_recentResearch">
	<div class="co_recentDocuments co_floatLeft">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentDocumentsHeader">Recent Documents</h3>
			<a class="co_floatRight co_recentDocumentsAll" href="javascript:void(0);" id="co_recentDocumentsLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentDocumentsList" id="co_recentDocumentsList"></ul>
		</div>
	</div>
	<div class="co_recentSearches co_floatRight">
		<div class="co_globalNavDropdownBox_header">
			<h3 class="co_recentSearchesHeader">Recent Searches</h3>
			<a class="co_floatRight co_recentSearchesAll" href="javascript:void(0);" id="co_recentSearchesLink">View all</a>
		</div>
		<div class="co_scrollWrapper">
			<ul class="co_recentSearchesList" id="co_recentSearchesList"></ul>
		</div>
	</div>
	<div class="co_clear"></div>
</div></div><button class="co_overlayBox_closeButton" type="button" title="Close history menu">Close Recent History window</button><span class="co_accessibilityLabel">End of history window.</span></div></li>
								<li id="co_signOffContainer" class="">

									<div class="co_dropdownTabCollapsed">
										<div class="co_dropdownTab">
											<button id="coid_website_signOffRegion" class="co_dropdownBoxanchorLabel co_hasTooltip iac-a11y-header-redesign" title="Settings &amp; Sign Off">
												<span class="th_simple_icon icon_user reversed"></span>
												<span class="th_simple_icon icon_down_arrow reversed"></span>
												<span class="co_accessibilityLabel" aria-hidden="true">Settings &amp; Sign Off</span>
											</button>
										</div>
									</div>
									<div class="co_dropdownBoxCollapsed co_globalNavDropdownBox" aria-hidden="true" aria-labelledby="coid_dropdownAriaLabel_0"><span class="co_accessibilityLabel">Beginning of profile settings window.</span>
										<div class="co_globalNavDropdownBox_header">
											<h3 id="coid_dropdownAriaLabel_0">Profile Settings</h3>
										</div>
										<div class="co_globalNavDropdownBox_content">
											<div class="co_signOff_profile">
												<h4></h4>
												<ul>
													<li></li>
												</ul>
											</div>

											<div class="co_signOff_links">
												<ul>


	<li>
		<a id="coid_website_mycontent" href="/MyPlan/Show\?transitionType=Default&amp;contextData=(sc.Default)">My Content</a>
	</li>


													<li>
														<a id="coid_website_userSetting" href="javascript:void(0);">My Preferences</a>
													</li>
													<li>
														<a class="co_signOff_updateProfile" href="https://onepass.westlaw.com/v2/profile/general?productid=CBT&amp;viewproductid=&amp;returnto=1.next.westlaw.com">Update OnePass Profile</a>
													</li>
												</ul>

											</div>

											<div class="co_signOff_buttons">
												<div>
													<button type="button" class="co_primaryBtn js_website_signoff">Sign Off</button>
												</div>
											</div>
										</div>
									<button class="co_overlayBox_closeButton" type="button" title="Close profile menu">Close Profile Settings window</button><span class="co_accessibilityLabel">End of profile settings window.</span></div>

								</li>
						</ul>

			</div>
			<div id="co_newHeader_bottom" class="headerContent">







<div id="headerLogo" class="" data-compartment-start-page-id="">

	<a id="coid_website_logo" href="/?transitionType=Default&amp;contextData=(sc.Default)" tabindex="1" class="co_hasTooltip">
		<img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/logo.png" title="Westlaw Home">
		<span class="co_accessibilityLabel" aria-hidden="true">Westlaw Home</span>
	</a>
</div>







<div id="coid_website_searchWidget" style="display:none;"></div>
<div id="co_headerSearch" class="">
	<div id="co_searchWidgetInnerId" class="co_noAdvancedSearch">
		<form action="" onsubmit="return false;">
			<div id="co_searchFormLeft">
				<a href="javascript:void(0);" id="co_categorySearchButton">
					<span id="co_currentSelectedCategoryText">291 PATENTS</span>
					<span id="co_currentSelectedCategoryToggle" class="th_simple_icon icon_down_arrow co_hasTooltip">
						<span class="co_accessibilityLabel">Content Menu</span>
					</span>
				</a>
				<div class="co_dropdownBoxCollapsed" id="co_searchCategoryDropdown"><ul>  <li class="co_tabLeft" id="co_searchWidgetAllWestlawTab" title="Search All Content">    <div class="co_tabRight"><a href="#" onclick="return false;">All Content</a></div>  </li>  <li class="co_tabLeft co_hideState" id="co_searchWidgetCompartmentCustomTab" title="compartmentCustomTab">    <div id="compartmentCustomTabDivId" class="co_tabRight"><a title="Search " href="#" onclick="return false;">{compartmentCustomTabLinkText}</a></div>  </li>  <li class="co_tabActive co_tabLeft" id="co_searchWidgetCustomTab">    <div id="customTabDivId" class="co_tabRight"><a title="Search 291 PATENTS" href="#" onclick="return false;">291 PATENTS</a></div>  </li></ul>

				</div>
			</div>
			<div class="co_searchFormOuter">
				<div class="co_searchInputContainer" id="co_searchInputContainer">
					<div class="co_inputTop">
						<div class="co_inputTopRight"></div>
					</div>
					<div class="co_inputMidLeft">
						<div class="co_inputMidRight">
							<!-- Search text box -->
							<div class="co_textarea">
								<label id="searchInputIdLabel" for="searchInputId">Search:</label>
									<textarea style="" title="Search" name="searchInputId" aria-label="Westlaw Search. Search suggestions available after typing 3 characters. Use arrow keys to navigate suggestions." id="searchInputId" rows="1" spellcheck="false" autocorrect="off" autocapitalize="off" class="co_defaultInput"></textarea>
							</div>

							<!-- Medical litigator check box container -->
							<div id="co_medLitExpandedTerms" class="co_floatRight co_formInline"></div>



<!-- Recent search query toggle -->
<a id="co_searchLast10Link" class="th_simple_icon icon_down_arrow co_hasTooltip" href="#" onclick="return false;" title="Recent Searches Menu">
		<span class="co_accessibilityLabel">Recent Searches Menu</span>
</a>
						</div>
					</div>
					<div class="co_inputBottom">
						<div class="co_inputBottomRight"></div>
					</div>


<!-- Hold recent query drop down -->
<div id="co_recentQueryListBox" class="co_hideState">
	<ul class="co_searchSuggestionContainer" id="co_searchLast10List"></ul>
</div>
				<span role="application" id="searchBoxIndexSpan" style="display: none;"><p class="co_accessibilityLabel" id="co_resultsAvailable">Results are available, use up and down arrow keys to navigate</p><p class="co_accessibilityLabel" id="co_endOfList">End Of List</p><div id="co_typeAheadStatusAlert" aria-live="assertive" role="alert" aria-labelledby="co_resultsAvailable"></div><ul class="co_searchSuggestionContainer" aria-live="polite" aria-relevant="additions removals" id="co_searchSuggestion" style="display: none;" tabindex="-1"><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers_allcases" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_westlawanswers_elastic_westlawanswers" style="display:none"></li><li class="co_autoCompleteSection" id="coid_snapshotExactMatch_elastic_snapshots" style="display:none"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_case"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_docket"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_statute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_regulation"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_admindecision"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_analytical"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_pendingstatute"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_othercourtdocument"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_snapshots"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_static_questions_allcases"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_westlawanswers_it_depends_question"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_antitrust"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_arbitration"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_bankruptcy"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_capmarket_corpgovern"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_commtrans"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_corp_mna"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_empbenefits_excomp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_fedcivilpract"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_finance"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_inhousecounsel"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_intelprop_tech"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_labor_emp"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_realestate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_startup_smallbus"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointhier_trust_estate"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_practicallaw"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_forms"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepointpicks_secondarysrc"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_rulebooks"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicepoint_categorypage"></li><li class="co_autoCompleteSection" id="coid_autoCompleteSection_elastic_practicallaw"></li></ul></span></div>
			</div>
			<div id="co_searchFormRight">
				<div id="co_searchFormRightWrapper">
					<!-- Jurisdiction selected -->
					<div id="co_jurisdictionWidgetContainer" class="">

<a class="co_jurisdictionSelectorDropDownArrowCollapsed" href="javascript:void(0);" id="jurisdictionId">
    <span id="jurisdictionIdInner">Federal Circuit</span>
</a>
</div>
					<!-- Search button -->
					<button title="Search" id="searchButton" class="co_hasTooltip" aria-label="Search 291 PATENTS">


						Search Westlaw
						<span class="co_accessibilityLabel">Search 291 PATENTS</span>
					</button>
					<!-- Advanced search -->
					<a href="#" onclick="return false;" class="co_hideState" id="co_search_advancedSearchLink" title="Advanced Search">Advanced</a>
					<!-- Holder jurisdiction pop up -->
					<div id="co_searchJurisdictionHoverContainer"></div>
				</div>
			</div>
			<!-- Search error container -->
			<div id="co_searchInputErrorMessageContainer" class="co_hideState"></div>
		</form>
	</div>
</div>
						<div id="coid_website_searchWidget" class="co_hideState"></div>
						<div id="co_researchAcceleratorWrapper">
							
						</div>
						<div class="co_skipToLink">
							<a id="coid_website_startContent" name="coid_website_startContent"></a>
						</div>

			</div><!--newHeader_bottom-->
		</div><!--headerContainer-->
	</div><!--newHeader-->
</div><!--co_headerWrapper-->




	
	
<!-- moved delivery toolbar to separate ascx control -->	








	<div id="co_body">
		<!-- BODY HEADER -->
		<div id="co_bodyHeader"></div>
		

	
	<!-- Reporting Name is "CTA" for document with guid "I8757585ab8fa11e3a341ea44e5e1f25f". -->
	
	<!-- CENTER COLUMN -->  
	<div id="co_contentWrapper">
		<div id="co_contentColumn">
			<div class="co_innertube">










<div id="co_docHeaderContainer">
	<a class="co_skipToLink" href="#coid_website_errorsSummaryPlaceHolder">
		Skip Page Header
	</a>
	<div id="co_docHeader">
		<div id="co_docFixedHeader"><div id="co_docHeaderCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;transitionType=Document&amp;originationContext=docHeaderFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_docHeaderTitle"><h2 id="co_docHeaderTitleLine" title="Endo Pharmaceuticals Inc. v. Actavis, Inc."><span id="title"><a class="co_drag co_draggabled co_drag_0 ui-draggable" href="https://1.next.westlaw.com/Document/I8757585ab8fa11e3a341ea44e5e1f25f/View/FullText.html?listSource=Search&amp;navigationPath=Search%2fv1%2fresults%2fnavigation%2fi0ad6ad3d0000016305665c98a975de34%3fNav%3dCUSTOMDIGEST%26fragmentIdentifier%3dI8757585ab8fa11e3a341ea44e5e1f25f%26startIndex%3d1%26contextData%3d%2528sc.CustomDigest%2529%26transitionType%3dCustomDigestItem&amp;list=CUSTOMDIGEST&amp;rank=63&amp;listPageSource=3c84f03b3d51e9334632eab48e8663c5&amp;originationContext=docHeader&amp;contextData=(sc.CustomDigest)&amp;transitionType=Document&amp;needToInjectTerms=False&amp;enableBestPortion=True&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7">Endo Pharmaceuticals Inc. v. Actavis, Inc.</a></span></h2><ul id="co_documentStatusIcons" class="co_document_indicators"></ul><h3 id="co_docHeaderCitation" title="United States Court of Appeals, Federal Circuit. | March 31, 2014 | 746 F.3d 1371 | 110 U.S.P.Q.2d 1199&nbsp;(Approx. 17 pages)"><span id="courtline">United States Court of Appeals, Federal Circuit.</span><span id="filedate">March 31, 2014</span><span id="cite0">746 F.3d 1371</span><span id="cite1">110 U.S.P.Q.2d 1199</span><em>&nbsp;(Approx. 17 pages)</em></h3><h4 id="co_docHeaderNegativeTreatment"><span id="co_document_compositeHeader_citatorFlag" class="co_citatorFlag"></span></h4></div></div>
		<div class="co_clear"></div>
		<div id="co_docPrimaryTabNavigationContainer" class="co_docTabs">
				<a id="co_iPadKeyCiteMenuToggle">
					Toggle Menu
				</a>
			<ul id="co_docPrimaryTabNavigation" class="co_tabs">










<li id="DocumentTab" class="co_tabLeft co_tabActive co_dropdownTab">
	<h2 class="co_tabRight">
		<a id="coid_DocumentTab_link" class="co_tabLink" href="javascript:void(0);">
			<span>Document</span>
		</a>
				<div class="co_clear"></div> 
	</h2>
	</li>







<li id="riFilingsTab" class="co_tabLeft" countstatus="" categoryenum="riFilings">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_riFilings_link" class="co_tabLink" href="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/riFilings.html?originationContext=documentTab&amp;transitionType=Filings&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false">
			
			<span>
				Filings 
			 (13)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcNegativeTreatmentTab" class="co_tabLeft" countstatus="" categoryenum="kcNegativeTreatment">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcNegativeTreatment_link" class="co_tabLink" href="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcNegativeTreatment.html?originationContext=documentTab&amp;transitionType=NegativeTreatment&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false">
			
			<span>
				Negative Treatment 
			 (1)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcJudicialHistoryTab" class="co_tabLeft" countstatus="" categoryenum="kcJudicialHistory">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcJudicialHistory_link" class="co_tabLink" href="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcJudicialHistory.html?originationContext=documentTab&amp;transitionType=History&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false">
			
			<span>
				History 
			 (137)</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>







<li id="kcCitingReferencesTab" class="co_tabLeft co_dropdownTab" countstatus="" categoryenum="kcCitingReferences">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcCitingReferences_link" class="co_tabLink" href="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcCitingReferences.html?originationContext=documentTab&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false">
			
			<span>
				Citing References 
			 (78)</span>
		</a>





<span id="co_kcCitingReferencesNavAnchor" class="co_dropdownArrowCollapsed">Navigate Citing References</span>
		<div class="co_clear"></div> 
	</h2>
		<div id="co_kcCitingReferencesNavContent" class="co_dropdownBoxCollapsed" style="display:none;"></div>
</li>







<li id="kcTableOfAuthoritiesTab" class="co_tabLeft" countstatus="" categoryenum="kcTableOfAuthorities">
	<h2 class="co_tabRight">
		<a id="coid_relatedInfo_kcTableOfAuthorities_link" class="co_tabLink" href="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false" hiddenhref="/RelatedInformation/I8757585ab8fa11e3a341ea44e5e1f25f/kcTableOfAuthorities.html?originationContext=documentTab&amp;transitionType=TableOfAuthorities&amp;contextData=(sc.CustomDigest)&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;rulebookMode=false">
			
			<span>
				Table of Authorities 
			</span>
		</a>
		<div class="co_clear"></div> 
	</h2>
</li>




<li id="co_powByKCContainer">
	<a id="co_powByKC" href="javascript:void(0)">
		Powered by KeyCite
	</a>
</li>

			</ul>
		</div>
		<div class="co_clear"></div>
		<div id="co_docToolbarContainer" class="">
			<div id="co_docToolbar"><div><ul id="co_docToolbarMenuLeft"><li id="co_docToolbarBackToResults"><div id="co_documentFooterBreadcrumb"><a class="co_tbButton" href="/Search/Results.html?jurisdiction=CTAF&amp;saveJuris=False&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad6ad3d0000016305665c98a975de34&amp;startIndex=1&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad6ad3d0000016305665c98a975de34&amp;kmSearchIdRequested=False&amp;simpleSearch=False&amp;isAdvancedSearchTemplatePage=False&amp;skipSpellCheck=False&amp;isTrDiscoverSearch=False&amp;ancillaryChargesAccepted=False&amp;proviewEligible=False&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#I8757585ab8fa11e3a341ea44e5e1f25f"><span class="icon25 icon_back_arrow btnOffset"></span>Return to list</a></div></li><li id="co_docToolbarDocumentNavigation"><div id="co_documentFooterResultsNavigation" class="co_prevNextNavigation"><button title="Previous Document" id="co_documentFooterResultsNavigationPrevious" class="co_prev co_tbButton">
	                <span class="icon25 icon_prev_arrow">Previous Document</span>
                </button>
                <span class="co_navigationText"><strong>63</strong> of <strong>1,157 results</strong></span>
                <button title="Next Document" id="co_documentFooterResultsNavigationNext" class="co_next co_tbButton">
                    <span class="icon25 icon_next_arrow">Next Document</span>
                </button></div></li></ul><ul id="co_docToolbarMenuRight"><li id="co_docToolbarMenuRightChildWidget0" class="co_hideState"></li><li id="co_docHeaderSearchGrading"></li><li id="co_docToolbarGoTo"><div class="co_dropdownTabCollapsed"><div class="co_dropdownTab"><a href="javascript:void(0);" class="co_dropdownBoxanchorLabel" role="button">Go to</a><a href="javascript:void(0);" role="button" class="co_dropdownArrowCollapsed">Open Skip to Menu</a></div></div><div id="co_docGoToWidget" class="co_dropdownBoxCollapsed"><div class="co_dropdownBoxContent" id="co_skipTo"><div class="co_dropdownBoxContentRight"><div><div><a href="#co_synopsis">Synopsis</a></div><div><a href="#co_headnoteHeader">West Headnotes</a></div><div><a href="#co_attorneysAndLawFirms">Attorneys and Law Firms</a></div><div><a href="#co_opinion">Opinion</a></div><div><a href="#co_dissent_opinion">Dissenting Opinion</a></div><div><a href="#co_allCitations">All Citations</a></div></div></div></div><div id="co_starPage" class="co_dropdownBoxContent"><div class="co_dropdownBoxContentRight"><label for="co_document_starPage_starPageNavInput">Page #</label><input id="co_document_starPage_starPageNavInput" maxlength="6" size="6" type="text"><span id="co_document_starPage_starPageNavGo" class="co_primaryBtn">Go</span><div id="co_document_starPage_starPageNavError"></div><div class="co_clear"></div></div></div></div></li><li id="co_docToolbarTocNavigation"></li><li id="co_docToolbarTocFlyout"></li><li id="co_docToolbarMenuRightChildWidget5"></li><li id="co_docToolbarMenuRightChildWidget6"></li><li id="co_docToolbarMenuRightChildWidget7" class="co_toolbarSeparator"></li><li id="co_docToolbarSearchWithinDocument"><div id="co_docSearchWithinContainer"><a role="button" href="javascript:void(0);" class="co_dropdownTitle" title="Search text in this document">Search Within this Document</a>
<div id="co_docSearchWithinDropdownContainer">
	<div id="co_docSearchWithinDropdownContainerInner">
		<div id="co_docSearchWithinDropdownContainerInnerContent" class="co_dropdownBoxCollapsed">
			<!-- toggle between co_dropDownBoxCollapsed and co_dropdownBoxExpanded to show/hide -->
			<div class="co_dropdownBoxHeader">
				<span></span>
			</div>
			<div class="co_dropdownBoxContent">
				<div class="co_dropdownBoxContentRight">
					<div id="co_docSearchWithin_input">
						
<div id="co_docSearchWithin_searchInputContainer_withRecentSearch">
	<a id="co_searchLast10Link" class="co_recentSearchesLink" href="javascript:void(0);" title="Recent Searches">
		Last 10 Searches
	</a>
	<div class="co_textarea">
		<textarea id="co_docSearchWithin_searchInput_withRecentSearch" rows="1" autocorrect="off" autocapitalize="off" role="textbox" aria-label="Enter term to search for in current document"></textarea>
	</div>
	<div id="co_documentRecentQueryListBox" class="co_hideState"><ul class="co_searchSuggestionContainer" id="co_documentSearchLast10List"></ul></div>
</div>

						<input id="co_docSearchWithin_searchButton" class="co_secondaryBtn" value="Search" role="button" aria-label="Search Within this Document" type="button">
					</div>
					<div class="co_prevNextNavigation co_hideState">
						<button title="Previous Term" class="co_prev co_tbButton">
							<span class="icon25 icon_prev_arrow">Previous Term</span>
						</button>
						<button title="Next Term" class="co_next co_tbButton">
							<span class="icon25 icon_next_arrow">Next Term</span>
						</button>
						<span class="co_navigationText co_hideState"></span>
					</div>
					<button id="co_docSearchWithin_help" class="co_helpLink">Terms &amp;amp; Connectors</button>
					<button id="co_docSearchWithinCloseButton" class="co_widget_closeIcon">Close</button>
					<div id="co_docSearchWithinMessage"></div>
					<div class="co_clear"></div>
				</div>
				<div id="searchWithinTncContainer" class="co_hideState"><div id="co_search_advancedSearch_tncLegendBox">  <h2 id="co_search_advancedSearch_tncHelpTitle">Connectors and Expanders</h2>  <a id="co_search_advancedSearch_tncHelpLink" href="#" class="co_hideState">Help</a>  <dl id="co_search_advancedSearch_tncLegendList">    <dt>&amp;</dt><dd>AND</dd>    <dt>/s</dt><dd>In same sentence</dd>    <dt>or</dt><dd>OR</dd>    <dt>+s</dt><dd>Preceding within sentence</dd>    <dt>/p</dt><dd>In same paragraph</dd>    <dt>""</dt><dd>Phrase</dd>    <dt>+p</dt><dd>Preceding within paragraph</dd>    <dt>%</dt><dd>But not</dd>    <dt>/n</dt><dd>Within n terms of</dd>    <dt>!</dt><dd>Root expander</dd>    <dt>+n</dt><dd>Preceding within n terms of</dd>    <dt>*</dt><dd>Universal character</dd>    <dt>#</dt><dd>Prefix to turn off plurals and equivalents</dd>  </dl></div></div>
			</div>
			<div class="co_dropdownBoxFooter">
				<span></span>
			</div>
		</div>
	</div>
</div></div></li><li id="co_docToolbarDisplayOptions"><a role="button" id="co_displayOptionsLink" class="co_tbButton" href="javascript:void(0);" title="Display Options"><span class="icon25 icon_text_resize">Display Options</span></a></li><li id="co_docToolbarDeliveryWidget"><div id="deliveryWidget1" class="co_dropDownMenu collapsed"><div class="co_dropDownButton"><a role="button" id="deliveryLink1" title="Email" class="co_tbButton" href="javascript:void(0);"><span class="icon25 icon_email">Email</span></a><a href="javascript:void(0);" class="co_tbButton co_dropDownAnchor" role="button" id="deliveryDropButton1" aria-label="Delivery menu" title="Delivery menu" aria-describedby="navigation1"><span class="icon25 icon_down_blue_arrow"></span></a><span id="navigation1" class="co_accessibilityLabel">Enter to open, tab to navigate, enter to select</span></div><div id="deliveryWidgetMenu1" class="co_dropDownMenuContent" role="document"><ul class="co_dropDownMenuList checkmarks icons" role="listbox" aria-multiselectable="true" aria-hidden="false" aria-expanded="true"><li id="deliveryRow1Email" name="Email" role="presentation" class="checked"><a title="Email" id="deliveryLinkRow1Email" role="option" aria-posinset="1" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="true"><span class="icon25 icon_email"></span>Email</a></li><li id="deliveryRow1Print" name="Print" role="presentation"><a title="Print" id="deliveryLinkRow1Print" role="option" aria-posinset="2" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_print"></span>Print</a></li><li id="deliveryRow1Download" name="Download" role="presentation"><a title="Download" id="deliveryLinkRow1Download" role="option" aria-posinset="3" aria-setsize="3" class="co_deliveryLinkOptions" tabindex="0" aria-selected="false"><span class="icon25 icon_download"></span>Download</a></li></ul><div class="co_deliveryWidgetMenuFooter"></div></div><div id="co_deliveryWidget_Message1"></div></div></li><li id="co_docToolbarReadingModeWidget"><a role="button" id="co_fullscreenModeLink" class="co_tbButton" href="javascript:void(0);" title="Fullscreen Mode"><span class="icon25 icon_fullscreen">Fullscreen Mode</span></a></li></ul></div></div> 
			<div class="co_clear"></div>
		</div>
	</div>
</div>

				<div id="coid_website_errorsSummaryPlaceHolder"><div class="co_infoBox failure" style="display: none;"><div class="co_infoBox_container"><div class="co_infoBox_outer"><div class="co_infoBox_inner"><a id="co_website_errorSumarryCloseLink" class="co_infoBox_closeButton">Close</a><div class="co_infoBox_message" tabindex="-1">Sorry, there was an error on this page.<a href="javascript:void(0);" id="co_website_errorSummaryToggleLink">More info</a><a href="javascript:void(0);" id="co_website_errorSummaryToggleLinkLessInfo" style="display: none; margin-left: 6px;">Less info</a><ul class="co_website_errorsSummaryList" style="display: none;"></ul></div></div></div></div></div></div>
				<div id="coid_website_messagePlaceholder"></div>







				<div id="test_hplink"></div>
				<div class="co_scrollWrapper">





							<div id="coid_website_documentWidgetDiv" class=" co_khSpeedReadExpandAll">
<div id="co_briefItDiv" class="co_excludeAnnotations"><button id="co_briefItButton" class="co_primaryBtn co_floatRight">Brief It</button><div class="undefined"></div></div><div id="co_document" class="co_addFocusCorrection"><div id="co_document_0" class="co_document co_caselawNRS"><div id="co_readingModeKC" class="co_keyCiteFlagWidgetContainer co_excludeAnnotations"><div id="co_readingModeCitatorFlag"><span class="co_citatorFlag"><a href="https://1.next.westlaw.com/Link/RelatedInformation/Flag?documentGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;transitionType=Document&amp;originationContext=docHeaderSntTitleFlag&amp;contextData=(sc.CustomDigest)"><img class="crsw_DocumentIndicator" alt="KeyCite Yellow Flag - Negative Treatment" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/flag_yellow.png" title="KeyCite Yellow Flag - Negative Treatment"></a><span class="co_citatorFlagText">KeyCite Yellow Flag - Negative Treatment</span></span></div><div id="co_readingModeNegativeTreatment"><span id="NegativeTreatmentWidget_I8757585ab8fa11e3a341ea44e5e1f25f"><span class="co_snt_treatmentPhrase">Distinguished by </span><a href="https://1.next.westlaw.com/Document/Iaaecd330411711e7b69fcb5ae0fb9a47/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DIaaecd330411711e7b69fcb5ae0fb9a47%26ss%3D2032992124%26ds%3D2041724987&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29">Silver Buckle Mines, Inc. v. United States</a><span>, </span><span class="co_snt_courtLine">Fed.Cl., </span><span class="co_snt_dateFiled">May 23, 2017</span></span></div></div><input id="co_keyCiteFlagPlaceHolder" type="hidden"><input id="co_document_starPageMetadata" value="{ &quot;citations&quot;: { &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;:&quot;746 F.3d 1371&quot; }, &quot;pubs&quot;: { &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;:&quot;506&quot; } }" alt="metadata" type="hidden"><div><a href="https://1.next.westlaw.com/Link/Document/Blob/I285DE53C1DD211B2A50FC100220A7BAD/746_F.3d_1371.pdf?targetType=NRS&amp;originationContext=pagepdflink&amp;transitionType=DocumentImage&amp;uniqueId=8914a7b2-6905-4cd7-8c15-75ef792638be&amp;contextData=(sc.CustomDigest)" class="co_blobLink" type="application/pdf"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v1/co_pdf-icon.gif" class="co_pdfIcon" alt="PDF">​Original Image of 746 F.3d 1371 (PDF)</a></div><div class="co_cites">746 F.3d 1371</div><input id="co_document_paraNumbersSourceCiteMetadata" value="{ &quot;paraNumbersSourceCite&quot;: &quot;746 F.3d 1371&quot;, &quot;publicationNumber&quot;: &quot;506&quot; }" alt="metadata" type="hidden"><div class="co_contentBlock co_briefItState co_courtBlock"><div><div class="co_hAlign2">United States Court of Appeals,</div>Federal Circuit.</div></div><div class="co_title"><div class="co_suit"><div class="co_partyLine">ENDO PHARMACEUTICALS INC., Plaintiff–Appellant,</div><div>v.</div><div class="co_partyLine">ACTAVIS, INC. and <a id="co_link_I2745dd5ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Search/Results.html?query=advanced%3a+OAID(5038916382)&amp;saveJuris=False&amp;contentType=BUSINESS-INVESTIGATOR&amp;startIndex=1&amp;contextData=(sc.Default)&amp;categoryPageUrl=Home%2fCompanyInvestigator&amp;originationContext=document&amp;transitionType=DocumentItem">Actavis South Atlantic, LLC</a>, Defendants–Appellees.</div></div><div class="co_suit"><div class="co_partyLine">Endo Pharmaceuticals Inc., Plaintiff–Appellant,</div><div>v.</div><div class="co_partyLine">Roxane Laboratories, Inc., Defendant–Appellee.</div></div></div><div class="co_docketDate"><div class="co_contentBlock co_briefItState co_docketBlock"><span>Nos. 2013–1658, 2013–1662.</span></div><div class="co_date"><span>March 31, 2014.</span><span>Rehearing En Banc Denied June 3, 2014.</span></div></div><div class="co_contentBlock co_briefItState co_synopsis"><h2 id="co_synopsis" class="co_printHeading">Synopsis</h2><div><div class="co_paragraph"><div class="co_paragraphText"><strong>Background:</strong> Owner of patents directed to extended-release oxymorphone compositions and methods of treating pain using those compositions brought infringement action against manufacturers of generic drugs. Patentee moved for preliminary injunction to prohibit manufacturers from marketing and selling generic drug products during pendency of litigation. The United States District Court for the Southern District of New York, <a id="co_link_I2745dd5db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0251430101&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Thomas P. Griesa</a>, Senior District Judge, denied motion. Patentee appealed.</div></div></div><div class="co_contentBlock co_briefItState co_synopsisHolding"><div class="co_paragraph"><div class="co_paragraphText"><strong>Holdings:</strong> The Court of Appeals, <a id="co_link_I2745dd5eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0368246101&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Moore</a>, Circuit Judge, held that:</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F42032992124" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">1</a> manufacturers did not have express license to practice asserted patents, and</div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F52032992124" class="co_internalLink co_excludeAnnotations co_disableHighlightFeatures">2</a> patent owner was not estopped from bringing infringement claims.</div></div></div><div class="co_paragraph"><div class="co_paragraphText">Vacated and remanded.</div></div><div class="co_paragraph"><div class="co_paragraphText"><a id="co_link_I2745dd5fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0127930301&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Dyk</a>, Circuit Judge, filed an opinion dissenting in part.</div></div></div><div id="co_headnotes" class="co_headnotes co_fancyHeadnotes"><h2 id="co_headnoteHeader" class="co_headnoteHeader co_printHeading"><span class="co_headnoteHeaderSpan">West Headnotes (8)</span><a id="co_headnoteExpandCollapseLink" class="co_accLink co_excludeAnnotations co_disableHighlightFeatures" href="javascript:void(0);" role="button">Collapse West Headnotes</a></h2><div class="co_headnotesContentContainer"><div id="co_expandedHeadnotes"><div id="co_headnoteTools"><a id="co_headnotesShowOrHideFancy" href="javascript:void(0);" class="co_fancyHeadnotesShowHide co_excludeAnnotations co_disableHighlightFeatures">Change View</a></div><div class="co_headnoteRow" id="co_anchor_2032992124001"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F12032992124"><span class="co_headnoteNumber" id="co_anchor_headNote_1"><a href="#co_anchor_B12032992124" class="co_internalLink">1</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EPFAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Federal Courts</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E4HAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3616(2)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Preliminary injunction;  temporary restraining order</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Court of Appeals reviews decisions to grant or deny a preliminary injunction for an abuse of discretion, which may be established when a district court based its decision on an error of law.</div></div><div id="co_headnoteId_203299212400120150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EMIAC" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212400120150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 1"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd60b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170B/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170B</a></span><span class="co_headnoteTopicKey">Federal Courts</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd61b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII</a></span><span class="co_headnoteTopicKey">Courts of Appeals</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd62b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)</a></span><span class="co_headnoteTopicKey">Scope and Extent of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd63b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170BXVII(K)2/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170BXVII(K)2</a></span><span class="co_headnoteTopicKey">Standard of Review</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd64b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3612/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3612</a></span><span class="co_headnoteTopicKey">Remedial Matters</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd65b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3616/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3616</a></span><span class="co_headnoteTopicKey">Injunction</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd66b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/170Bk3616(2)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">170Bk3616(2)</a></span><span class="co_headnoteTopicKey">Preliminary injunction;  temporary restraining order</span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2032992124002"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F22032992124"><span class="co_headnoteNumber" id="co_anchor_headNote_2"><a href="#co_anchor_B22032992124" class="co_internalLink">2</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0E5IAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EVKAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k428/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Assignor, grantor, or licensor</a></span></div><div class="co_secondaryHeadnoteNodes"> <span class="co_hiddenKeyText"><strong><a id="co_link_ID0EKLAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EBNAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1487/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Implied license</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Whether legal estoppel has been created and whether an implied patent license exists are questions of law.</div></div><div id="co_headnoteId_203299212400220150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EWNAC" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212400220150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 2"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd67b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd68b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd69b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(A)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd6ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k424/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k424</a></span><span class="co_headnoteTopicKey">Estoppel to Dispute Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd6bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k428/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k428</a></span><span class="co_headnoteTopicKey">Assignor, grantor, or licensor</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k129(2))</span></span></div></div></div></div></div><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd6cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd6db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VI/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VI</a></span><span class="co_headnoteTopicKey">Patent Rights and Duties</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd6eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VI(D)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VI(D)</a></span><span class="co_headnoteTopicKey">Licenses and Royalties</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd6fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1484/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1484</a></span><span class="co_headnoteTopicKey">Requisites and Validity of Licenses</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd70b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1487/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1487</a></span><span class="co_headnoteTopicKey">Implied license</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k210)</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2032992124003"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F32032992124"><span class="co_headnoteNumber" id="co_anchor_headNote_3"><a href="#co_anchor_B32032992124" class="co_internalLink">3</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EIOAC" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EKAAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1817/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">License</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">The burden of proving that an implied license exists is on the party asserting an implied license as a defense to patent infringement.</div></div><div id="co_headnoteId_203299212400320150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E6AAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212400320150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 3"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">4 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd71b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd72b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII</a></span><span class="co_headnoteTopicKey">Patent Infringement</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd73b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)</a></span><span class="co_headnoteTopicKey">Actions</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd74b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VII(C)3/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VII(C)3</a></span><span class="co_headnoteTopicKey">Evidence</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd75b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1812/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1812</a></span><span class="co_headnoteTopicKey">Presumptions and Burden of Proof</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd76b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1817/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1817</a></span><span class="co_headnoteTopicKey">License</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k312(1.5))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2032992124004"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F42032992124"><span class="co_headnoteNumber" id="co_anchor_headNote_4"><a href="#co_anchor_B42032992124" class="co_internalLink">4</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ERBAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E1CAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1488/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Construction and Operation of Licenses</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Asserted patents directed to extended-release oxymorphone compositions and methods of treating pain using those compositions were not continuations, continuations-in-part, or divisionals of previously licensed patents, and thus manufacturers of generic drugs did not have express license to practice any of the patents asserted in infringement action under license agreement for other patents. <a id="co_link_I2745dd7cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 120</a>; <a id="co_link_I2745dd7db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000547&amp;cite=37CFRS1.78&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_4be3000003be5">37 C.F.R. § 1.78(d)(2)</a>.</div></div><div id="co_headnoteId_203299212400420150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0E4DAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212400420150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 4"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">4 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd77b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd78b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VI/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VI</a></span><span class="co_headnoteTopicKey">Patent Rights and Duties</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd79b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VI(D)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VI(D)</a></span><span class="co_headnoteTopicKey">Licenses and Royalties</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd7ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1488/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1488</a></span><span class="co_headnoteTopicKey">Construction and Operation of Licenses</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd7bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1489/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1489</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k211(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2032992124005"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F52032992124"><span class="co_headnoteNumber" id="co_anchor_headNote_5"><a href="#co_anchor_B52032992124" class="co_internalLink">5</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EBFAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EYGAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k428/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Assignor, grantor, or licensor</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Owner of patents directed to extended-release oxymorphone compositions and methods of treating pain using those compositions was not estopped from bringing infringement claims against manufacturers of generic drugs, although manufacturers had licenses to use other patents held by patentee; none of the asserted patents were continuation of any of the licensed patents, and license agreement contained explicit disclaimer of any other licenses not within literal terms of license agreement. <input id="co_docMarker_0" type="hidden"><a id="co_link_I2745dd83b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS154&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C.A. § 154</a>.</div></div><div id="co_headnoteId_203299212400520150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ENHAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212400520150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 5"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">3 </span>Cases that cite this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd7eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd7fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd80b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(A)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd81b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k424/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k424</a></span><span class="co_headnoteTopicKey">Estoppel to Dispute Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd82b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k428/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k428</a></span><span class="co_headnoteTopicKey">Assignor, grantor, or licensor</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k129(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2032992124006"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F62032992124" tabindex="0"><span class="co_headnoteNumber" id="co_anchor_headNote_6"><a href="#co_anchor_B62032992124" class="co_internalLink">6</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EIIAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0E6JAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k428/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Assignor, grantor, or licensor</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">The doctrine of legal estoppel refers to a narrow category of conduct encompassing scenarios where a patentee has licensed or assigned a right, received consideration, and then sought to derogate from the right granted.</div></div><div id="co_headnoteId_203299212400620150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EUKAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212400620150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 6"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">1 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd84b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd85b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II</a></span><span class="co_headnoteTopicKey">Patentability and Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd86b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291II(A)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291II(A)</a></span><span class="co_headnoteTopicKey">In General</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd87b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k424/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k424</a></span><span class="co_headnoteTopicKey">Estoppel to Dispute Validity</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd88b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k428/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k428</a></span><span class="co_headnoteTopicKey">Assignor, grantor, or licensor</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k129(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2032992124007"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_F72032992124"><span class="co_headnoteNumber" id="co_anchor_headNote_7"><a href="#co_anchor_B72032992124" class="co_internalLink">7</a></span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0EGLAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EPMAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1488/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Construction and Operation of Licenses</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText">Patent license agreements can be written to convey different scopes of promises not to sue, e.g., a promise not to sue under a specific patent or, more broadly, a promise not to sue under any patent the licensor now has or may acquire in the future.</div></div><div id="co_headnoteId_203299212400720150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0ESNAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212400720150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 7"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd89b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd8ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VI/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VI</a></span><span class="co_headnoteTopicKey">Patent Rights and Duties</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd8bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291VI(D)/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291VI(D)</a></span><span class="co_headnoteTopicKey">Licenses and Royalties</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd8cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1488/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1488</a></span><span class="co_headnoteTopicKey">Construction and Operation of Licenses</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd8db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k1489/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k1489</a></span><span class="co_headnoteTopicKey">In general</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k211(1))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div><div class="co_headnoteRow" id="co_anchor_2032992124501"><div class="co_headnoteCell"><div class="co_headnoteCellInner"><div class="co_primaryHeadnoteNodes"><span class="co_headnoteNumber co_excludeAnnotations co_disableHighlightFeatures" id="co_anchor_2032992124"><span class="co_headnoteNumber" id="co_anchor_headNote_8">8</span></span><span class="co_headnoteNode"><strong><a id="co_link_ID0ECOAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Patents</a></strong></span><div class="co_keyIcon co_excludeAnnotations co_disableHighlightFeatures"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Display Key Number Topics" title="Display Key Number Topics"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_popupHeadnote"></div></div></div></div></div><span class="co_lastKeyText"><a id="co_link_ID0EBPAE" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">In general;  utility</a></span></div> <div class="co_headnote"><div class="co_headnoteParagraph"><div class="co_paragraphText"><a id="co_link_I2745dd91b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997337711&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I348a3040745611d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 5,662,933</a>, <a id="co_link_I2745dd92b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999403460&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Iee15c440741811d7b433bc7aed88dbc8&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 5,958,456</a>, <a id="co_link_I2745dd93b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 7,276,250</a>, <a id="co_link_I2745dd94b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 7,851,482</a>, <a id="co_link_I2745dd95b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029183428&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I75808c302ddc11e285d282b694d913aa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 8,309,122</a>, <a id="co_link_I2745dd96b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">US Patent 8,329,216</a>. Cited.</div></div><div id="co_headnoteId_203299212450120150217141951" class="co_headnoteCitedCaseRef"><a id="co_link_ID0EWPAE" class="co_link co_excludeAnnotations co_disableHighlightFeatures co_hideState" href="https://1.next.westlaw.com/Link/RelatedInformation/DocHeadnoteLink?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;headnoteId=203299212450120150217141951&amp;originationContext=document&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;rank=63&amp;transitionType=CitingReferences&amp;contextData=(sc.CustomDigest)" title="Cases that cite headnote 8"><span class="co_citedRefCount co_excludeAnnotations co_disableHighlightFeatures">0 </span>Case that cites this headnote</a></div></div></div></div> <div class="co_headnoteTopicsCell"><div class="co_headnoteTopics co_excludeAnnotations co_disableHighlightFeatures"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/headnoteKey.png" class="co_headnoteKeyIcon" alt="Key Number Symbol" title="Key Number Symbol"><div class="co_fancyKeyciteContainerBottom"><div class="co_fancyKeyciteContainer"><div class="co_topicKeyContentTable"><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd8eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291</a></span><span class="co_headnoteTopicKey">Patents</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd8fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291X/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291X</a></span><span class="co_headnoteTopicKey">Patents Enumerated</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteRefNumber"><a id="co_link_I2745dd90b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Browse/Home/KeyNumber/291k2091/View.html?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">291k2091</a></span><span class="co_headnoteTopicKey">In general;  utility</span></div><div class="co_headnoteKeyPair"><span class="co_headnoteTopicKey"><span class="co_headnotePriorClassification">(Formerly 291k328(2))</span></span></div></div></div></div></div></div><div class="co_clear"></div></div></div></div><div> </div></div><a id="co_headnotesEnd"></a><h2 class="co_attorneyBlockLabel co_printHeading co_briefItState" id="co_attorneysAndLawFirms">Attorneys and Law Firms</h2><div class="co_contentBlock co_briefItState co_attorneyBlock"><div> <span class="co_starPage" id="co_pp_sp_506_1372"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1372&quot; }" alt="metadata" type="hidden">*1372</span> <a id="co_link_I2745dd97b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0126470501&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Martin J. Black</a>, Dechert LLP, of Philadelphia, PA, argued for plaintiff-appellant. With him on the brief were <a id="co_link_I2745dd98b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0182761201&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Robert D. Rhoad</a> and <a id="co_link_I2745dd99b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0380583801&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Jonathan D. Loeb</a>. Of counsel were <a id="co_link_I2745dd9ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0414385801&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Vincent August Gallo</a> and <a id="co_link_I2745dd9bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0352607301&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Joseph Raymond Heffern</a>.</div><div><a id="co_link_I2745dd9cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0148988601&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Charles A. Weiss</a>, Holland &amp; Knight LLP, of New York, NY, argued for defendants-appellees, Actavis, Inc., et al. With him on the brief were <a id="co_link_I2745dd9db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0378194201&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Eric H. Yecies</a> and <a id="co_link_I2745dd9eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0344789001&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Nicholas P. Chiara</a>.</div><div><a id="co_link_I2745dd9fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0232799301&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Alan B. Clement</a>, Locke Lord LLP, of New York, NY, argued for defendant-appellee, Roxane Laboratories, Inc. With him on the brief were <a id="co_link_I2745dda0b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0125123701&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Keith D. Parr</a>, <a id="co_link_I2745dda1b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0203653401&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Hugh S. Balsam</a>, and <a id="co_link_I2745dda2b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0414760701&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">Myoka Kim Goodin</a>, of Chicago, IL.</div></div><div class="co_contentBlock co_briefItState co_panelBlock"><div>Before <a id="co_link_I2745dda3b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0245882601&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">NEWMAN</a>, <a id="co_link_I2745dda4b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0127930301&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">DYK</a>, and <a id="co_link_I2745dda5b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0368246101&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MOORE</a>, Circuit Judges.</div></div><div class="co_contentBlock co_briefItState co_opinionBlock"><h2 id="co_opinion" class="co_printHeading">Opinion</h2><div class="co_docDelivery_dottedLine"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/co_docDelivery_dottedLine.png" alt=""></div><div class="co_contentBlock x_opinionBlockBody"><div class="co_contentBlock x_opinionLead"><div class="co_contentBlock x_leadAuthorLineBlock"><div class="co_contentBlock x_leadAuthorLine"><a id="co_link_I2745dda6b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0368246101&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MOORE</a>, Circuit Judge.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d8eb93511e498db8b09b4f043e0"><div class="co_paragraph"><div class="co_paragraphText">Endo Pharmaceuticals, Inc. (Endo) appeals from the district court's order denying its motions for a preliminary injunction to prevent Roxane Laboratories, Inc. (Roxane), Actavis Inc., and Actavis South Atlantic LLC (Actavis) from marketing and selling their respective generic drug products during the pendency of this litigation. Because the district court erred in concluding that Roxane and Actavis (Appellees) had an implied license to practice the asserted patents, and because Appellees do not have an express license, we <em>vacate</em> and <em>remand.</em></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d8fb93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">Background</span></div><div class="co_paragraph"><div class="co_paragraphText">Endo sells <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3">Opana</a>® ER, which are branded extended-release tablets containing a painkiller called <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3c672fd9475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3c672fd9475111db9765f9243f53508a">oxymorphone</a>. The asserted patents are listed in the Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) entry for <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_0">Opana</a>® ER. Two of the asserted patents, <a id="co_link_I2745ddaab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029183428&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I75808c302ddc11e285d282b694d913aa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Nos. 8,309,122 (the ′122 patent)</a> and <a id="co_link_I2745ddabb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">8,329,216 (the ′216 patent)</a>, are each continuations of the same parent application and are directed to extended-release <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=gdrug&amp;entityId=I3c672fd9475111db9765f9243f53508a&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I3c672fd9475111db9765f9243f53508a_0">oxymorphone</a> compositions and methods of treating pain using those compositions. The third patent-in-suit, <a id="co_link_I2745ddadb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 7,851,482 (the ′482 patent)</a>, is not related to the other two patents. It recites purified oxymorphone compositions and methods of making those compositions. The ′122 and ′<a id="co_link_I2745ddaeb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> are at issue in both appeals, and the ′<a id="co_link_I2745ddafb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a> is at issue only in the Actavis appeal.</div></div><div class="co_paragraph"><div class="co_paragraphText">Prior to this litigation, Endo sued Appellees for patent infringement under <input id="co_docMarker_1" type="hidden"><a id="co_link_I2745ddb0b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS271&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_9e660000185f2">35 U.S.C. § 271(e)(2)(A)</a> based on their Abbreviated New Drug Applications (ANDAs) to market generic versions of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_1">Opana</a>® ER-the same products as those at issue in these appeals. The first set of  <span class="co_starPage" id="co_pp_sp_506_1373"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1373&quot; }" alt="metadata" type="hidden">*1373</span> lawsuits settled after Endo granted to Appellees a license and a covenant not to sue. The settlement and license agreement between Endo and Roxane (Roxane Agreement) defines “Licensed Patents” as follows:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(a) any [U.S.] patents that are <em>both</em> (i) <em>now owned</em> by Endo ... and (ii) <em>issued as of the Effective Date of this Agreement,</em> including the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_2">Opana</a>® ER Patents,</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(b) <em>any [U.S.] patent applications that claim priority to the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_3">Opana</a>® ER Patents, including any continuation,</em> continuation-in-part and divisional <em>patent applications that claim priority to <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_4">Opana</a>® ER Patents,</em> and</div></div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText">(c) any patents resulting from the reissue or reexamination of patents or patent application of patents or patent applications comprised within clauses (a) and (b) ...</div></div><div class="co_paragraphText co_flush">J.A. in appeal no. 2013–1662 (Roxane J.A.), at 4973 § 1.16 (emphases added). The Roxane Agreement defines “<a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_5">Opana</a>® ER Patents” as <a id="co_link_I2745ddb6b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997337711&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I348a3040745611d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Nos. 5,662,933</a>, <a id="co_link_I2745ddb7b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999403460&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Iee15c440741811d7b433bc7aed88dbc8&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">5,958,456</a>, and <a id="co_link_I2745ddb8b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">7,276,250</a>. <em>Id.</em> § 1.20.</div></div><div class="co_paragraph"><div class="co_paragraphText">Pursuant to the agreement, Endo granted Roxane a covenant that it would not assert that Roxane's generic versions of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_6">Opana</a>® ER “infringe[ ] the <em>Licensed Patents</em> ” and a license “<em>under the Licensed Patents</em> ... to make, use, have made, sell, offer to sell, import and use” those generic products. Roxane J.A. 4978 §§ 4.1(a),(b) (emphases added); <em>see also</em> Roxane J.A. 4974 §§ 1.28, 1.29. Finally, the Roxane Agreement includes a “No Implied Rights” provision stating that Endo does not grant to Roxane any license or right “whether by implication, estoppel or otherwise, other than as expressly granted herein.” Roxane J.A. 4949 § 4.4. The settlement and license agreement between Endo and Actavis (Actavis Agreement) is similar. The Actavis Agreement includes a grant of a license, a covenant not to sue, and a “No Implied Rights” provision, but covers one additional patent not included in the Roxane Agreement and not relevant to this appeal. J.A. in appeal no. 2013–1658 (Actavis J.A.), at 4893–908.</div></div><div class="co_paragraph"><div class="co_paragraphText">The patents that are the subject of this litigation issued after Endo's agreements with Appellees. The ′122 and ′<a id="co_link_I2745ddbbb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> issued to Endo and the ′<a id="co_link_I2745ddbcb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a> was acquired by Endo. Endo again sued Appellees for patent infringement under <a id="co_link_I2745ddbdb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS271&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_9e660000185f2">35 U.S.C. § 271(e)(2)(A)</a> and moved for a preliminary injunction to prevent the marketing and sales of their generic oxymorphone formulations. Appellees opposed on the theories of express license and implied license by reason of legal estoppel. With regard to the latter, Appellees argued that Endo attempted to deprive them “of the benefit of [the] earlier bargain.” Roxane J.A. 4823; <em>see also</em> Actavis J.A. 2717.</div></div><div class="co_paragraph"><div class="co_paragraphText">At a joint hearing, the district court commented that “this is a highly unfair and unjust situation if ... infringement of the new patents would stop the marketing and permitting process that was going on by Actavis and Roxane.” Actavis J.A. 6411. The court held that “as a matter of law ... Endo is estopped from claiming that the activity of Actavis and Roxane, which has gone on for a substantial period of time, is now suddenly barred because of these new patents.” <em>Id.</em> The court therefore denied Endo's motions. <em>Endo Pharm., Inc. v. Actavis Inc.,</em> C.A. No. 12–cv–8985–TPG (S.D.N.Y. Sept. 18, 2013), ECF No. 35.</div></div><div class="co_paragraph"><div class="co_paragraphText">Endo appeals. We have jurisdiction under <a id="co_link_I2745ddc0b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=28USCAS1292&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_7b9b000044381">28 U.S.C. § 1292(a)(1)</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d90b93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">Discussion</span></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F12032992124" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF1">1</a><a id="co_anchor_B12032992124"></a><a href="#co_anchor_F22032992124" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF2">2</a><a id="co_anchor_B22032992124"></a><a href="#co_anchor_F32032992124" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF3">3</a><a id="co_anchor_B32032992124"></a> We review decisions to grant or deny a preliminary injunction for an abuse of discretion, which may be established <input id="co_docMarker_2" type="hidden"> <span class="co_starPage" id="co_pp_sp_506_1374"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1374&quot; }" alt="metadata" type="hidden">*1374</span> when a district court based its decision on an error of law. <a id="co_link_I2745ddc1b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2010878011&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1374&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1374"><em>Sanofi–Synthelabo v. Apotex, Inc.,</em> 470 F.3d 1368, 1374 (Fed.Cir.2006)</a>. “To the extent the court's decision is based upon an issue of law, we review that issue <em>de novo.</em>” <em>Id.</em> Whether legal estoppel has been created and whether an implied license exists are questions of law. <a id="co_link_I2745ddc3b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997024437&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1578&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1578"><em>Wang Labs., Inc. v. Mitsubishi Elecs. Am., Inc.,</em> 103 F.3d 1571, 1578, 1580 (Fed.Cir.1997)</a>. “The interpretation of a Settlement Agreement, <em>i.e.,</em> a contract, is a question of law that we [also] review <em>de novo.</em>” <a id="co_link_I2745ddc4b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999240223&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1370&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1370"><em>Augustine Med., Inc. v. Progressive Dynamics, Inc.,</em> 194 F.3d 1367, 1370 (Fed.Cir.1999)</a>. “The burden of proving that an implied license exists is on the party asserting an implied license as a defense to infringement.” <em>Id.</em></div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d91b93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2">I. Express License</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F42032992124" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF4">4</a><a id="co_anchor_B42032992124"></a> Endo argues that the district court abused its discretion in denying Endo's motions for a preliminary injunction. Endo contends that the plain language of the agreements, which limit “Licensed Patents” to several enumerated patents and applications claiming priority to them, does not grant Appellees an express license to practice the asserted patents. It argues that the “No Implied Rights” provision further makes clear that the agreements do not cover the asserted patents. In the district court, both Actavis and Roxane argued that they have an express license to practice these newly issued patents. In this appeal, Actavis no longer presents this argument, although Roxane continues to do so. The district court did not decide the question of express license, stating that “I do not feel, for the purposes of a preliminary injunction motion, that I am able to make any findings on the issues that I have just described.” Actavis J.A. 6438.</div></div><div class="co_paragraph"><div class="co_paragraphText">Roxane responds that the express terms of the settlement and license agreement grant it a license to practice the asserted patents because the previously licensed <a id="co_link_I2745ddc6b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 7,276,250 (′250 patent)</a> claims priority to U.S. Provisional Application No. 60/303,357 (′357 application), and the ′122 and ′<a id="co_link_I2745ddc7b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> also claim priority to that provisional application. It contends that the word “including” in § 1.16(b) of the Roxane Agreement shows that the agreement covers more than just continuation, continuation-in-part, and divisional applications that claim priority to the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_7">Opana</a>® ER Patents. Roxane argues that this section “necessarily embraces any patent applications that claim priority to any applications and provisional applications” to which the licensed patents likewise claim priority. Roxane Br. 29. It contends that Endo's interpretation reads out the word “including” and other license terms, and argues that the common provisional application teaches subject matter that “binds” the ′<a id="co_link_I2745ddc9b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a> to the asserted ′122 and ′<a id="co_link_I2745ddcab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">Roxane's express license arguments are meritless. Section 1.16(b) of the Roxane Agreement covers U.S. patent applications that “claim priority to the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_8">Opana</a>® ER Patents [<em>e.g.,</em> any of the licensed patents], including any continuation, continuation-in-part and divisional patent applications that claim priority to <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_9">Opana</a>® ER Patents.” Roxane J.A. 4973 § 1.16(b). There can be no dispute that the ′122 and ′<a id="co_link_I2745ddcdb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> are not continuations of any of the licensed patents.<sup id="co_footnoteReference_B00112032992124_ID0EJRAG"><a href="#co_footnote_B00112032992124" class="co_footnoteReference">1</a></sup> Likewise, there is no reasonable  <span class="co_starPage" id="co_pp_sp_506_1375"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1375&quot; }" alt="metadata" type="hidden">*1375</span> argument that the ′122 and ′<a id="co_link_I2745ddceb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> claim priority to any of the licensed patents. An application that claims priority to another patent must contain an express cross-reference to “a prior-filed nonprovisional application from which the patent issued.”<input id="co_docMarker_3" type="hidden"> <a id="co_link_I2745ddcfb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000547&amp;cite=37CFRS1.78&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_4be3000003be5">37 C.F.R. § 1.78(d)(2) (2013)</a>; <em>see</em> <a id="co_link_I2745ddd0b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS120&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 120 (2012)</a>; <a id="co_link_I2745ddd1b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2022335948&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1351&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1351"><em>Encyclopaedia Britannica, Inc. v. Alpine Elecs. of Am., Inc.,</em> 609 F.3d 1345, 1351 (Fed.Cir.2010)</a>. The ′216 and ′<a id="co_link_I2745ddd2b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029183428&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I75808c302ddc11e285d282b694d913aa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">122 patents</a>, however, do not cross-reference the applications that issued as any of the licensed patents. <em>See</em> ′<a id="co_link_I2745ddd3b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029183428&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I75808c302ddc11e285d282b694d913aa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">122 patent</a> col. 1 ll. 6–7; <a id="co_link_I2745ddd4b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">′216 patent</a> col. 1 ll. 6–7. Therefore, it is quite clear that the ′122 and ′<a id="co_link_I2745ddd5b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> do not “claim priority to” any of the licensed patents.</div></div><div class="co_paragraph"><div class="co_paragraphText">Roxane's argument that the word “including” somehow broadens what it means “to claim priority to” another patent is unpersuasive. The Roxane Agreement covers “any applications that claim priority to the [′<a id="co_link_I2745dde1b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>], including any continuation, continuation-in-part and divisional” patent applications. Roxane J.A. 4973. Claiming priority to a licensed patent is a prerequisite for the license, and “including” by no means eviscerates that requirement. There is no reading of this language that extends coverage to patents that merely have a provisional application in common with the licensed patents. The figure reproduced below, which is part of the record, shows this clearly. <em>See</em> Roxane J.A. 5232. The ′122 and ′<a id="co_link_I2745dde2b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> claim priority to the ′357 provisional application, and the ′<a id="co_link_I2745dde3b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a> claims priority to the ′357 application as well. The ′122 and ′<a id="co_link_I2745dde4b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> <em>do not</em> claim priority to the ′<a id="co_link_I2745dde5b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>. Although the language is clear on its face, the fact that Endo and Roxane considered including in their agreement a grant of a license to “any application <em>claiming a common priority date as</em> the licensed patents” reinforces this conclusion. Roxane J.A. 4864–65 (emphasis added). Because the ′122 and ′<a id="co_link_I2745dde6b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 216 patents</a> have a provisional application in common with the ′<a id="co_link_I2745dde7b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>, the “common priority date” language would have expressly covered the ′ 122 and ′<a id="co_link_I2745dde8b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>. <em>See</em> <a id="co_link_I2745dde9b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS119&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_06a60000dfdc6">35 U.S.C. § 119(e)(1) (2012)</a>. But that language does not appear in the final version of the Roxane Agreement.</div></div><div class="co_contentBlock x_figure" id="co_anchor_If01a7d92b93511e498db8b09b4f043e0"><div><div class="co_imageBlock"><a class="co_imageLink" type="image/x-png" href="https://1.next.westlaw.com/Link/Document/Blob/I4735d0f0b92311e3bbd4010000000000.png?originationContext=document&amp;transitionType=DocumentImage&amp;uniqueId=8914a7b2-6905-4cd7-8c15-75ef792638be&amp;contextData=(sc.CustomDigest)"><img alt="Image 1 within Endo Pharmaceuticals Inc. v. Actavis, Inc." src="https://1.next.westlaw.com/Link/Document/Blob/I4735d0f0b92311e3bbd4010000000000.png?maxHeight=585&amp;originationContext=document&amp;transitionType=DocumentImage&amp;uniqueId=8914a7b2-6905-4cd7-8c15-75ef792638be&amp;contextData=(sc.CustomDigest)" class="co_shrunkImage" width="810" height="585">​</a></div></div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1376"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1376&quot; }" alt="metadata" type="hidden">*1376</span> The Actavis Agreement likewise does not cover the ′122, ′216, and ′<a id="co_link_I2745ddeab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patents</a> at issue in the Actavis appeal. It contains the same “continuations, continuations-in-part or divisionals” language as the Roxane Agreement. <em>See</em> Actavis J.A. 4893, 4895, 4898. For the reasons discussed above, the asserted patents are not continuations, continuations-in-part, or divisionals of the licensed patents. <em>See</em> <a id="co_link_I2745ddebb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.06&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP §§ 201.06</a>–<a id="co_link_I2745ddecb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.08&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">.08</a>. Finally, the ′<a id="co_link_I2745ddedb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a> is completely unrelated to any of the previously licensed patents, and is likewise not covered by the agreement. We hold that Appellees do not have an express license to practice any of the patents asserted in this litigation.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d94b93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2">II. Implied License</div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F52032992124" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF5">5</a><a id="co_anchor_B52032992124"></a> Endo argues that the district court legally erred in concluding that Appellees are impliedly licensed to practice the asserted patents due to legal estoppel. It contends that the court's recognition of an implied license defense is incorrect. It argues that the specifications of the asserted patents are different from those of the previously licensed patents, and that the claims cover different subject matter. Endo points out that the previously licensed patent (the ′<a id="co_link_I2745ddeeb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>) that claims priority to the same provisional application as the ′122 and ′<a id="co_link_I2745ddefb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> was not even asserted in the previous litigation, and only added to the final settlement and license agreements because Endo realized that Appellees did not infringe it. Endo argues that, in contrast, the ′122 and ′<a id="co_link_I2745ddf0b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>—and the unrelated ′<a id="co_link_I2745ddf1b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 482 patent</a>—cover the accused generic tablets.<input id="co_docMarker_4" type="hidden"> Endo argues that the cases relied upon by Appellees regarding estoppel are distinguishable because they involved continuations and because the licenses in those cases included products as well as patents. Endo argues that, by ignoring the language of the agreements and the parties' intent, the district court's approach violates the sanctity of contract and thus implicates serious public policy concerns.</div></div><div class="co_paragraph"><div class="co_paragraphText">Appellees respond that they have an implied license to practice the asserted patents based on the principle that equity does not permit the licensor to detract from its grant of a property right. Appellees contend that Endo granted them a license to market their accused generic  <span class="co_starPage" id="co_pp_sp_506_1377"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1377&quot; }" alt="metadata" type="hidden">*1377</span> products for valuable consideration, that they relied on the license in going forward with the Food and Drug Administration approval of the ANDAs, and that Endo's later-obtained patents “eviscerated” the benefit of the licenses. Appellees argue that the “No Implied Rights” language in the agreements is not dispositive because estoppel “must override any such provision.” Roxane Br. 22; <em>see</em> Actavis Br. 29–30.</div></div><div class="co_paragraph"><div class="co_paragraphText">Appellees contend that the facts here are analogous to those in <em>TransCore, LP v. Electronic Transaction Consultants Corp.,</em> where we held that the patentee was legally estopped from bringing a second infringement action even though the earlier settlement agreement stated that it “shall not apply to any other patents.” <a id="co_link_I2745ddf3b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279">563 F.3d 1271, 1279 (Fed.Cir.2009)</a>. They argue that <em>TransCore</em> and related cases dictate that Endo cannot deprive Appellees of the benefit of the earlier bargain, and that nothing in the reasoning of <em>TransCore</em> limits its holding to continuations or even related applications. Appellees contend that the settlement and license agreements should be deemed as allowing them to make, use, and sell their generic tablets without threat of further lawsuits by Endo.</div></div><div class="co_paragraph"><div class="co_paragraphText">We hold that Appellees' broad reading of <em>TransCore</em> is incorrect and agree with Endo that the district court erred as a matter of law in finding legal estoppel in favor of Actavis and Roxane. We begin with the well-established proposition, recognized in <em>TransCore,</em> that a patent license does not convey to the licensee “an absolute right” to make, use, or sell a product “because not even the patentee ... is given that right.” <a id="co_link_I2745ddf8b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987111056&amp;pubNum=0000350&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_350_1081&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1081"><em>Spindelfabrik Suessen–Schurr, Stahlecker &amp; Grill GmbH v. Schubert &amp; Salzer Maschinenfabrik Aktiengesellschaft,</em> 829 F.2d 1075, 1081 (Fed.Cir.1987)</a> (quoted in <a id="co_link_I2745ddf9b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1275&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1275"><em>TransCore,</em> 563 F.3d at 1275–76).</a> The patentee's right “is merely one to exclude others from making, using or selling [the product covered by the licensed patent], <a id="co_link_I2745ddfab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS154&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=LQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">35 U.S.C. § 154</a>” and “the patentee ... and his licensee, when making, using, or selling [the product], can be subject to suit under other patents” when practicing the patented invention. <a id="co_link_I2745ddfbb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987111056&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F62032992124" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF6">6</a><a id="co_anchor_B62032992124"></a> The doctrine of legal estoppel does not nullify these general principles. Instead, it “refers to a <em>narrow category of conduct</em> encompassing scenarios where a patentee has licensed or assigned a right, received consideration, and then sought to derogate from the right granted.” <a id="co_link_I2745ddfcb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279"><em>TransCore,</em> 563 F.3d at 1279</a> (alteration omitted) (emphasis added). In <em>TransCore,</em> the patentee asserted a continuation patent that “was broader than, and necessary to practice” one of the patents included in a prior settlement agreement. <a id="co_link_I2745ddfeb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> We observed that the fact that the patentee “adopted its [licensed] patent infringement contentions as its contentions related to the [asserted] patent,” <a id="co_link_I2745ddffb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.,</em></a> provided undisputed evidence that the patentee <input id="co_docMarker_5" type="hidden">“sought to enforce the [asserted] patent in derogation of the rights it granted” under the prior agreement, <a id="co_link_I2745de00b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>id.</em> at 1279 n. 4.</a> Even though the agreement stated that it “shall not apply to other patents ... to be issued in the future,” we concluded that the patentee was legally estopped from asserting a patent whose claim scope fully encompassed that of the claims of one of the licensed patents. <a id="co_link_I2745de01b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1279.</a> We thus recognized that the asserted patent claims were broader than the licensed claims. To avoid a windfall to the licensee, we expressly limited the implied license to the scope of the licensed claims. <a id="co_link_I2745de02b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> (“[T]o obtain the benefit of its bargain with [the licensor], [the licensee] must be permitted to practice the [asserted patent] to the same extent it may practice the [licensed patents].”); <a id="co_link_I2745de03b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279"><em>id.</em> at 1279–80</a> (“[Licensee's] rights under its implied license to the [asserted patent] are necessarily <span class="co_starPage" id="co_pp_sp_506_1378"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1378&quot; }" alt="metadata" type="hidden">*1378</span>  coextensive with the rights it received in the ... license agreement.”).</div></div><div class="co_paragraph"><div class="co_paragraphText">Our subsequent cases confirm the limited scope of <em>TransCore.</em> In <em>General Protecht Group, Inc. v. Leviton Manufacturing Co., Inc.,</em> we found an implied license where the asserted patents had “[t]he same inventive subject matter [as that] disclosed in the licensed patents” and “[t]he same products were accused.” <a id="co_link_I2745de06b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1361&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1361">651 F.3d 1355, 1361 (Fed.Cir.2011)</a>. As in <em>TransCore,</em> the patents at issue in <em>General Protecht</em> were <em>continuations</em> of the licensed patents. <em>See </em><a id="co_link_I2745de09b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1360&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1360"><em>id.</em> at 1360</a> (quoting <a id="co_link_I2745de0ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279"><em>TransCore,</em> 563 F.3d at 1279–80).</a> We observed that “the newly asserted continuations are based on the same disclosure as the previously licensed patents and that, by definition, the continuations can claim no new inventions not already supported in the earlier issued patents.” <a id="co_link_I2745de0bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1361.</a> After explaining that <em>TransCore</em> “prohibits a patent licensor from derogating from rights granted under the license,” we held that “where ... <em>continuations issue from parent patents that previously have been licensed as to certain products,</em> it may be presumed that, absent a clear indication of mutual intent to the contrary, those products are impliedly licensed under the continuations as well.” <a id="co_link_I2745de0db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> (emphasis added). In <em>Intel Corp. v. Negotiated Data Solutions, Inc.,</em> we explained that <em>TransCore</em> and <em>General Protecht</em> “analyzed a licensee's rights when the patent holder received a <em>continuation patent</em> ” and “recognized that allowing the patent holder to sue on subsequent patents, when those later patents contain <em>the same inventive subject matter that was licensed,</em> risks derogating rights for which the licensee paid consideration.” <a id="co_link_I2745de11b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029450569&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1366&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1366">703 F.3d 1360, 1366 (Fed.Cir.2012)</a> (emphases added). Taken together, these cases stand for the rule that a license or a covenant not to sue enumerating specific patents may legally estop the patentee from asserting <em>continuations</em> of the licensed patents in the absence of mutual intent to the contrary. <em>See </em><a id="co_link_I2745de12b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1361&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1361"><em>Gen. Protecht,</em> 651 F.3d at 1361;</a> <a id="co_link_I2745de13b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279"><em>TransCore,</em> 563 F.3d at 1279.</a> We reject Appellees' invitation to expand the implied license doctrine. You get what you bargain for. And we will not use the implied license doctrine to insert ourselves into that bargain and rewrite the contract.</div></div><div class="co_paragraph"><div class="co_paragraphText">Endo is not estopped from asserting the patents at issue in these appeals because none of the asserted patents is a continuation of any of the licensed patents. The only familial relationship between the asserted and licensed patents is that the ′122 and ′<a id="co_link_I2745de14b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> claim priority to the same provisional application as the ′<a id="co_link_I2745de15b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>. That, however, does not make these patents continuations of the ′<input id="co_docMarker_6" type="hidden"><a id="co_link_I2745de16b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>. <em>See</em> <a id="co_link_I2745de17b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.07&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP § 201.07</a>. The ′<a id="co_link_I2745de18b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a> is not related to any of the licensed patents. The lack of a continuation relationship between any of the asserted and licensed patents and explicit disclaimer of any other licenses not within the literal terms of the contract are dispositive.</div></div><div class="co_paragraph"><div class="co_paragraphText">Appellees rely heavily on the general rule that “[t]he grantor is estopped from taking back in any extent that for which he has already received consideration.” Actavis Br. 27 (quoting <a id="co_link_I2745de19b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279"><em>TransCore,</em> 563 F.3d at 1279</a> (quoting <a id="co_link_I2745de1ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1968116336&amp;pubNum=0000350&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_350_452&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_452"><em>AMP Inc. v. United States,</em> 389 F.2d 448, 452 (Ct.Cl.1968)</a>)); <em>see also</em> Roxane Br. 20–21. But this rule does not apply to the cases before us because, unlike accused infringers in <em>TransCore</em> and <em>General Protecht,</em> Appellees seek to capture via implied license subject matter <em>in addition to that</em> for which they bargained. <em>AMP</em> is not to the contrary because the agreement at issue in that case gave the Government the license “to practice, and cause to be practiced ... throughout the world, each <em>Subject Invention</em> ”—rather than any specific patents. <a id="co_link_I2745de1eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1968116336&amp;pubNum=0000350&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_350_450&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_450">389 F.2d at 450, 454</a> (emphasis added). <em>AMP</em> made clear  <span class="co_starPage" id="co_pp_sp_506_1379"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1379&quot; }" alt="metadata" type="hidden">*1379</span> that “[t]he facet of this licensing agreement which is of crucial importance ... is that it licenses the Government to use an <em>idea</em> and not just the Byrem Patent itself.” <a id="co_link_I2745de20b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1968116336&amp;pubNum=0000350&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_350_454&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_454"><em>Id.</em> at 454</a> (emphasis in original). By asserting a newly acquired patent covering the licensed invention, AMP derogated from its grant, and the Court of Claims concluded that AMP's patent infringement suit was barred by legal estoppel “in order to protect the specific rights granted to the Government by contract.” <a id="co_link_I2745de21b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1968116336&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 454.</a></div></div><div class="co_paragraph"><div class="co_paragraphText"><a href="#co_anchor_F72032992124" class="co_internalLink co_headnoteLink co_excludeAnnotations co_disableHighlightFeatures" id="co_pp_HNF7">7</a><a id="co_anchor_B72032992124"></a> Here, rather than grant a license to an “idea,” Endo has granted to Appellees a license and covenant not to sue limited to specific patents and patent applications. If Appellees wanted to market and sell their accused generic products free from any threat of being sued by Endo for patent infringement, they could have negotiated for the appropriate language in the settlement and license agreements. As we observed in <em>Spindelfabrik,</em> “patent license agreements can be written to convey different scopes of promises not to sue, <em>e.g.,</em> a promise not to sue under a specific patent or, more broadly, a promise not to sue under any patent the licensor now has or may acquire in the future.” <a id="co_link_I2745de23b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1987111056&amp;pubNum=0000350&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_350_1081&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_350_1081">829 F.2d at 1081</a> (quoted in <a id="co_link_I2745de24b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1276&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1276"><em>TransCore,</em> 563 F.3d at 1276).</a> Having agreed to licenses that do not cover the patents at issue in these appeals, Appellees will not now be heard to complain.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d95b93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">Conclusion</span></div><div class="co_paragraph"><div class="co_paragraphText">We have considered the parties' remaining arguments and do not find them to be persuasive. We <em>vacate</em> the district court's denials of a preliminary injunction in both cases and <em>remand</em> for further proceedings.</div></div><div class="co_paragraph"><div class="co_paragraphText"><strong>VACATED AND REMANDED</strong></div></div></div></div><div class="co_contentBlock x_voteBlock"><div class="co_contentBlock x_voteLine">Opinion dissenting in part filed by Circuit Judge <a id="co_link_I2745de25b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0127930301&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">DYK</a>.</div></div></div></div></div><div class="co_contentBlock co_briefItState co_opinionBlock"><h2 id="co_dissent_opinion"></h2><div class="co_docDelivery_dottedLine"><img src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/co_docDelivery_dottedLine.png" alt=""></div><div class="co_contentBlock x_opinionBlockBody"><div class="co_contentBlock x_opinionDissent"><div class="co_contentBlock x_dissentAuthorLineBlock"><div class="co_contentBlock x_dissentAuthorLine"><a id="co_link_I2745de26b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=h&amp;pubNum=176284&amp;cite=0127930301&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RQ&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">DYK</a>, Circuit Judge, dissenting in part.</div></div><div class="co_contentBlock x_opinionBody"><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d9bb93511e498db8b09b4f043e0"><div class="co_paragraph"><div class="co_paragraphText">I agree with the majority that Roxane did not have an express or implied license to practice the ′122 and ′<a id="co_link_I2745de27b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>. Roxane was aware of Endo's applications for those patents at the time of the settlement with Endo, and the parties agreed not to include them in the settlement agreement. This, it seems to me, is inconsistent with an implied license. I also agree that Actavis does not have an implied license to the ′<a id="co_link_I2745de28b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a>, which Endo did not own at the time of the Actavis settlement agreement.</div></div><div class="co_paragraph"><div class="co_paragraphText">I part company with the majority on the question of whether Actavis has an implied license to the ′122 and ′<a id="co_link_I2745de29b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>. At the time of their settlement agreement, Endo owned those patent applications, which claimed priority to the same provisional application that provided priority to a patent covered by the settlement agreement (the ′<input id="co_docMarker_7" type="hidden"><a id="co_link_I2745de2ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>). During the settlement negotiations, Endo did not disclose the ′122 and ′<a id="co_link_I2745de2bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patent</a> applications, but rather licensed Actavis to produce the product at issue here. Furthermore, there are material differences between the Actavis and Roxane agreements and negotiations. Under these circumstances, I conclude that Actavis has an implied license to practice the ′122 and ′<a id="co_link_I2745de2cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> with respect to the product covered by the ANDA that was the subject of the settlement agreement. I respectfully dissent from the majority's contrary conclusion.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d9cb93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">I</span></div><div class="co_paragraph"><div class="co_paragraphText">Under the Hatch–Waxman Act, pharmaceutical manufacturers filing a New Drug Application (NDA) must list patents in the FDA's Orange Book that “could reasonably be asserted” against a competing generic producer. <a id="co_link_I2745de2db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=21USCAS355&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_3fed000053a85">21 U.S.C. § 355(b)(1)</a>; <a id="co_link_I2745de2eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000547&amp;cite=21CFRS314.53&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_b8cb00003f743">21 C.F.R. § 314.53(c)(2)(ii)</a>.  <span class="co_starPage" id="co_pp_sp_506_1380"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1380&quot; }" alt="metadata" type="hidden">*1380</span> Endo filed an NDA for a pain relief medication called Opana® ER on June 22, 2006 (NDA No. 21–610). Endo listed four patents covering the NDA product—the ′250, ′933, ′456, and ′ 143 patents—in the Orange Book. The FDA approved Endo's NDA.</div></div><div class="co_paragraph"><div class="co_paragraphText">On February 14, 2008, Actavis sent Endo notice that it had filed an Abbreviated New Drug Application (ANDA) seeking FDA approval to market a generic version of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_10">Opana</a>® ER, as did Roxane on December 21, 2009. After receiving these notices, Endo sued Actavis and Roxane (which had also filed a similar ANDA) in the United States District Court for the District of New Jersey, claiming that Actavis and Roxane's ANDA filings constituted an act of infringement. <em>See</em> <a id="co_link_I2745de31b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS271&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_9e660000185f2">35 U.S.C. § 271(e)(2)(A)</a>. Endo asserted only the ′<a id="co_link_I2745de32b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999403460&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Iee15c440741811d7b433bc7aed88dbc8&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">456 patent</a> in the complaint.</div></div><div class="co_paragraph"><div class="co_paragraphText">Before the litigation could proceed to trial, Endo entered into separate settlement and license agreements with Actavis in 2009 and Roxane in 2011, permitting these companies to sell generic versions of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_11">Opana</a>® ER pursuant to their ANDA filings. Sections 4.1(a) and (b) of Actavis's agreement with Endo granted Actavis a license to produce and sell generic versions of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_12">Opana</a>® ER under the ′<a id="co_link_I2745de35b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1999403460&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Iee15c440741811d7b433bc7aed88dbc8&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">456 patent</a> and specified that “Endo ... covenant[s] not to sue [<em>i.e.,</em> licenses] Actavis ... for infringement of ... the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_13">Opana</a>® ER Patents [<em>i.e.,</em> the ′250, ′933, and ′143 patents] based on the manufacture, use, import, sale or offer for sale of any <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_14">Opana</a>® ER Generic Products....” Actavis J.A. 3305. The Actavis agreement defined “<a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_15">Opana</a>® ER Generic Product” as “any product that is ... sold under the Actavis ANDA.” Actavis J.A. 3302. Sections 4.1(a) and (b) of Roxane's settlement agreement with Endo were similar.<sup id="co_footnoteReference_B00212032992124_ID0ECPAI"><a href="#co_footnote_B00212032992124" class="co_footnoteReference">1</a></sup> Both agreements also contained clauses stating: “Endo ... do[es] not grant to Actavis [or Roxane] ... any license, right or immunity, whether by implication, estoppel or otherwise, other than as expressly granted herein.” Actavis J.A. 3306; Roxane J.A. 4569. However, as I later discuss, Roxane's negotiation history and resulting agreement differed significantly in other respects from that of Actavis.</div></div><div class="co_paragraph"><div class="co_paragraphText">The FDA approved both Actavis's and Roxane's ANDAs, and those companies have been selling generic versions of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_16">Opana</a>® ER under their ANDAs since 2011.</div></div><div class="co_paragraph"><div class="co_paragraphText">At the time of the settlement agreements, Endo had pending patent applications for the ′122 and ′<a id="co_link_I2745de3bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>. This was disclosed to Roxane but not to Actavis. After Actavis and Roxane began to sell their generic versions of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_17">Opana</a>® ER pursuant to their settlement agreements, the PTO issued the ′122 and ′<a id="co_link_I2745de3db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> to Endo in November and December 2012, respectively. These patents cover <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I310428574f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I310428574f5611dca51ecfdfa1ed2cd3">Opana® ER's</a> active ingredient as well as its slow release method.<input id="co_docMarker_8" type="hidden"> <em>See</em> <a id="co_link_I2745de3fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029183428&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I75808c302ddc11e285d282b694d913aa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 8,309,122</a>; <a id="co_link_I2745de40b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 8,329,216</a>. Endo has now listed these new patents in the Orange Book as related to <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_18">Opana</a>® ER. The ′122 and ′<a id="co_link_I2745de42b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> claim priority to the same 2001 provisional application that gave priority to the ′<a id="co_link_I2745de43b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a> licensed under the settlement agreements.</div></div><div class="co_paragraph"><div class="co_paragraphText">In this case, Endo has sought to enjoin Actavis and Roxane's production of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_19">Opana</a>® ER generic products on the ground that such sales infringe the ′122 and ′<a id="co_link_I2745de45b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>. Thus, the question is whether, as the district court held, these companies have implied licenses to produce the disputed products under their settlement agreements with Endo.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d9db93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">II</span></div><div class="co_paragraph"><div class="co_paragraphText">In my view, the majority's holding that Actavis has no right to an implied license  <span class="co_starPage" id="co_pp_sp_506_1381"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1381&quot; }" alt="metadata" type="hidden">*1381</span> is inconsistent with our prior decisions in <a id="co_link_I2745de46b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>TransCore, LP v. Electronic Transaction Consultants Corp.,</em> 563 F.3d 1271 (Fed.Cir.2009)</a> and <a id="co_link_I2745de47b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>General Protecht Group, Inc. v. Leviton Manufacturing Co., Inc.,</em> 651 F.3d 1355 (Fed.Cir.2011)</a>. The majority reads these cases as standing for the proposition “that a license or a covenant not to sue enumerating specific patents may legally estop the patentee from asserting <em>continuations</em> of the licensed patents in the absence of mutual intent to the contrary.” Majority Op. at 1378. I think there is no meaningful distinction between the provisional patent relationship at issue in this appeal and the continuation patent relationships at issue in our earlier decisions.</div></div><div class="co_paragraph"><div class="co_paragraphText">The logic driving <em>TransCore</em> and <em>General Protecht</em> is rooted in a decision of our predecessor court, <a id="co_link_I2745de4ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1968116336&amp;pubNum=0000350&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>AMP Inc. v. United States,</em> 389 F.2d 448 (Ct.Cl.1968)</a>. Our predecessor court's decision in <em>AMP</em> recognized that a patentee may convey rights to future patents on that invention in licensing agreements even when the licensing agreement does not explicitly cover future patents on the same invention. <a id="co_link_I2745de4cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1968116336&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 454–56.</a> <em>TransCore</em> applied <em>AMP's</em> holding to a situation similar to the present appeals. <em>TransCore</em> held that a patentee cannot license existing patents to another party for the production of a specific product and then assert a newly acquired patent against that party to prevent it from producing the same product. <a id="co_link_I2745de50b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1278&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1278"><em>TransCore,</em> 563 F.3d at 1278–79.</a> As the majority accurately summarizes, the patentee in <em>TransCore,</em> after agreeing to license the product under existing patents, “asserted a continuation patent that ‘was ... necessary to practice’ one of the patents included in a prior settlement agreement.” Majority Op. at 1377 (quoting <a id="co_link_I2745de52b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279"><em>TransCore,</em> 563 F.3d at 1279).</a> Although the <em>TransCore</em> settlement agreement, similar to the settlement agreements at issue here, provided that “ ‘[t]his Covenant Not To Sue shall not apply to any other patents ... to be issued in the future,’ ” <a id="co_link_I2745de54b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1273&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1273">563 F.3d at 1273,</a> we held that “in order for [the licensee] to obtain the benefit of its bargain with TransCore, it must be permitted to practice the [new patent] to the same extent it may practice the [licensed] patents.” <a id="co_link_I2745de55b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1279.</a> We further explained that “[t]his language may protect TransCore against broad claims that future patents generally are impliedly licensed, but it does not permit TransCore to derogate from the rights it has expressly granted and thus does not preclude a finding of estoppel.” <a id="co_link_I2745de56b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> Thus, <em>TransCore</em> clarified that an explicit disclaimer of any other license not within the literal terms of the contract does not protect the patentee from an implied license when such a license is necessary to ensure the licensee obtains “the benefit of its bargain.” <a id="co_link_I2745de58b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a></div></div><div class="co_paragraph"><div class="co_paragraphText">Similarly, in <input id="co_docMarker_9" type="hidden"><em>General Protecht,</em> the patentee sued General Protecht for infringement of two patents, reached a license and settlement agreement with General Protecht allowing it to produce a defined product under the existing patents, and then, three years later, sued General Protecht again, alleging infringement of two new patents that issued after the settlement agreement. <a id="co_link_I2745de5ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1357&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1357"><em>Gen. Protecht,</em> 651 F.3d at 1357–58.</a> The patentee argued that <em>TransCore</em> “d[id] not control” its appeal because <em>TransCore</em> “is limited to cases where the claims of the continuation are broader than and therefore necessary to practice the claims of the expressly licensed patents.” <a id="co_link_I2745de5db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em> at 1361.</a> In response, this court reasoned that</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>[the patentee] cannot deny ... that the newly asserted continuations are based on the same disclosure as the previously licensed patents and that, by definition, the continuations can claim no new invention not already supported in the earlier issued patents. Moreover, the  <span class="co_starPage" id="co_pp_sp_506_1382"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1382&quot; }" alt="metadata" type="hidden">*1382</span> same products accused in the earlier suit are accused here. <em>TransCore</em> prohibits a patent licensor from derogating from rights granted under the license by taking back in any extent that for which it has already received consideration. In this case, [the patentee's] actions have unquestionably derogated from [General Protecht]' s rights under the Settlement Agreement. <em>The same products were accused. The same inventive subject matter was disclosed in the licensed patents. If [the patentee] did not intend its license of these products to extend to claims presented in continuation patents, it had an obligation to make that clear.</em></div></blockquote></div></div><div class="co_paragraphText co_flush"><a id="co_link_I2745de5fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Id.</em></a> (emphasis added) (internal quotation marks and citation omitted) (alteration in original omitted).</div></div><div class="co_paragraph"><div class="co_paragraphText">Here too, if Endo succeeds on its infringement allegations, Actavis will not be able to sell the very product for which it secured licenses in its settlement agreement. Although the ′122 and ′<a id="co_link_I2745de60b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> are not continuations of the licensed patents, as was the case in <em>TransCore</em> and <em>General Protecht,</em> the logic of those cases applies equally here. Under <a id="co_link_I2745de63b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS119&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_06a60000dfdc6">35 U.S.C. § 119(e)(1)</a>, a patent that claims priority to a provisional application must “have the same effect, as to such invention [the provisional invention], as though filed on the date of the provisional application.” <a id="co_link_I2745de64b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=L&amp;pubNum=1000546&amp;cite=35USCAS119&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RB&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_06a60000dfdc6">35 U.S.C. § 119(e)(1)</a>. Thus, as we have explained in the past, “ ‘[w]hat is claimed by the patent application [claiming priority to a provisional application] must be the same as what is disclosed in the [provisional] specification.’ ” <a id="co_link_I2745de65b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002475581&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1296&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1296"><em>New Railhead Mfg., L.L.C. v. Vermeer Mfg. Co.,</em> 298 F.3d 1290, 1296 (Fed.Cir.2002)</a> (quoting <a id="co_link_I2745de66b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2002330186&amp;pubNum=0000708&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"><em>Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.,</em> 535 U.S. 722, 122 S.Ct. 1831, 152 L.Ed.2d 944 (2002)</a>) (citing <a id="co_link_I2745de67b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997062584&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1572&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1572"><em>Lockwood v. Am. Airlines, Inc.,</em> 107 F.3d 1565, 1572 (Fed.Cir.1997)</a>); <em>see also </em><a id="co_link_I2745de68b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2021584873&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1342&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1342"><em>Ariad Pharms. Inc. v. Eli Lilly &amp; Co.,</em> 598 F.3d 1336, 1342 (Fed.Cir.2010)</a>. That is to say, a patent claiming priority to a provisional application must cover the same inventive subject matter as the provisional application.</div></div><div class="co_paragraph"><div class="co_paragraphText">Since the ′<a id="co_link_I2745de69b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a> (covered by the license agreements) and the ′ 122 and ′<a id="co_link_I2745de6ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patent</a> applications (subsequently issued) claim priority to the same provisional application and, thus, must cover the same inventive subject matter, the agreements confer an implied license to the two new patents absent contrary evidence. In other words, under our decisions in <em>TransCore</em> and <em>General Protecht,</em> the settlement agreements here created a presumption that the ′122 and ′<a id="co_link_I2745de6db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> were impliedly licensed to Actavis and Roxane, even though the only licenses explicitly mentioned in the settlement agreements were to the ′250, ′456, and ′<input id="co_docMarker_10" type="hidden"><a id="co_link_I2745de6eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997337711&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I348a3040745611d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patents</a>.</div></div></div><div class="co_contentBlock co_briefItState co_section" id="co_anchor_If01a7d9eb93511e498db8b09b4f043e0"><div class="co_headtext co_hAlign2"><span class="co_smallCaps">III</span></div><div class="co_paragraph"><div class="co_paragraphText">Nevertheless, I also think that the parties can agree to eliminate the presumption of implied licenses. Under our prior decisions, this cannot be accomplished simply by stating that the agreement does not extend to any patents beyond those listed in the agreement. <em>TransCore</em> and <em>General Protecht</em> rejected this very contention. <em>See </em><a id="co_link_I2745de71b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1362&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1362"><em>Gen. Protecht,</em> 651 F.3d at 1362–63;</a> <a id="co_link_I2745de72b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1279&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1279"><em>TransCore,</em> 563 F.3d at 1279.</a> Here, as to Roxane there is more. In the course of its negotiations with Endo, Roxane became aware of the ′122 and ′<a id="co_link_I2745de73b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patent</a> applications, sought to have these pending patents included in the agreement, and ultimately failed to secure a license to them. That history, it seems to me, is sufficient to negate an implied license. But the Actavis negotiations were different, having occurred two years before the Roxane agreement. The record contains no indication that the ′122 and ′<a id="co_link_I2745de74b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patent</a> applications <span class="co_starPage" id="co_pp_sp_506_1383"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1383&quot; }" alt="metadata" type="hidden">*1383</span>  were discussed during Actavis–Endo negotiations or that Actavis was even aware of Endo's applications for the ′122 and ′<a id="co_link_I2745de75b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">While the majority states that the language of the Actavis and Roxane agreements is “similar,” Majority Op. at 1373, there are, in fact, important differences. <em>Compare</em> Actavis J.A. 3300, 3302, 3305 <em>with</em> Roxane J.A. 4563, 4568. While both agreements provide an explicit license to produce generic versions of <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_20">Opana</a>® ER covered by Actavis's and Roxane's ANDAs under the ′ 250, ′456, and ′<a id="co_link_I2745de77b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997337711&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I348a3040745611d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patents</a>, clause (c) of the agreements is different. Clause (c) of the Actavis agreement reads:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>(c) For avoidance of doubt, and notwithstanding anything to the contrary in this Agreement, the License and Covenant Not to Sue do not grant to Actavis any rights or immunities with respect to any products <em>other than the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_21">Opana</a>® ER Generic Products,</em> including any combination products.</div></blockquote></div></div><div class="co_paragraphText co_flush">Actavis J.A. 3305 (emphasis added). Critically, the agreement defines “<a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_22">Opana</a>® ER Generic Products” as “<em>any product</em> that is marketed and/or sold under <em>the Actavis ANDA.</em>” Actavis J.A. 3302 (emphases added). Actavis sells the allegedly infringing product under the Actavis ANDA.</div></div><div class="co_paragraph"><div class="co_paragraphText">In contrast, clause (c) of the Roxane license agreement reads:</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>(c) ... the License and Covenant Not to Sue does not grant to Roxane any rights or immunities with respect to any products other than the Roxane Products or <em>with respect to any patents other than the Licensed Patents.</em></div></blockquote></div></div><div class="co_paragraphText co_flush">Roxane J.A. 4568 (emphasis added). The agreement defines “Licensed Patents” as</div><div class="co_paragraph co_indentLeft1"><div class="co_paragraphText"><blockquote><div>(a) any United States patents that are both (i) <em>now owned</em> by Endo ... and (ii) <em>issued as of the Effective Date of this Agreement,</em> including the Opana® ER Patents, (b) any United States patent applications that <em>claim priority to the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_23">Opana</a>® ER Patents,</em> including any continuation, continuation-in-part and divisional patent applications that claim priority to the <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_24">Opana</a>® ER Patents, and (c) any patents resulting from the reissue or reexamination of patents or parent applications comprised within clauses (a) and (b) above, in each case that Endo ... could assert would be infringing by the making, using, selling, offering to sell or importing of the Roxane Product.</div></blockquote></div></div><div class="co_paragraphText co_flush">Roxane J.A. 4563 (emphases added). Thus, while the Actavis license is only limited to “<em>any product</em> that is marketed and/or sold under the Actavis ANDA,” Actavis J.A. 3302 (emphasis added), the Roxane license specifies that it neither extends to any other “products” <em>nor</em> “to any patents <em>other than the Licensed Patents,</em>” Roxane J.A. 4568 (emphasis added), <em>i.e.,</em> the 250, ′456, and ′<a id="co_link_I2745de7cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997337711&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I348a3040745611d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patents<input id="co_docMarker_11" type="hidden"></a>. Thus, in subsection (c), the Actavis agreement does not limit the license to specific patents as the Roxane agreement does. A comparison of the two license agreements and the different negotiation histories suggests that Actavis could reasonably conclude it had negotiated a right to sell all <a href="https://1.next.westlaw.com/Link/Document/FullText?entityType=bdrug&amp;entityId=I2c349ed34f5611dca51ecfdfa1ed2cd3&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.Default)" class="co_link co_drag ui-draggable" id="co_link_I2c349ed34f5611dca51ecfdfa1ed2cd3_25">Opana</a>® ER generic products despite the interim issuance of the ′122 and ′<a id="co_link_I2745de7eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a>, not merely practice the patents expressly licensed.<sup id="co_footnoteReference_B00322032992124_ID0EHWBI"><a href="#co_footnote_B00322032992124" class="co_footnoteReference">2</a></sup></div></div><div class="co_paragraph"><div class="co_paragraphText"> <span class="co_starPage" id="co_pp_sp_506_1384"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1384&quot; }" alt="metadata" type="hidden">*1384</span> The majority concludes: “If Appellees wanted to market and sell their accused generic products free from any threat of being sued by Endo for patent infringement, they could have negotiated for the appropriate language in the settlement and license agreements.” Majority Op. at 1379. But under that theory, this court's precedent in <em>TransCore</em> and <em>General Protecht</em> would have been wrongly decided. An implied license is not foreclosed simply because the parties could have negotiated for an express license. Here, as in <em>General Protecht,</em> Actavis's agreement allowed it to produce and sell a defined product, and we should imply licenses to the new patents because “the same products accused in the earlier suit are accused here,” <a id="co_link_I2745de85b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1361&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1361"><em>Gen. Protecht,</em> 651 F.3d at 1361,</a> and the patents relate to the same inventive subject matter claimed in the provision application.</div></div><div class="co_paragraph"><div class="co_paragraphText">That the ′122 and ′<a id="co_link_I2745de86b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patent</a> applications were published at the time of the settlement negotiations should not affect this conclusion: in both <em>General Protecht</em> and <em>TransCore,</em> at least one of the new patents at issue was published as a pending application at the time of the settlement and licensing negotiations. <em>See </em><a id="co_link_I2745de89b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2025638336&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1357&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1357"><em>Gen. Protecht,</em> 651 F.3d at 1357–58</a> (the patentee and General Protecht entered into a licensing agreement in 2007, and then the patentee sued General Protecht for infringement of two new patents—<a id="co_link_I2745de8ab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017614758&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I8642602cc61611ddb77d9846f86fae5c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent Nos. 7,463,124</a> and <a id="co_link_I2745de8bb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2022615838&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I04ccafb29a1811df9d41aa3fcf7bbc6d&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">7,764,151</a>—in 2010); <a id="co_link_I2745de8cb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2017614758&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I8642602cc61611ddb77d9846f86fae5c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">U.S. Patent No. 7,463,124</a> (first published on March 24, 2005, and issued on December 9, 2008); <a id="co_link_I2745de8db93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2018560884&amp;pubNum=0000506&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=RP&amp;fi=co_pp_sp_506_1273&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_506_1273"><em>TransCore,</em> 563 F.3d at 1273–74</a>.</div></div><div class="co_paragraph"><div class="co_paragraphText">There is nothing unfair in granting an implied license in Actavis's favor. Although Actavis could have researched pending patent applications at the time of the settlement, placing the burden of disclosure on the party with greater access to information (here, Endo) increases the efficiency of the bargaining process. <em>See generally</em> Bruce L. Hay, <a id="co_link_I2745de8eb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=0104952596&amp;pubNum=0001458&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=LR&amp;fi=co_pp_sp_1458_31&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)#co_pp_sp_1458_31"><em>Effort, Information, Settlement, Trial,</em> 24 J. Legal Stud. 29, 31, 55–56, 62 (1995)</a>; Lucian Arye Bebchuk, <em>Suing Solely To Extract a Settlement Offer,</em> 17 J. Legal Stud. 437, 448 (1988); Lucian Arye Bebchuk, <em>Litigation and Settlement Under Imperfect Information,</em> 15 RAND J. Econ. 404, 414 (1984). Assigning this burden to the party with inferior access to information creates an incentive for the more knowledgeable party to hide information: the more informed party will not face repercussions for failing to disclose information, and, indeed, will benefit from such information asymmetries. <em>See generally</em> Bebchuk, <em>Suing Solely, </em><em>supra,</em> at 448; Bebchuk, <em>Litigation and Settlement, </em><em>supra,</em> at 414 (“[L]egal rules and institutions that magnify the extent to which an informational asymmetry is present might well increase the likelihood of litigation.”); Richard A. Posner, <em>An Economic Approach to Legal Procedure and Judicial Administration,</em> 2 J. Legal Stud. 339, 422–26 (1973). By creating incentives to hide and obscure important information in settlement negotiations, we undermine the purpose of the settlement process: the avoidance of further litigation.</div></div><div class="co_paragraph"><div class="co_paragraphText">I respectfully dissent.<input id="co_docMarker_12" type="hidden"></div></div></div></div></div></div></div><div class="co_parallelCites"><h2 id="co_allCitations" class="co_parallelCitesBlockLabel co_printHeading">All Citations</h2>746 F.3d 1371, 110 U.S.P.Q.2d 1199</div><div id="co_footnoteSection" class="co_footnoteSection co_briefItState"><h2 class="co_footnoteSectionTitle co_printHeading">Footnotes</h2><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1375&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00112032992124"><a href="#co_footnoteReference_B00112032992124_ID0EJRAG">1</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">We note that counsel for Actavis repeatedly argued to the district court that the ′122 and ′<a id="co_link_I2745ddd6b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> are continuations of the ′ <a id="co_link_I2745ddd7b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 250 patent</a> and are therefore expressly licensed. <em>See, e.g.,</em> Actavis J.A. 2716 (“Endo's ′<a id="co_link_I2745ddd8b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029183428&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I75808c302ddc11e285d282b694d913aa&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">122 patent</a> and ′<a id="co_link_I2745ddd9b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patent</a> are continuations of a patent called out by number as licensed in the 2009 settlement and license agreement.”). This is flatly wrong, and it is difficult to believe that this argument was made given what is required for an application to be a continuation. For example, to be called a “continuation” of a prior patent, a patent must make an express cross-reference to the nonprovisional application from which the prior patent issued. The continuation must also have the same disclosure as the prior patent. <em>See</em> Manual of Patent Examining Procedure (<a id="co_link_I2745dddab93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;pubNum=1015320&amp;cite=MPEPs201.07&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=TS&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">MPEP) § 201.07 (8th ed. Rev.9, Oct. 2012)</a>. The ′ 122 and ′<a id="co_link_I2745dddbb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">216 patents</a> do not have the same disclosure as the ′<a id="co_link_I2745dddcb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>, nor do they claim priority to the application that issued as the ′ <a id="co_link_I2745ddddb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 250 patent</a>. To be continuations of the ′<a id="co_link_I2745dddeb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>, the ′122 and ′ <a id="co_link_I2745dddfb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2029388466&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Id928cd3043ce11e2b93ceb40ed73d7b7&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)"> 216 patents</a> would have to, on their face, expressly indicate that they are continuations of the application that issued as the ′<a id="co_link_I2745dde0b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2013356643&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I9a1cee12710311dc8200d0063168b01f&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">250 patent</a>—unequivocally, they do not.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1380&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00212032992124"><a href="#co_footnoteReference_B00212032992124_ID0ECPAI">1</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">The Roxane agreement defined “Opana® ER Patents” as only the ′ 250, ′456, and ′<a id="co_link_I2745de39b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=1997337711&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=I348a3040745611d7a94bace56a9eba1c&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">933 patents</a> because the ′143 patent expired in 2008.</div></div></div></div><div><div class="co_footnoteNumber"><input class="co_starPageMetadataItem" value="{ &quot;pageset&quot;: &quot;Sc89f5d54da9b11e3a795ac035416da91&quot;, &quot;pageNumber&quot;: &quot;1383&quot; }" alt="metadata" type="hidden"><span id="co_footnote_B00322032992124"><a href="#co_footnoteReference_B00322032992124_ID0EHWBI">2</a></span></div><div class="co_footnoteBody"><div class="co_paragraph"><div class="co_paragraphText">With respect to the ′<a id="co_link_I2745de7fb93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a>, that patent does not claim priority to the provisional application, and the negotiating history does not suggest that Actavis could reasonably conclude that it had negotiated a license to all future patents that might be acquired by Endo relating to Opana® ER. Because the ′<a id="co_link_I2745de80b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a> issued to another company, Johnson Matthey, in 2010, was acquired by Endo in 2012, and does not claim priority to the provisional application, Actavis should not be treated as having an implied license to the ′<a id="co_link_I2745de81b93611e498db8b09b4f043e0" class="co_link" href="https://1.next.westlaw.com/Link/Document/FullText?findType=Y&amp;serNum=2024070670&amp;pubNum=0004074&amp;originatingDoc=I8757585ab8fa11e3a341ea44e5e1f25f&amp;refType=PA&amp;docFamilyGuid=Ide4bec8a07a911e09d9cae30585baa87&amp;originationContext=document&amp;transitionType=DocumentItem&amp;contextData=(sc.CustomDigest)">482 patent</a>. Neither Endo nor Actavis could have known that Endo might later acquire this patent.</div></div></div></div></div><table id="co_endOfDocument"><tbody><tr><td>End of Document</td><td class="co_endOfDocCopyright">© 2018 Thomson Reuters. No claim to original U.S. Government Works.</td></tr></tbody></table></div><input class="co_chunkNumber" value="0" type="hidden"><input id="co_finalChunkMarker" type="hidden"></div><input id="co_document_metaInfo_I8757585ab8fa11e3a341ea44e5e1f25f" value="{&quot;FirstLineCite&quot;:null,&quot;PU&quot;:null,&quot;accessControl&quot;:null,&quot;accessionNumber&quot;:&quot;&quot;,&quot;acquirerCompany&quot;:null,&quot;activeDate&quot;:null,&quot;additionalLinks&quot;:null,&quot;agreementDisplayDate&quot;:null,&quot;announcementDate&quot;:null,&quot;articleTitle&quot;:null,&quot;borrower&quot;:null,&quot;caseRequired&quot;:null,&quot;ciCompany&quot;:null,&quot;cicOfficer&quot;:null,&quot;cipOfficer&quot;:null,&quot;cite&quot;:&quot;746 F.3d 1371&quot;,&quot;citeAbbreviation&quot;:null,&quot;citePrimary&quot;:null,&quot;city&quot;:null,&quot;collection&quot;:&quot;w_cs_fed3&quot;,&quot;compoundTitle&quot;:null,&quot;containerId&quot;:null,&quot;containerType&quot;:null,&quot;contentType&quot;:&quot;Cases&quot;,&quot;contentTypeId&quot;:&quot;1&quot;,&quot;correlationIds&quot;:null,&quot;country&quot;:null,&quot;countryDocumentCountry&quot;:null,&quot;countryDocumentGuid&quot;:null,&quot;court&quot;:&quot;C.A.Fed. (N.Y.)&quot;,&quot;courtDocumentType&quot;:null,&quot;courtNumber&quot;:&quot;4242&quot;,&quot;courtYear&quot;:&quot;C.A.Fed. (N.Y.),2014.&quot;,&quot;date&quot;:&quot;March 31, 2014&quot;,&quot;dateFile&quot;:&quot;March 31, 2014&quot;,&quot;dealDate&quot;:null,&quot;dealTrackPublishDate&quot;:null,&quot;dealType&quot;:null,&quot;dealValue&quot;:null,&quot;description&quot;:null,&quot;docFamilyGuid&quot;:&quot;I8757585bb8fa11e3a341ea44e5e1f25f&quot;,&quot;docGuid&quot;:&quot;I8757585ab8fa11e3a341ea44e5e1f25f&quot;,&quot;docLink&quot;:&quot;https://1.next.westlaw.com/Document/I8757585ab8fa11e3a341ea44e5e1f25f/View/FullText.html?originationContext=document&amp;contextData=(sc.CustomDigest)&amp;needToInjectTerms=False&quot;,&quot;documentTitle&quot;:null,&quot;edgarFileNumber&quot;:null,&quot;entityId&quot;:null,&quot;expertType&quot;:null,&quot;fileName&quot;:null,&quot;fileNumber&quot;:&quot;&quot;,&quot;fileSize&quot;:0,&quot;fileType&quot;:null,&quot;filerCik&quot;:null,&quot;filerName&quot;:null,&quot;filingDate&quot;:null,&quot;filingYear&quot;:null,&quot;firmName&quot;:null,&quot;formNumber&quot;:null,&quot;formSubType&quot;:null,&quot;formType&quot;:null,&quot;formTypeDisplay&quot;:null,&quot;formVolume&quot;:null,&quot;functionalCite&quot;:&quot;746 F.3d 1371&quot;,&quot;fundFirmCompoundTitle&quot;:null,&quot;fundLocation&quot;:null,&quot;fundName&quot;:null,&quot;fundTargetSize&quot;:null,&quot;fundType&quot;:null,&quot;fundYear&quot;:null,&quot;fundraisingStatus&quot;:null,&quot;getTocData&quot;:false,&quot;hasDraftingNotes&quot;:null,&quot;hasVideoContent&quot;:null,&quot;impersonationKey&quot;:null,&quot;inlineKeyCiteFlagsIncluded&quot;:false,&quot;inlineKeyCiteFlagsResolutionStatus&quot;:null,&quot;insiderName&quot;:null,&quot;ip_assignmentsAction&quot;:null,&quot;ip_citeParallel&quot;:null,&quot;ip_derwentPublishedDate&quot;:null,&quot;ip_docket&quot;:null,&quot;ip_documentDate&quot;:&quot;March 31, 2014&quot;,&quot;ip_issuedDate&quot;:null,&quot;ip_litAlertAttorney&quot;:null,&quot;ip_patStatCode&quot;:null,&quot;ip_patentOwner&quot;:null,&quot;ip_publishedDate&quot;:null,&quot;ip_shortTitle&quot;:null,&quot;isDisplayMiniReport&quot;:false,&quot;isGatewayDocument&quot;:false,&quot;isLargeDocument&quot;:false,&quot;isPersistedContent&quot;:false,&quot;isPublicRecordsBlockedByPermissibleUse&quot;:false,&quot;isPublicRecordsBlockedBySocialSecurityAdmin&quot;:false,&quot;isPublicRecordsDocument&quot;:false,&quot;isRefsAndAnnos&quot;:false,&quot;isRegChangeDocument&quot;:false,&quot;isSearchable&quot;:null,&quot;isSecureContent&quot;:false,&quot;issueDate&quot;:null,&quot;issuerName&quot;:null,&quot;jobDescription&quot;:null,&quot;judge&quot;:&quot;MOORE, Circuit Judge.&quot;,&quot;jurisAbbrev&quot;:null,&quot;jurisdiction&quot;:&quot;NY&quot;,&quot;jurisdictionFacet&quot;:&quot;Federal|**|Cts. of Appeals|**|Federal Cir.&quot;,&quot;jurisdictionText&quot;:&quot;New York&quot;,&quot;knos&quot;:null,&quot;lastRoundExitComb&quot;:null,&quot;legacyId&quot;:&quot;2032992124&quot;,&quot;letterType&quot;:null,&quot;locationOfIncorporation&quot;:null,&quot;maxOfferingPrice&quot;:null,&quot;natureOfTransaction&quot;:null,&quot;newsImageHrefLarge&quot;:null,&quot;newsImageHrefSmall&quot;:null,&quot;normalizedDocType&quot;:null,&quot;normalizedFormType&quot;:null,&quot;offeringType&quot;:null,&quot;organizationName&quot;:null,&quot;originatingDoc&quot;:null,&quot;pageCount&quot;:null,&quot;persistedDocGuid&quot;:null,&quot;plcFirmStyleAvailable&quot;:false,&quot;plcResourceName&quot;:&quot;&quot;,&quot;portfolioCompanyLocation&quot;:null,&quot;portfolioCompanyName&quot;:null,&quot;prMetaInfo1&quot;:null,&quot;prMetaInfo2&quot;:null,&quot;prMetaInfo3&quot;:null,&quot;prMetaInfo4&quot;:null,&quot;prMetaInfo5&quot;:null,&quot;primaryEditorialService&quot;:null,&quot;profileType&quot;:null,&quot;pubSeries&quot;:null,&quot;publishDate&quot;:null,&quot;questionText&quot;:null,&quot;redlined&quot;:false,&quot;registrationDate&quot;:null,&quot;renditionId&quot;:&quot;I285DE53C1DD211B2A50FC100220A7BAD&quot;,&quot;royaltyId&quot;:&quot;0&quot;,&quot;rulebookNViews&quot;:null,&quot;serialNumber&quot;:&quot;2032992124&quot;,&quot;status&quot;:null,&quot;subContentType&quot;:&quot;Caselaw - NRS&quot;,&quot;subContentTypeId&quot;:&quot;27&quot;,&quot;subTitle&quot;:null,&quot;targetCompany&quot;:null,&quot;testimonyType&quot;:null,&quot;titleHtml&quot;:&quot;Endo Pharmaceuticals Inc. v. Actavis, Inc.&quot;,&quot;titleText&quot;:&quot;Endo Pharmaceuticals Inc. v. Actavis, Inc.&quot;,&quot;totalAmountIssuedWithCurrency&quot;:null,&quot;totalPages&quot;:&quot;&quot;,&quot;trademarkStatus&quot;:null,&quot;transactionAmountWithCurrency&quot;:null,&quot;transactionValue&quot;:null,&quot;valuationComb&quot;:null,&quot;viewExpressions&quot;:&quot;EZ5|E3I|000&quot;,&quot;westlawDatabaseIdentifier&quot;:&quot;AWFED2&quot;,&quot;westlawDocumentNumber&quot;:&quot;1017908&quot;}" type="hidden"><input id="co_document_documentNavigation_Search_Search-v1-results-navigation-i0ad6ad3d0000016305665c98a975de34-Nav-CUSTOMDIGEST-fragmentIdentifier-I8757585ab8fa11e3a341ea44e5e1f25f-startIndex-1-contextData--28sc.CustomDigest-29-transitionType-CustomDigestItem_CUSTOMDIGEST_63" value="{&quot;AnswerSnippetId&quot;:null,&quot;CurrentDocumentGuid&quot;:&quot;I8757585ab8fa11e3a341ea44e5e1f25f&quot;,&quot;CurrentPosition&quot;:63,&quot;CurrentWatsonAnswerText&quot;:null,&quot;EnableConceptCounts&quot;:false,&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;InPlanUrl&quot;:null,&quot;IsSnapSnippet&quot;:false,&quot;ListCount&quot;:1157,&quot;Message&quot;:null,&quot;NextDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Semiconductor Energy Laboratory Co., Ltd. v. Nagata&quot;,&quot;Url&quot;:&quot;/Document/I155f0087744111e28a21ccb9036b2470/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad6ad3d0000016305665c98a975de34%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DI155f0087744111e28a21ccb9036b2470%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=64&amp;grading=na&amp;sessionScopeId=d20233481a5f0dfb615a8630219cd8b243c1c2e74fb3160800e76f7896b305b7&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=3c84f03b3d51e9334632eab48e8663c5#co_anchor_F52029830905&quot;},&quot;NovusQueryType&quot;:null,&quot;NovusSearchResult&quot;:null,&quot;NumberOfSnips&quot;:0,&quot;ParagraphId&quot;:null,&quot;PreviousDocument&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;Endo Pharmaceuticals Inc. v. Actavis, Inc.&quot;,&quot;Url&quot;:&quot;/Document/I8757585ab8fa11e3a341ea44e5e1f25f/View/FullText.html?navigationPath=Search%2Fv1%2Fresults%2Fnavigation%2Fi0ad6ad3d0000016305665c98a975de34%3FNav%3DCUSTOMDIGEST%26fragmentIdentifier%3DI8757585ab8fa11e3a341ea44e5e1f25f%26startIndex%3D1%26contextData%3D%2528sc.CustomDigest%2529%26transitionType%3DCustomDigestItem&amp;listSource=Search&amp;list=CUSTOMDIGEST&amp;rank=62&amp;grading=na&amp;sessionScopeId=d20233481a5f0dfb615a8630219cd8b243c1c2e74fb3160800e76f7896b305b7&amp;originationContext=Custom%20Digest&amp;transitionType=CustomDigestItem&amp;contextData=%28sc.CustomDigest%29&amp;listPageSource=3c84f03b3d51e9334632eab48e8663c5#co_anchor_F52032992124&quot;},&quot;ReturnTo&quot;:{&quot;SkipLinkOutDoc&quot;:false,&quot;Title&quot;:&quot;list&quot;,&quot;Url&quot;:&quot;/Search/Results.html?jurisdiction=CTAF&amp;saveJuris=False&amp;contentType=CUSTOMDIGEST&amp;querySubmissionGuid=i0ad6ad3d0000016305665c98a975de34&amp;startIndex=1&amp;tocGuid=I4aee2539c6f64c1812a4c2f3395c2607&amp;categoryPageUrl=Home%2FWestKeyNumberSystem&amp;searchId=i0ad6ad3d0000016305665c98a975de34&amp;kmSearchIdRequested=False&amp;simpleSearch=False&amp;isAdvancedSearchTemplatePage=False&amp;skipSpellCheck=False&amp;isTrDiscoverSearch=False&amp;ancillaryChargesAccepted=False&amp;proviewEligible=False&amp;transitionType=ReturnToList&amp;contextData=%28sc.CustomDigest%29#I8757585ab8fa11e3a341ea44e5e1f25f&quot;},&quot;SearchQuery&quot;:null,&quot;SearchQueryType&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null,&quot;ShowSkipOutOfPlanOption&quot;:false}" type="hidden"><div id="co_nrsOutline" class="co_hideState"></div><input id="co_documentContentCacheKey" value="WestlawNext|none|I8757585ab8fa11e3a341ea44e5e1f25f|||||||Search|Search/v1/results/navigation/i0ad6ad3d0000016305665c98a975de34?Nav=CUSTOMDIGEST&amp;fragmentIdentifier=I8757585ab8fa11e3a341ea44e5e1f25f&amp;startIndex=1&amp;contextData=%28sc.CustomDigest%29&amp;transitionType=CustomDigestItem|CUSTOMDIGEST|63|False|True|{&quot;HighlightPoints&quot;:null,&quot;HighlightTerms&quot;:null,&quot;SearchWithinQuery&quot;:null,&quot;SecondaryHighlightTerms&quot;:null}|False|||False|False|||True|S|False|Core|||001|False|False|False|False|False|" type="hidden"><input id="co_documentFlagInfo" value="{&quot;docGuid&quot;:&quot;I8757585ab8fa11e3a341ea44e5e1f25f&quot;,&quot;flags&quot;:[{&quot;categoryId&quot;:&quot;kcJudicialHistory&quot;,&quot;id&quot;:&quot;negative.indirect.history.mild&quot;,&quot;link&quot;:&quot;https://1.next.westlaw.com/Link/RelatedInformation/Flag?docGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;originationContext=docHeaderFlag&amp;transitionType=Document&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;metadata&quot;:{&quot;court&quot;:&quot;Fed.Cl.&quot;,&quot;docFamilyGuid&quot;:&quot;Iabda8e90411711e7ab98e98fcbfccded&quot;,&quot;docGuid&quot;:&quot;Iaaecd330411711e7b69fcb5ae0fb9a47&quot;,&quot;liveDate&quot;:&quot;May 23, 2017&quot;,&quot;title&quot;:&quot;Silver Buckle Mines, Inc. v. United States&quot;,&quot;titleLink&quot;:&quot;https://1.next.westlaw.com/Document/Iaaecd330411711e7b69fcb5ae0fb9a47/View/FullText.html?navigationPath=RelatedInfo%2Fv4%2Fkeycite%2Fnav%2F%3Fguid%3DIaaecd330411711e7b69fcb5ae0fb9a47%26ss%3D2032992124%26ds%3D2041724987&amp;listSource=RelatedInfo&amp;list=NegativeCitingReferences&amp;rank=0&amp;originationContext=docHeader&amp;transitionType=NegativeTreatment&amp;contextData=%28sc.CustomDigest%29&quot;,&quot;treatmentPhrase&quot;:&quot;Distinguished by&quot;},&quot;type&quot;:&quot;negative.indirect.history&quot;,&quot;value&quot;:&quot;mild&quot;}],&quot;metas&quot;:[{&quot;contentType&quot;:&quot;CASELAW&quot;,&quot;docCollection&quot;:&quot;w_cs_fed3&quot;,&quot;docFamilyGuid&quot;:&quot;I8757585bb8fa11e3a341ea44e5e1f25f&quot;,&quot;legacyId&quot;:&quot;2032992124&quot;,&quot;sourcePubId&quot;:&quot;506&quot;}]}" type="hidden">




							</div>

				</div>
			</div>
		</div>
	</div>
	<!-- LEFT COLUMN -->  
	<div id="co_leftColumn">
		<div class="co_innertube">
			<div id="coid_website_folderingWidgetDiv"></div>
		</div>
	</div>
			<!-- RIGHT COLUMN -->
			<div id="co_rightColumn" class="co_addFocusCorrection">
				<div class="co_innertube">		
					<div id="coid_website_relatedInfoIPWidgetDiv" style="display: none;" aria-expanded="false">
					</div>




<div id="coid_website_documentToolWidgetDiv"></div>
		<div id="coid_website_relatedInfoWidgetDiv"> <div class="co_genericBox co_relatedinfo_topic_container" id="co_relatedinfo_topic_container"> <h3 class="co_genericBoxHeader"><span><strong>Selected</strong> Topics</span></h3><div class="co_genericBoxContent"><ul><li class="co_relatedInfo_topic_item">Construction and Operation of Licenses</li><li><ul class="co_relatedInfo_topic_itemList"><li class="co_relatedInfo_topic_item" id="co_relatedInfo_topic_item_d813e141c05b54687bbadecbac0016eba"><div id="co_relatedInfo_topics_topic_d813e141c05b54687bbadecbac0016eba" class="co_relatedInfo_topics_topic"><a id="co_relatedInfo_topics_topics_link_d813e141c05b54687bbadecbac0016eba" class="co_relatedInfo_topics_document_title" href="https://1.next.westlaw.com/Search/Results.html?query=Construction%20and%20Operation%20of%20Licenses%2FFavored%20Licensee%20Provision%20of%20Patent%20Licensing%20Agreement&amp;topicId=d813e141c05b54687bbadecbac0016eba&amp;topicDocumentGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;topicJuris=NY-CS-ALL&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;transitionType=RelatedTopics&amp;contextData=%28sc.CustomDigest%29">Favored Licensee Provision of Patent Licensing Agreement</a></div></li></ul></li><li class="co_relatedInfo_topic_item">Infringement</li><li><ul class="co_relatedInfo_topic_itemList"><li class="co_relatedInfo_topic_item" id="co_relatedInfo_topic_item_d85496c238879487591859272a5f95cb5"><div id="co_relatedInfo_topics_topic_d85496c238879487591859272a5f95cb5" class="co_relatedInfo_topics_topic"><a id="co_relatedInfo_topics_topics_link_d85496c238879487591859272a5f95cb5" class="co_relatedInfo_topics_document_title" href="https://1.next.westlaw.com/Search/Results.html?query=Infringement%2FPatent%20or%20License%20Agreement&amp;topicId=d85496c238879487591859272a5f95cb5&amp;topicDocumentGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;topicJuris=NY-CS-ALL&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;transitionType=RelatedTopics&amp;contextData=%28sc.CustomDigest%29">Patent or License Agreement</a></div></li></ul></li><li class="co_relatedInfo_topic_item">Federal Courts</li><li><ul class="co_relatedInfo_topic_itemList"><li class="co_relatedInfo_topic_item" id="co_relatedInfo_topic_item_d0f2c668e756a49a28dfcebbf436616c7"><div id="co_relatedInfo_topics_topic_d0f2c668e756a49a28dfcebbf436616c7" class="co_relatedInfo_topics_topic"><a id="co_relatedInfo_topics_topics_link_d0f2c668e756a49a28dfcebbf436616c7" class="co_relatedInfo_topics_document_title" href="https://1.next.westlaw.com/Search/Results.html?query=Federal%20Courts%2FStandard%20of%20Court%20of%20Appeals%20Review%20of%20Grant%20or%20Denial%20of%20Preliminary%20Injunction&amp;topicId=d0f2c668e756a49a28dfcebbf436616c7&amp;topicDocumentGuid=I8757585ab8fa11e3a341ea44e5e1f25f&amp;topicJuris=NY-CS-ALL&amp;docSource=7903d1326e8e42fa91a82e1b8990f8c7&amp;transitionType=RelatedTopics&amp;contextData=%28sc.CustomDigest%29">Standard of Court of Appeals Review of Grant or Denial of Preliminary Injunction</a></div></li></ul></li></ul></div><div class="co_genericBoxFooter"><span></span></div></div><div class="co_genericBox co_relatedinfo_topic_container" id="co_relatedinfo_formfamilies_container"></div></div>
		<div id="coid_website_recommendedDocuments" class="co_recommendedDocumentContainer"><div class="co_genericBox"><ol class="co_searchResult_list co_genericBoxContent"><li><h3>Secondary Sources</h3><h3><a id="cobalt_result_title1" class="draggable_document_link" href="/Document/I1e820d1a31c211df9b8c850332338889/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I1e820d1a31c211df9b8c850332338889" subcontenttype="analytical">APPENDIX III - JUDICIAL OPINIONS</a></h3><div class="co_searchResults_citation"><span>FDA Enforcement Man. Appendix III</span></div><div id="co_snippet_1" class="co_snippet">...No. 74-215 Supreme Court of the United States 421 U.S. 658; 95 S. Ct. 1903 2d 489 Argued March 18-19, 1975 June 9, 1975 Mr. Chief Justice Burger delivered the opinion of the Court. We granted certiorar...</div></li><li><h3><a id="cobalt_result_title2" class="draggable_document_link" href="/Document/I6ea5afe5a57111d981cbf136477a35f6/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I6ea5afe5a57111d981cbf136477a35f6" subcontenttype="analytical">s 29. Transferee's protection against infringers</a></h3><div class="co_searchResults_citation"><span>82 N.Y. Jur. 2d Patents § 29</span></div><div id="co_snippet_2" class="co_snippet">...Unless the licensor of a patent right has agreed to protect a licensee from infringers, the licensor has no obligation to do so; hence, there is no breach of contract by assigning the patent to another...</div></li><li><h3><a id="cobalt_result_title3" class="draggable_document_link" href="/Document/I7b79585e629411e5b0dce59f1672918c/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I7b79585e629411e5b0dce59f1672918c" subcontenttype="analytical">s 107:27. Impact of other substantive areas of the law-Patents, trademarks and copyrights</a></h3><div class="co_searchResults_citation"><span>4D N.Y.Prac., Com. Litig. in New York State Courts § 107:27 (4th ed.)</span></div><div id="co_snippet_3" class="co_snippet">...A license to intellectual property rights is only as valuable as the underlying rights provided under the license. A trademark license is of no value if the trademark underlying the license is cancelle...</div></li><li id="co_relatedDocs_Secondary_Sources" class="co_relatedDocs_item co_relatedDocs_expandable" style="display: none;"><ol class="co_searchResult_list"><li><h3><a id="cobalt_result_title4" class="draggable_document_link" href="/Document/Idb6c064cb67c11d9a49dec8cdbddd959/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="Idb6c064cb67c11d9a49dec8cdbddd959" subcontenttype="analytical">s 473. Options to terminate-Notice</a></h3><div class="co_searchResults_citation"><span>67A C.J.S. Patents § 473</span></div><div id="co_snippet_4" class="co_snippet">...An agreement stating that, upon the failure of a party to a license to perform its covenant, the agreement may be forfeited by a written notice served on it, is valid and enforceable. A stipulation all...</div></li><li><h3><a id="cobalt_result_title5" class="draggable_document_link" href="/Document/I822c13cbda2711de982deeec888078b9/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I822c13cbda2711de982deeec888078b9" subcontenttype="analytical">s 19:36. Implied licenses-Licenses implied in fact</a></h3><div class="co_searchResults_citation"><span>6 Moy's Walker on Patents § 19:36 (4th ed.)</span></div><div id="co_snippet_5" class="co_snippet">...The patent owner will be held to have impliedly licensed the accused infringer where the circumstances indicate that he or she consented to the accused activities. Where such an implied license exists,...</div></li><li><h3><a id="cobalt_result_title6" class="draggable_document_link" href="/Document/I7b795846629411e5b0dce59f1672918c/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I7b795846629411e5b0dce59f1672918c" subcontenttype="analytical">s 107:19. Commonly arising substantive issues-Rights in jointly developed intellectual property</a></h3><div class="co_searchResults_citation"><span>4D N.Y.Prac., Com. Litig. in New York State Courts § 107:19 (4th ed.)</span></div><div id="co_snippet_6" class="co_snippet">...In licenses such as those conferred in relation to joint development efforts, there is an expectation that intellectual property will be created during these efforts. In the life sciences example that ...</div></li><li><h3><a id="cobalt_result_title7" class="draggable_document_link" href="/Document/Ia20ab965d32511e49382c32c978f72b0/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="Ia20ab965d32511e49382c32c978f72b0" subcontenttype="analytical">Requirements for Injunctive Relief</a></h3><div class="co_searchResults_citation"><span>Rutter Group Prac. Guide Fed. Civ. Pro. Before Trial Ch. 13-C</span></div><div id="co_snippet_7" class="co_snippet">...1. [13:38] Requirements Generally: An injunction is an equitable remedy. “The basis for injunctive relief [preliminary or permanent] in the federal courts has always been irreparable injury and the ina...</div></li><li><h3><a id="cobalt_result_title8" class="draggable_document_link" href="/Document/I4605a2686fad11d980f99e2bddcdbe88/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I4605a2686fad11d980f99e2bddcdbe88" subcontenttype="analytical">s 19:5. Distribution of rights embraced in a patent-Assignment vs. license-License, Exclusive or Nonexclusive</a></h3><div class="co_searchResults_citation"><span>5 Pat. L. Fundamentals § 19:5 (2d ed.)</span></div><div id="co_snippet_8" class="co_snippet">...A mere license is not deemed to constitute any interest in the patent. A license is but a promise by one having an interest in a patent to forbear from suing one who would commit what would be, but for...</div></li><li><h3><a id="cobalt_result_title9" class="draggable_document_link" href="/Document/I86e22fb4a06d11d98ef4a4183f77fc8a/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I86e22fb4a06d11d98ef4a4183f77fc8a" subcontenttype="analytical">s 11:30. Implied rights from authorized purchase</a></h3><div class="co_searchResults_citation"><span>2 Annotated Patent Digest § 11:30</span></div><div id="co_snippet_9" class="co_snippet">...In general, a patent holder is entitled to only one royalty for its sale of a patented article and, therefore, once the patent holder, or one of its licensees, has received consideration for the uncond...</div></li><li><h3><a id="cobalt_result_title10" class="draggable_document_link" href="/Document/I8980c024523d11da835ca3d7d3f11dae/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I8980c024523d11da835ca3d7d3f11dae" subcontenttype="analytical">s 8:63. Development of the law of infringement-Broadening exhaustion and effectively limiting implied license: Quanta v. LG</a></h3><div class="co_searchResults_citation"><span>2 Patent Law, Legal and Economic Principles § 8:63 (2d ed.)</span></div><div id="co_snippet_10" class="co_snippet">...In 2008, the Supreme Court in Quanta Computer v. LG Electronics broadened the reach of the exhaustion doctrine and effectively eliminated the operation of the implied license doctrine. Prior to the Qua...</div></li></ol></li><li class="co_relatedDocs_seeMore"><a href="javascript:void(0)" data-contenttype="Secondary Sources">See More Secondary Sources</a></li><li><h3>Briefs</h3><h3><a id="cobalt_result_title1" class="draggable_document_link" href="/Document/I5714231fdb7211e5b86bd602cb8781fa/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I5714231fdb7211e5b86bd602cb8781fa" subcontenttype="analytical">Brief and Special Appendix for Defendants-Appellants Matrix Distributors, Inc., Christopher Benevent and Seth Grumet</a></h3><div class="co_searchResults_citation"><span>2016 WL 727031</span><br><span>Abbott LABORATORIES, Abbott Diabetes Care, Inc., Abbott Diabetes Care Sales Corporation, Plaintiffs-Appellees, v. H&amp;H WHOLESALE SERVICES, INC., Howard Goldman, Lori Goldman, Matrix Distributors, Inc., Christopher Benevent, Seth Grumet, Defendants-Appellants, Adelphia Supply USA, Yudah Neuman, aka Lenny Neuman, Reuven Sobel, aka Chaim Sobel, Moses Neuman, Shmuel Lezell, Save Rite Medical.com LLC, Marc Kaplan, Papoutsanis USA, LLC,</span><br><span>United States Court of Appeals, Second Circuit.</span><br><span>Feb. 19, 2016</span></div><div id="co_snippet_1" class="co_snippet">...Appellant Matrix Distributors, Inc. states that it is not a subsidiary of other corporations, and no publicly held corporation owns more than 10% of its stock. 1.Did District Court err in ruling that w...</div></li><li><h3><a id="cobalt_result_title2" class="draggable_document_link" href="/Document/I29a4501194e811dc8200d0063168b01f/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I29a4501194e811dc8200d0063168b01f" subcontenttype="analytical">Brief Amici Curiae of Automotive Engine Rebuilders Association, Automotive Parts Remanufacturers Association, and International Imaging Technology Council in Support of the Petitioners</a></h3><div class="co_searchResults_citation"><span>2007 WL 3440938</span><br><span>QUANTA COMPUTER, INC., et al., Petitioners, v. LG ELECTRONICS, INC., Respondent.</span><br><span>Supreme Court of the United States</span><br><span>Nov. 12, 2007</span></div><div id="co_snippet_2" class="co_snippet">...FN1. The parties have consented to the filing of this brief. No counsel for a party authored this brief in whole or in part, and no counsel or party made a monetary contribution intended to fund the pr...</div></li><li><h3><a id="cobalt_result_title3" class="draggable_document_link" href="/Document/I0716b70384e411daa20eccddde63d628/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I0716b70384e411daa20eccddde63d628" subcontenttype="analytical">Brief for Petitioner</a></h3><div class="co_searchResults_citation"><span>1968 WL 112637</span><br><span>Lear, INCORPORATED, Petitioner, v. John S. ADKINS, Respondent.</span><br><span>Supreme Court of the United States</span><br><span>July 26, 1968</span></div><div id="co_snippet_3" class="co_snippet">...The opinion of the California Supreme Court (A-I. 164) is reported at 67 Cal. 2d 882, 156 U.S.P.Q. 258. A prior opinion had been rendered by the California District Court of Appeal (A-I. 121), which is...</div></li><li id="co_relatedDocs_Briefs" class="co_relatedDocs_item co_relatedDocs_expandable" style="display: none;"><ol class="co_searchResult_list"><li><h3><a id="cobalt_result_title4" class="draggable_document_link" href="/Document/If507375f3d8011da9bcc85e7f8e2f4cd/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="If507375f3d8011da9bcc85e7f8e2f4cd" subcontenttype="analytical">Brief of Subclass a Plaintiffs-Appellees</a></h3><div class="co_searchResults_citation"><span>2002 WL 32903159</span><br><span>Sharwline NICHOLSON, individually and on behalf of her infant children, Destince Barnett and Kendell Coles, infants, and on behalf of all others similarly situated, Destinee Barnett, Kendell Coles, infants, Sharlene Tillett, individually and on behalf of infants Winston Denton and Uganda Gray, Ekaete Udoh, individually and on behalf of her infant children, Edu Udoh, Ima Udoh, Nsikak Udoh and Asuno Udoh and J.A. and G.A., infants on behalf of all others similarly</span><br><span>United States Court of Appeals, Second Circuit.</span><br><span>Oct. 09, 2002</span></div><div id="co_snippet_4" class="co_snippet">...In 1993, the City's Child Welfare Administration (“CWA”), the predecessor agency to the Administration for Children's Services (“ACS”), began a six-month pilot project in Zone C of Manhattan to identif...</div></li><li><h3><a id="cobalt_result_title5" class="draggable_document_link" href="/Document/I55ffbdb8a33511dc8dba9deb08599717/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I55ffbdb8a33511dc8dba9deb08599717" subcontenttype="analytical">Brief of Respondent</a></h3><div class="co_searchResults_citation"><span>2007 WL 4244683</span><br><span>QUANTA COMPUTER, INC., QUANTA COMPUTER USA, INC., Q-LITY COMPUTER, INC., Petitioners, v. LG ELECTRONICS, INC., Respondent.</span><br><span>Supreme Court of the United States</span><br><span>Dec. 03, 2007</span></div><div id="co_snippet_5" class="co_snippet">...FN* Counsel of Record The relevant statutory provisions are reprinted in an appendix to this brief. 1. Respondent LG Electronics, Inc. (“LGE”) owns patents that claim components, including microprocess...</div></li><li><h3><a id="cobalt_result_title6" class="draggable_document_link" href="/Document/I0acf939189b611daa20eccddde63d628/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I0acf939189b611daa20eccddde63d628" subcontenttype="analytical">Brief for Respondent</a></h3><div class="co_searchResults_citation"><span>1968 WL 129413</span><br><span>LEAR, INCORPORATED, Petitioner, v. John S. ADKINS, Respondent.</span><br><span>Supreme Court of the United States</span><br><span>Sep. 23, 1968</span></div><div id="co_snippet_6" class="co_snippet">...This case is a suit for breach of contract brought by John S. Adkins (“Adkins”), an individual inventor, against Lear, Incorporated, a major corporation, which involves only one patented invention (use...</div></li><li><h3><a id="cobalt_result_title7" class="draggable_document_link" href="/Document/I39f7a9bb316511e8bbbcd57aa014637b/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I39f7a9bb316511e8bbbcd57aa014637b" subcontenttype="analytical">JOINT APPENDIX, VOL. III</a></h3><div class="co_searchResults_citation"><span>2017 WL 8382519</span><br><span>Donald J. TRUMP, President of the United States, et al., Petitioners v. INTERNATIONAL REFUGEE ASSISTANCE PROJECT, et al. Donald J. Trump, President of the United States, et al., Petitioners, v. State of Hawaii, et al.</span><br><span>Supreme Court of the United States</span><br><span>Aug. 10, 2017</span></div><div id="co_snippet_7" class="co_snippet">...1. The State of Hawai'i (the “State”) brings this action to protect its residents, its employers, its educational institutions, and its sovereignty against illegal actions of President Donald J. Trump ...</div></li><li><h3><a id="cobalt_result_title8" class="draggable_document_link" href="/Document/I401d8c0b55fc11dcb979ebb8243d536d/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I401d8c0b55fc11dcb979ebb8243d536d" subcontenttype="analytical">Brief for the United States as Amicus Curiae</a></h3><div class="co_searchResults_citation"><span>2007 WL 2425785</span><br><span>QUANTA COMPUTER, INC., et al., petitioners, v. LG ELECTRONICS, INC.</span><br><span>Supreme Court of the United States</span><br><span>Aug. 24, 2007</span></div><div id="co_snippet_8" class="co_snippet">...This brief is submitted in response to the Court's order inviting the Solicitor General to express the views of the United States. In the view of the United States, the petition for a writ of certiorar...</div></li><li><h3><a id="cobalt_result_title9" class="draggable_document_link" href="/Document/I59c4b885014411dba223cd6b838f54f9/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I59c4b885014411dba223cd6b838f54f9" subcontenttype="analytical">Brief for the United States as Amicus Curiae</a></h3><div class="co_searchResults_citation"><span>1950 WL 78703</span><br><span>AUTOMATIC RADIO MANUFACTURING COMPANY, INC., Petitioner, v. HAZELTINE RESEARCH, INC.</span><br><span>Supreme Court of the United States</span><br><span>Mar. 14, 1950</span></div><div id="co_snippet_9" class="co_snippet">...This case presents important issues of public policy with respect to the availability in private patent litigation of defenses based upon invalidity of patents and misuse of patent rights. The United S...</div></li><li><h3><a id="cobalt_result_title10" class="draggable_document_link" href="/Document/I0808b9a81b6b11e8ab20b3103407982a/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I0808b9a81b6b11e8ab20b3103407982a" subcontenttype="analytical">Joint Appendix</a></h3><div class="co_searchResults_citation"><span>2018 WL 1050344</span><br><span>Donald J. TRUMP, President of the United States, et al., Petitioners, v. STATE OF HAWAII, et al.</span><br><span>Supreme Court of the United States</span><br><span>Feb. 21, 2018</span></div><div id="co_snippet_10" class="co_snippet">...1. The State of Hawaii, Dr. Ismail Elshikh, John Does 1 and 2, and the Muslim Association of Hawaii bring this suit to challenge the President's continuing efforts to impose a sweeping policy banning t...</div></li></ol></li><li class="co_relatedDocs_seeMore"><a href="javascript:void(0)" data-contenttype="Briefs">See More Briefs</a></li><li><h3>Trial Court Documents</h3><h3><a id="cobalt_result_title1" class="draggable_document_link" href="/Document/I1f4d12d60db511deb5cbad29a280d47c/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I1f4d12d60db511deb5cbad29a280d47c" subcontenttype="analytical">Gutman v. Cabrera</a></h3><div class="co_searchResults_citation"><span>2009 WL 599805</span><br><span>Catherine GUTMAN, in her capacity as President of the Condominium Board of the unincorporated Condominium Association the Washington Condominium, Plaintiff(s), v. Heylin CABRERA, Defendant(s).</span><br><span>Supreme Court, New York.</span><br><span>Feb. 05, 2009</span></div><div id="co_snippet_1" class="co_snippet">...[This opinion is uncorrected and not selected for official publication.] The following papers numbered 1 to 8 read on this motion: Papers Numbered Notice of Motion/Order to Show Cause/Petition/Cross Mo...</div></li><li><h3><a id="cobalt_result_title2" class="draggable_document_link" href="/Document/I4c9fc9f7f2a911e0bc27967e57e99458/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I4c9fc9f7f2a911e0bc27967e57e99458" subcontenttype="analytical">New York Skyline, Inc. v. City of New York</a></h3><div class="co_searchResults_citation"><span>2011 WL 4707067</span><br><span>In the Matter of the Application of, NEW YORK SKYLINE, INC., and Calaif Parks, Petitioners, v. CITY OF NEW YORK; Michael R. Bloomberg, in his Official Capacity as Mayor of the City of New York; New York City Police Department; Raymond W. Kelly, in his Official Capacity as Commissioner of the New York City Police Department; New York City Environmental Control Board; and Meredith A. Feinman, in her Official Capacity as Executive Director of the New York City Environmental</span><br><span>Supreme Court, New York.</span><br><span>Sep. 20, 2011</span></div><div id="co_snippet_2" class="co_snippet">...[This opinion is uncorrected and not selected for official publication.] The following papers, numbered 1 to _ were read on this motion for _ CROSS-MOTION: _ YES X NO Upon the foregoing papers, it is o...</div></li><li><h3><a id="cobalt_result_title3" class="draggable_document_link" href="/Document/Ifb880835a32111e1b11ea85d0b248d27/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="Ifb880835a32111e1b11ea85d0b248d27" subcontenttype="analytical">Riccelli Enterprises, Inc. v. State</a></h3><div class="co_searchResults_citation"><span>2012 WL 1802558</span><br><span>In the Matter of RICCELLI ENTERPRISES, INC., Riccelli Trucking, Inc. and Syracuse Sand and Gravel, LLC, Petitioners, v. State of New York Workers' Compensation Board, and Robert E. Beloten, as Chairman of the Workers' Compensation Board, Respondents.</span><br><span>Supreme Court, New York.</span><br><span>Apr. 30, 2012</span></div><div id="co_snippet_3" class="co_snippet">...[This opinion is uncorrected and not selected for official publication.] New York State law requires that employers maintain Workers' Compensation insurance for their employees. Petitioners/plaintiffs ...</div></li><li id="co_relatedDocs_Trial_Court_Documents" class="co_relatedDocs_item co_relatedDocs_expandable" style="display: none;"><ol class="co_searchResult_list"><li><h3><a id="cobalt_result_title4" class="draggable_document_link" href="/Document/I19fb0f782a3611e1bd928e1973ff4e60/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I19fb0f782a3611e1bd928e1973ff4e60" subcontenttype="analytical">Korenzecher v. Blass</a></h3><div class="co_searchResults_citation"><span>2000 WL 35923321</span><br><span>Rafael KORENZECHER, as assignee of Edward Ullendorff, Plaintiff, v. Norman BLASS, Esq., et al., Defendants.</span><br><span>Supreme Court, New York.</span><br><span>July 24, 2000</span></div><div id="co_snippet_4" class="co_snippet">...Motions sequence No. 05 and No. 06 are consolidated for disposition. By Decision and Order dated July 13, 1998, this Court granted plaintiff's motion for a preliminary injunction enjoining the Ullendor...</div></li><li><h3><a id="cobalt_result_title5" class="draggable_document_link" href="/Document/If242e7af5a7411ddb6a3a099756c05b7/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="If242e7af5a7411ddb6a3a099756c05b7" subcontenttype="analytical">Barletta v. 453 West 17th Rest. Corp.</a></h3><div class="co_searchResults_citation"><span>2008 WL 2855984</span><br><span>Emilio BARLETTA, Plaintiff, v. 453 WEST 17TH REST. CORP., John Yonkus, Richie Akiva, Scott Sartiano, Ronald Kaplan, Eytan Sugarman, Defendants.</span><br><span>Supreme Court, New York.</span><br><span>July 11, 2008</span></div><div id="co_snippet_5" class="co_snippet">...[This opinion is uncorrected and not selected for official publication.] The following papers, numbered 1 _ to were read on this injunction in and of arbitration. PAPERS NUMBERED Notice of Motion/ Orde...</div></li><li><h3><a id="cobalt_result_title6" class="draggable_document_link" href="/Document/I98c96fddb2c211dc9876f446780b7bdc/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I98c96fddb2c211dc9876f446780b7bdc" subcontenttype="analytical">In re Marciano v. Champion Motor Group, Inc.</a></h3><div class="co_searchResults_citation"><span>2007 WL 4473342</span><br><span>In the Matter of the Application of John MARCIANO, Petitioner-Plaintiff, for a Judgment pursuant to Business Corporation Law | 1104-a, dissolving CHAMPION MOTOR GROUP, INC., d/b/a Bentley of Long Island, Respondent, Gary Brustein, Michael Todd, 115 South Service Road, LLC, Bentley Long Island, LLC, Gold Coast Luxury Auto, LLC, BTM Group, LLC, Champion Motor Service, Inc., Champion Auto Brokers, Inc. and Champion Leasing Group, Inc., Additional</span><br><span>Supreme Court, New York.</span><br><span>Dec. 07, 2007</span></div><div id="co_snippet_6" class="co_snippet">...[This opinion is uncorrected and not selected for official publication.] MOTION DATE: 11/02/2007 MOTION SEQUENCE: 010 ACTION NO. 1 MOTION DATE: 11/02/2007 MOTION SEQUENCE: 001 The following papers read...</div></li><li><h3><a id="cobalt_result_title7" class="draggable_document_link" href="/Document/I9a599b978a9911e3a659df62eba144e8/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="I9a599b978a9911e3a659df62eba144e8" subcontenttype="analytical">Harlem Real Estate LLC v. New York City Economic Development Corp.</a></h3><div class="co_searchResults_citation"><span>2007 WL 8321284</span><br><span>HARLEM REAL ESTATE LLC and Citarella Operating LLC, Plaintiff, v. NEW YORK CITY ECONOMIC DEVELOPMENT CORPORATION and the City of New York, Defendants.</span><br><span>Supreme Court, New York.</span><br><span>Mar. 13, 2007</span></div><div id="co_snippet_7" class="co_snippet">...The following papers, numbered 1 to _ were read on this motion to/for _ Cross-Motion:  Yes  No Upon the foregoing papers, it is ordered that this motion Dated: 3/6/07 &lt;&lt;signature&gt;&gt; MARILYN SHAFER J.S.C...</div></li><li><h3><a id="cobalt_result_title8" class="draggable_document_link" href="/Document/Iadc36230e7b411e490d4edf60ce7d742/View/FullText.html?navigationPath=%252FDocument%252FI8757585ab8fa11e3a341ea44e5e1f25f%252FView%252FFullText.html%253FlistPageSource%253D3c84f03b3d51e9334632eab48e8663c5%2526navigationPath%253DSearch%25252Fv1%25252Fresults%25252Fnavigation%25252Fi0ad6ad3d0000016305665c98a975de34%25253FNav%25253DCUSTOMDIGEST%252526fragmentIdentifier%25253DI8757585ab8fa11e3a341ea44e5e1f25f%252526startIndex%25253D1%252526contextData%25253D%25252528sc.CustomDigest%25252529%252526transitionType%25253DCustomDigestItem%2526listSource%253DSearch%2526list%253DCUSTOMDIGEST%2526rank%253D63%2526transitionType%253DDocLevelRelatedDocItem%2526contextData%253D(sc.CustomDigest)&amp;transitionType=DocLevelRelatedDocItem&amp;contextData=(sc.Recommended)" docguid="Iadc36230e7b411e490d4edf60ce7d742" subcontenttype="analytical">Zylon Corp. v. Medtronic, Inc.</a></h3><div class="co_searchResults_citation"><span>2015 WL 1779010</span><br><span>ZYLON CORP. and Alan Zamore, Plaintiffs, v. MEDTRONIC, INC., Medtronic Vascular, Inc., and Ave Gal Way Ltd., Defendants.</span><br><span>Supreme Court, New York.</span><br><span>Apr. 17, 2015</span></div><div id="co_snippet_8" class="co_snippet">...Plaintiffs Zylon Corp. (“Zylon”) and Alan Zamore (“Zamore”) (collectively “Plaintiffs”) commenced this action alleging that defendants misappropriated their trade secret for forming a zero-fold balloon...</div></li></ol></li><li class="co_relatedDocs_seeMore"><a href="javascript:void(0)" data-contenttype="Trial Court Documents">See More Trial Court Documents</a></li></ol><div class="co_genericBoxFooter"><span></span></div></div></div>

<div id="downloadUserDocument"></div>
					<div id="downloadUserDocument"></div>
				</div>
			</div>

 <input class="hideTopTopics" id="hideTopTopics" name="hideTopTopics" type="hidden">
		<div class="co_clear"></div>
	</div>


	<!-- BEGIN FOOTER -->
	<div id="co_footerContainer"><div id="co_cookiePolicyContainer">
	<div class="co_cookiePolicyContent">
			<h3><b>Our policy towards the use of cookies</b></h3>
			<p>All Thomson Reuters websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.</p>
			<ul class="co_inlineList">
				<li>
					<a id="coid_website_cookiePolicyLinkOut" href="javascript:void(0)">Read cookie policy</a>
				</li>
				<li>
					<a id="coid_website_closeCookiePolicy" href="javascript:void(0)">Close</a>
				</li>
			<p></p>
			<button type="button" id="coid_website_cookiePolicyAcknowledged" title="Close message to acknowledge cookie policy" class="co_absolute">
				<span class="icon25 icon_close_x"></span>
			</button>
	</ul></div>
</div>


		
		<div class="co_innertube co_clearfix" id="co_footer" style="display: block;">







<div class="co_floatLeft">
	<div id="co_footerLinks">
		<ul class="co_inlineList">
					<li><a id="coid_websiteFooter_userSettings" href="javascript:void(0);"><span class="icon25 icon_gear_document"></span>Preferences</a></li>
				<li><a id="coid_websiteFooter_helplink" href="javascript:void(0);"><span class="icon25 icon_question_mark"></span>Training &amp; Support</a></li>
				
					<li><a id="coid_websiteFooter_signofflink" href="javascript:void(0);"><span class="icon25 icon_exit_door"></span>Sign Off</a></li>

		</ul>
	</div>
	<div id="co_footerCopyright">
		<ul class="co_inlineList">

			<li>Westlaw. <a href="/Copyright?transitionType=Default&amp;contextData=(sc.Default)"> © 2018</a> Thomson Reuters</li>
			<li><a id="coid_websiteFooter_privacyPolicyLink" href="javascript:void(0)">Privacy Statement</a></li>
			<li><a href="/Accessibility?transitionType=Default&amp;contextData=(sc.Default)">Accessibility</a></li>
				<li id="co_footer_supplier"><a id="coid_website_supplierTerms" href="javascript:void(0);">Supplier Terms</a></li>
				<li id="co_footerContactUs"><a href="/ContactUs?transitionType=Default&amp;contextData=(sc.Default)">Contact Us</a></li>
				<li id="co_footerCs">1-800-REF-ATTY (1-800-733-2889)</li>
				<li id="co_footer_improve"><strong><a id="coid_websiteFooter_pageSurvey" href="javascript:void(0);">Improve Westlaw</a></strong></li>
		</ul>


	</div>
</div>





<div id="co_trLogo" class="co_floatRight">

	<a id="co_trLogo_link" href="#">
		<img alt="Thomson Reuters" src="https://ia.next.westlaw.com/StaticContent_40.1.1015/images/v2/co_logo_thomsonReuters.png" width="134" height="30">
	</a>
</div>



		</div>
	</div>
			<div id="coid_Trmr" style="display:none; visibility:hidden"></div>
		</div>
	</div>
	
	<!--static content version number-->
<script type="text/javascript">





	
		window['Server/Routing'] = {
			Search: 'search.int.next.westlaw.com',
			TypeAhead: 'typeahead.int.next.westlaw.com',
			Nlu: 'nlu.int.next.westlaw.com',
			Document: 'document.int.next.westlaw.com',
			Foldering: 'foldering.int.next.westlaw.com',
			CSS: 'ca.next.westlaw.com/StaticContent_40.1.1015',
			Images: 'ia.next.westlaw.com/StaticContent_40.1.1015',
			JavaScript: 'ja.next.westlaw.com/StaticContent_40.1.1015',
			RelatedInfo: 'relatedinfo.int.next.westlaw.com',
			Events: 'events.int.next.westlaw.com',
			KM: 'NONE',
			RequestDirector: 'www.westlaw.com',
			SocialPlatform: 'https://community-sso.thomsonreuters.com',
			Sync: 'sync.westlaw.com',
			Video: 'v1.next.westlaw.com',
			FormsAssembly: 'formsassembly.int.forms.westlaw.com',
			Publishing: 'publishing.int.next.westlaw.com',
			WebContent: 'webcontent.int.next.westlaw.com',
			Alert: 'alert.int.next.westlaw.com',
			Report: 'report.int.next.westlaw.com',
			ProductMetadata: 'pmd.int.next.westlaw.com/pmd',
			Website: '1.next.westlaw.com',
			WebsiteDefault: '1.next.westlaw.com',
			HistoryListener: 'historylistener.int.next.westlaw.com',
			FormsAssemblyTest: ''
		};
	
		
			if (window.location.host !== '1.next.westlaw.com') {
				window['Server/Routing'].ProxiedWebsite = '1.next.westlaw.com';
				window['Server/Routing'].Website = window.location.host;
				window['Server/Routing'].WebsiteDefault = window.location.host;
			}
		
</script>

<script type="text/javascript"></script>

	<script type="text/javascript" src="https://1.next.westlaw.com/v2/js/UrlRouting.40.1.1013.0.js"></script>
	
	<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/External/vendor/datejs@1.0/cultures/en-US.js"></script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/v2/Products/WestlawNext/js/LocalizationResources/Localized/Messages.js"></script>

	
<script type="text/javascript">

	







</script>





















	
	














<script type="text/javascript">
window['Server/User'] = {
  "FirmName": "SEOUL NATIONAL UNIV (LV A)",
  "_AlertsIsAdmin": false,
  "_FeatureExposure": "Released",
  "ClientId": "SEOUL NU - WL NEXT",
  "_AlertsAccessFunctionalityTurnedOn": true,
  "_AlertsAccessCategoryApplied": false,
  "_ShowErrorDetails": false,
  "OnePassUserName": "5405685",
  "OnePassUserNameEncoded": "5405685",
  "ClientMatter": {
    "ClientId": "SEOUL NU - WL NEXT",
    "CompositeClientMatter": "SEOUL NU - WL NEXT",
    "DefaultClientId": "Seoul NU - WL Next",
    "ClientIdPromptText": "",
    "IsClientNonChargeable": "False",
    "NoClientId": "False",
    "TrackableCode": "D",
    "UserTurnedTrackingOn": false
  },
  "ClientReportingAttributes": {
    "PracticeArea": "",
    "ResearchReasonCode": "",
    "ResearchDescription": ""
  },
  "BillingMethodForDisplayOnly": "TRANSACTIONAL",
  "HasFlashPlayer": false,
  "IsUltra": true,
  "CustomerStorageKey": "E41F133AB8A01ED395E1D85D67D9406C",
  "SessionCreatedDateTime": "04/27/2018 04:39:12",
  "HasLoggedAggregateNotificationCount": false
};


window['Server/ViewModelData'] = {
  "DocumentGuid": "I8757585ab8fa11e3a341ea44e5e1f25f",
  "DocumentCitation": "746 F.3d 1371",
  "DocumentTitle": "Endo Pharmaceuticals Inc. v. Actavis, Inc.",
  "DocumentMetaDescription": "View on Westlaw or start a FREE TRIAL today, Endo Pharmaceuticals Inc. v. Actavis, Inc., Cases",
  "ViewType": "FullText",
  "Rank": 63,
  "Grading": "na",
  "KMEnableTermNavigation": false,
  "KMEnableDocumentNavigation": false,
  "LegacyId": "2032992124",
  "DocumentSource": {
    "Key": "7903d1326e8e42fa91a82e1b8990f8c7",
    "NavigationPath": "Search/v1/results/navigation/i0ad6ad3d0000016305665c98a975de34?Nav=CUSTOMDIGEST&fragmentIdentifier=I8757585ab8fa11e3a341ea44e5e1f25f&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "ListPageSourceKey": "3c84f03b3d51e9334632eab48e8663c5"
  },
  "HasDraftingNotes": false,
  "HasDocumentSections": false,
  "EnableBestPortion": true,
  "SubContentTypeId": "27",
  "DisableDocMetaInfoRetrievalOnWarningPage": false,
  "TermNavigationPreference": "AllTerms",
  "ShowMainToolbar": true,
  "ShowRelatedAnalysis": false,
  "ListSource": "Search",
  "IsRelatedFullTextView": false,
  "KeyCiteAlertWarning": "None",
  "DocketTrackWarning": "None",
  "DocumentSections": [],
  "RulebookMode": false,
  "RulebookModeContent": false,
  "NotesOfDecisionsCount": 0,
  "TocReportDocGuids": [],
  "TocReportViewMode": false,
  "IsMedLitStubDocument": false,
  "TrackableCode": "D",
  "NonTrackableCode": "H",
  "FullTocOnDoc": false,
  "ViewExpressions": []
};


window['Server/WidgetDomIds'] = {
  "DocToolbar": "co_docToolbar",
  "DocDisplay": "coid_website_documentWidgetDiv",
  "DocTools": "coid_website_documentToolWidgetDiv",
  "DocTopToolbar": "co_docTopToolbar",
  "DocRightToolbar": "co_newDocToolbar",
  "TopTopics": "coid_website_relatedInfoWidgetDiv",
  "DocBottomToolbar": "co_docFooterToolbar"
};


window['Server/PageData'] = {
  "DocumentTabView": {
    "IsSkipOutOfPlanChecked": false,
    "IsUserDocument": false,
    "UserDocumentData": {
      "documentGuid": "I8757585ab8fa11e3a341ea44e5e1f25f"
    },
    "HasProfileSubTab": false,
    "DisplayOptions": {
      "showMainToolbar": true,
      "isNewDocumentView": false,
      "disableDocToolbar": false,
      "isAbstractView": false,
      "chunkSize": "L",
      "chunkableHeadnotes": false,
      "doCompleteSizeChecking": true,
      "ViewType": "FullText",
      "stickyHeader": true,
      "displayRelatedContentLink": true,
      "snippetRelocationInfo": {
        "contentType": "Cases",
        "subContentTypeId": "27"
      }
    },
    "ShowMainToolbar": true,
    "DocumentPersisted": false,
    "DocumentGuidNotFound": false,
    "ContentType": "Cases",
    "ExpandDocumentLevelTOC": true
  },
  "CobaltPageHeader": {
    "ShowPauseLink": false,
    "ShowCommunityContainer": false,
    "EnablePageHeaderV2": true,
    "ShowBetaFeedbackLink": false,
    "Notifications": {
      "HideNotificationToastAfterDuration": false,
      "NotificationClickGoDirectlyToAlerts": false
    }
  },
  "CompartmentStartPageId": "",
  "CobaltMasterFooterInSession": {
    "TRLogoImageLinkUrl": "http://www.thomsonreuters.com",
    "ShowWhatIsNewLink": false,
    "Unreleased": false,
    "IsAnonymousSession": false,
    "ShowMyContacts": false,
    "ShowPromotions": false,
    "ShowResetPromotions": false,
    "ShowCampusPolicy": false,
    "IsTransferContentAvailable": false,
    "ShowProductStartGuide": false,
    "HelpGuideDisplayName": "",
    "HelpGuideFileName": "",
    "HelpGuidePath": "",
    "CampusPolicyDisplayName": "",
    "CampusPolicyPath": "",
    "ShowAnalyticsLink": false,
    "AnalyticsPath": "Session/SignOn.html?transitionType=Default&contextData=(sc.Default)",
    "ShowMyAccountLink": false,
    "MyAccountPath": "WESTLAW/Common/Landing/MyAccountLanding",
    "LegalSolutionsLink": "http://legalsolutions.thomsonreuters.com/law-products/westlaw-legal-research/training-support",
    "SupplierTermsUrl": "http://legalsolutions.com/westlaw-additional-terms",
    "PrivacyPolicyPath": "https://www.thomsonreuters.com/en/privacy-statement.html"
  },
  "ActOnTracking": {
    "EnableActOnTracking": false,
    "ActOnTrackingInstanceId": ""
  },
  "CobaltPage": {
    "SetInCache": [
      {
        "Vertical": "Global",
        "Name": "ResultsPerPage",
        "Value": 20
      },
      {
        "Vertical": "Global",
        "Name": "ResultsPerPageAllowableValues",
        "Value": [
          "100",
          "20",
          "50"
        ]
      },
      {
        "Vertical": "Global",
        "Name": "Locale",
        "Value": ""
      },
      {
        "Vertical": "Global",
        "Name": "TimeZone",
        "Value": "Central Standard Time"
      },
      {
        "Vertical": "Global",
        "Name": "MultiFacetsEnabled",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_CASE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ANALYTICAL",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGREG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PENDINGLEG",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_KNOWHOW",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsContentType",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_DOCKET",
        "Value": "CASE_TITLE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_BRIEF",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TRIAL-TRANSCRIPTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ADMINDECISION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_FORM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_NEWS",
        "Value": "DATE_DESCENDING"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_ORAL-ARGUMENTS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "InstantSuggestions",
        "Value": true
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_TCO",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultNews_DuplicateIdentifier",
        "Value": false
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_REGULATION",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_EXPERTWITNESS",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SliderDetail",
        "Value": "default"
      },
      {
        "Vertical": "Search",
        "Name": "ViewExpression",
        "Value": ""
      },
      {
        "Vertical": "Search",
        "Name": "DefaultPage",
        "Value": "ALL"
      },
      {
        "Vertical": "Search",
        "Name": "JurisdictionsGlobal",
        "Value": "CTAF"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_PMM",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_STATUTE",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "DefaultSortType_JURYVERDICT",
        "Value": "RELEVANCE"
      },
      {
        "Vertical": "Search",
        "Name": "SuppressRecentFiltersTooltip",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "HeadnotesDualColumnView",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorRulesSet",
        "Value": "standard"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorItalicizeTitle",
        "Value": false
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorParallelCites",
        "Value": "CAFormat"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUseForCopyWithReference",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorCitationStyle",
        "Value": "LegalBriefs"
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorIncludeHistory",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "CiteAdvisorUnderlineTitle",
        "Value": true
      },
      {
        "Vertical": "Document",
        "Name": "HideHeadnotesBox",
        "Value": false
      },
      {
        "Vertical": "Foldering",
        "Name": "ShowAnnotationsPreferenceKey",
        "Value": "checked"
      },
      {
        "Vertical": "Website",
        "Name": "ShowKeyboardInstructions",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "NewFeatureLightboxDisplayBlackList",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DeliveryOptionSelected",
        "Value": "None"
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenShowLinks",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "LastViewNotificationDate",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayTextSize",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DisplaySearchTerms",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "KnowHowSpeedReadExpandAll",
        "Value": true
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayFont",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentDisplayMargin",
        "Value": ""
      },
      {
        "Vertical": "Website",
        "Name": "DocumentFullscreenFont",
        "Value": ""
      },
      {
        "Vertical": "SAP",
        "Name": "PLAN ICONS",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "SKIP OUT OF PLAN",
        "Value": "NO"
      },
      {
        "Vertical": "SAP",
        "Name": "WARNING FLAG",
        "Value": "N"
      }
    ],
    "PingSync": "false",
    "ViewData": {
      "IsSponsorSession": true,
      "SearchWidgetParameters": {
        "search": {
          "renderCustomPageSearchWidget": false,
          "categoryPageTitle": "291 PATENTS",
          "isCategoryPageTopical": false,
          "topicKeyText": "291 PATENTS",
          "filters": {
            "jurisdiction": "CTAF",
            "sequence": 0,
            "content": "CUSTOMDIGEST",
            "index": false,
            "customDigest": true,
            "collectionSets": [
              "w_cs_cd_toc"
            ],
            "tocNode": "I4aee2539c6f64c1812a4c2f3395c2607",
            "keyNumber": "291",
            "displayJurisdictionSelector": true,
            "displayAdvancedSearchLink": false,
            "categoryPageUrl": "Home/WestKeyNumberSystem",
            "categoryPageContentType": "CUSTOMDIGEST",
            "categoryPageCheckboxLimit": 0,
            "resultsLimit": 0,
            "categoryPageAlertClippable": false,
            "isAdvancedSearchTemplatePage": false
          },
          "CustomPageSetForZone": false,
          "supportedFeatures": [],
          "skipSpellCheck": false,
          "browseHierarchyPathFromRoot": []
        },
        "SearchCompartmentName": "WestlawNext",
        "SearchDropDownItems": [],
        "grading": "na",
        "searchWidgetPosition": "Default",
        "hideSearchWidget": false,
        "makeSearchWidget": true,
        "prefersForceTnc": false,
        "prefersForceTncSingleQuote": true,
        "forceTncCounter": 0,
        "forceTncCounterThreshold": 5,
        "enableFavoriteSearch": false,
        "dynamicPage": false,
        "isAdvancedSearchTemplatePage": false
      },
      "ShowClientIdWidget": true,
      "OpenFindDropDown": false,
      "TimeoutInMinutes": 90,
      "FeatureConfigurations": {
        "FOLDERS": false,
        "HISTORY": true,
        "FOLDER_SHARING": false,
        "HIGHLIGHTS": false,
        "NOTES": false,
        "ANNOTATIONS": false,
        "BLOCK NOTES SHARING": false,
        "CONTACTS": false,
        "FAVORITES": false,
        "USER PROFILE": false,
        "KM": false,
        "FolderCachingDisabled": true,
        "KM IPAD": false,
        "SAO_INVITING": true,
        "SAO_SAMEEMAILDOMAIN": false,
        "CASENOTEBOOKEXPORT": false,
        "DOWNLOADDELIVERY": true,
        "DROPBOXDELIVERY": false,
        "EMAILDELIVERY": true,
        "EMAILWITHREFERENCEDELIVERY": false,
        "KINDLEDELIVERY": false,
        "PRINTDELIVERY": true,
        "KEYCITEALERTS": false,
        "LEGACYALERTACCESS": false,
        "BLOCKPERSISTENTINFO": true,
        "BLOCK100KANCILLARY": false,
        "DISPLAYMASHUPCHARGEWARNING": false,
        "SHOWCHARGEONWARNINGSCREEN": false,
        "SHOWCHARGELINKONWARNINGSCREEN": false,
        "USERISTRANSACTIONAL": true,
        "USER FORM UPLOAD": false,
        "MATTERUPLOADUSERDOC": false,
        "FOLDERUPLOADUSERDOC": false,
        "DISPLAY SESSION PAUSE LINK": false,
        "PASSTHRUPDFS": false,
        "processRIHistoryAsynchronously": true,
        "processDocumentHistoryAsynchronously": true,
        "PRINTBLANKFORMS": false,
        "WFBTRIALBLOCKSHARE": false,
        "ATTORNEY PORTAL": false,
        "SMALLLAWWORKBENCHMATTERTREE": false,
        "JUDICIALCHAMBERS": false,
        "CITATIONUS": false,
        "CITATIONCAN": false,
        "MYPLANSTATICDOC": true,
        "ALLOWFOLDERSHAREACROSSORGS": true,
        "BLOCKFOLDERSHAREFROMORGS": true,
        "ALLOWOFFLINEACCESS": false,
        "WEBHOSTEDCLIENTID": false,
        "WEBHOSTEDCLIENTIDIPAD": false,
        "WEBHOSTEDCLIENTIDSELECTION": false,
        "PRERELCONTENTFEAT": false,
        "ALERTS": false,
        "ALERTS ENHANCED": false,
        "ISEMULATEUSER": false,
        "WCLP": false,
        "NEWSLETTER": false,
        "KCALERT": false,
        "COINV ALERTS": false,
        "CITRANSITION": false,
        "BLCALERT": false,
        "DKTALERT": false,
        "DKTTRACK": true,
        "PUBALERT": false,
        "CWALERT": false,
        "POB ALERT": false,
        "POB WATCH": false,
        "CWALERTPremium": false,
        "CAPITOLWATCH": false,
        "ALERT SUMMARY REPORT": false,
        "WCLP CONTINUOUS": false,
        "KCALERT CONTINUOUS": false,
        "CWALERT CONTINUOUS": false,
        "POBA CONTINUOUS": false,
        "POBW CONTINUOUS": false,
        "NEWSLETTER DLY": false,
        "NEWSLETTER WKDY": false,
        "KCALERT DLY SINGLE": false,
        "KCALERT WKDY SINGLE": false,
        "BIALERT DLY SINGLE": false,
        "BLCALERT DAILY": false,
        "BLCALERT MULTI DAILY": false,
        "CWALERT DAILY": false,
        "BIALERT WKDY SINGLE": false,
        "BLCALERT BIWEEKLY": false,
        "BLCALERT CONTINUOUS": false,
        "WCLP WEEKLY": false,
        "NEWSLETTER WEEKLY": false,
        "KCALERT WEEKLY": false,
        "BIALERT WEEKLY": false,
        "BLCALERT WEEKLY": false,
        "DKTALERT WEEKLY": false,
        "DKTTRACK WEEKLY": true,
        "POBA WEEKLY": false,
        "POBW WEEKLY": false,
        "WCLP BIWEEKLY": false,
        "KCALERT BIWEEKLY": false,
        "BIALERT BIWEEKLY": false,
        "DKTALERT BIWEEKLY": false,
        "DKTTRACK BIWEEKLY": true,
        "NEWSLETTER BIWEEKLY": false,
        "POBA BIWEEKLY": false,
        "POBW BIWEEKLY": false,
        "WCLP MONTHLY": false,
        "NEWSLETTER MONTHLY": false,
        "KCALERT MONTHLY": false,
        "BIALERT MONTHLY": false,
        "BLCALERT MONTHLY": false,
        "DKTALERT MONTHLY": false,
        "DKTTRACK MONTHLY": true,
        "POBA MONTHLY": false,
        "POBW MONTHLY": false,
        "WCLP DLY SINGLE": false,
        "WCLP DLY MULT": false,
        "WCLP WKDY SINGLE": false,
        "WCLP WKDY MULT": false,
        "PUBALERT DLY SINGLE": false,
        "PUBALERT WKDY SINGLE": false,
        "DKTALERT WKDY SINGLE": false,
        "DKTALERT DLY SINGLE": false,
        "DKTTRACK WKDY SINGLE": true,
        "DKTTRACK DLY SINGLE": true,
        "CAPITOLWATCHTRACK DLY SINGLE": false,
        "CAPITOLWATCHTRACK DLY MULT": false,
        "CAPITOLWATCHTRACK WKDY SINGLE": false,
        "CAPITOLWATCHTRACK WKDY MULT": false,
        "CAPITOLWATCHTRACK WEEKLY": false,
        "CAPITOLWATCHTRACK BIWEEKLY": false,
        "CAPITOLWATCHTRACK MONTHLY": false,
        "POBA DLY SINGLE": false,
        "POBA DLY MULT": false,
        "POBA WKDY SINGLE": false,
        "POBA WKDY MULT": false,
        "POBW DLY SINGLE": false,
        "POBW DLY MULT": false,
        "POBW WKDY SINGLE": false,
        "POBW WKDY MULT": false,
        "showMatterTree": false,
        "WELCOME TO WLN BOX": false,
        "dataRoomReadSource": "Original",
        "dataRoomWriteDestination": "Single",
        "dataRoomFoldersWriteDestination": "SingleDataRoom",
        "showNapaContent": true,
        "PublicRecordsAccess": false,
        "PublicRecordsEnhancedSecurity": false,
        "PublicRecordsBlockRoaming": false,
        "PublicRecordsBlockHomeTrust": false,
        "PublicRecordsAllowRoamTrust": false,
        "PublicRecordsBypassCountry": false,
        "PublicRecordsBlockIPUndefined": false,
        "PublicRecordsBlockUndefinedTrust": false,
        "PublicRecordsDowngradeEmailIPRoaming": false,
        "PublicRecordsDowngradeEmailIPUndefined": false,
        "PublicRecordsUnmaskRoam": false,
        "DISABLE PR ANC MASK": false,
        "PublicRecordsSsnOnlyOK": false,
        "ReversePhoneGateway": false,
        "QSentReport": false,
        "CreditHeaderContentDatabaseGroup": false,
        "PolkGateway": false,
        "PolkReport": false,
        "DriversLicenseRecordsContentDatabaseGroup": false,
        "UCC COLUMN RESULTS": false,
        "matterTreeType": "None",
        "ISCAMPUSUSER": false,
        "ISCAMPUSNEWSUSER": false,
        "ISCAMPUSBUSINESSUSER": false,
        "isUnreleasedFeatureExposure": false,
        "WLANALYTICS ACCESS": false,
        "NEWSALERTAUTHOR": false,
        "NEWSALERTEDITOR": false,
        "UNRELEASED CAT PAGES": false,
        "INTERNAL ADMIN LIMITS": false,
        "DATAROOMALERTS": false,
        "DLVRY SESSION LIMIT": false,
        "DLVRY DAILY LIMIT": false,
        "DLVRY SESSION LIMIT PRAC LAW": false,
        "DLVRY DAILY LIMIT PRAC LAW": false,
        "DLVRY SESSN LIMIT PRAC LAW TRL": false,
        "DLVRY DAILY LIMIT PRAC LAW TRL": false,
        "CONTENT DLVRY RSTRCT": true,
        "BLOCKAUWLN": false,
        "BLOCKCANWLN": false,
        "BLOCKHKWLN": false,
        "BLOCKUKWLN": false,
        "ALERTS ADDRESS BOOK": true,
        "ALERTS BATCH PROCESSING": false,
        "ALERTS CALENDARING": true,
        "ALERTS FUNCTIONALITY": true,
        "ECHACCESS": false,
        "PMD VERSION": "5207",
        "USER ACADEMIC": true,
        "USER CORPORATE": false,
        "USER DEVELOPER": false,
        "USER GOVERNMENT": false,
        "USER INTERNAL": false,
        "USER LARGE LAW": false,
        "USER MEDIUM LAW": false,
        "USER SMALL LAW": false,
        "SIGNOFF SURVEY": false,
        "INLINE KC CASES BRIEF": false,
        "BYPASS WARN INLINE KC": false,
        "BLOCK PL ITEMS": false,
        "PRACTICAL LAW": false,
        "PRDCT PLCUK": false,
        "PRDCT PLCAU": false,
        "DISABLE PL REL CONTENT CACHE": false,
        "HISTORY UI": true,
        "EDSECTIONALLOW": false,
        "TAPSELECTED": false,
        "REDLINING": false,
        "WLNBYPASSBLOCK": false,
        "BLOCK NATIVE SIGNIN": false,
        "BLC ZONE": false,
        "CUSTOM PAGES": false,
        "CUSTOM PAGES READ": false,
        "CUSTOM PAGE ADMIN": false,
        "ELIBRARIES CP ZONE": false,
        "TYPE AHEAD": false,
        "PATRONHELP": false,
        "HISTORY RETENTION 1": false,
        "HISTORY RETENTION 180": false,
        "BLC POWERSEARCH": false,
        "PRDCT CORRECTIONAL": false,
        "EASY EDIT": false,
        "ENHANCED RB": false,
        "ENHANCED RB STICKY": false,
        "WMGRAPHICAL": false,
        "PRPTSUBSCRIBER": false,
        "BLOCK PRPT BLC": false,
        "PLCT DISPLAY LEGAL ANALYTICS": false,
        "PRPT SMALL": false,
        "PRPT CORPCOUNSEL": false,
        "PRPT LARGE": false,
        "BLOCK PRPT LARGE PAGES": false,
        "PRPT GOVT": false,
        "PRPT NONTRACKABLE": false,
        "PRPT KM LITIGATION": false,
        "PRPT KM TRANSACTIONAL": false,
        "WAYWO": false,
        "AnonymousSession": false,
        "AnonymousSessionBlock": false,
        "SOCIAL PLATFORM": false,
        "BLOCK TNP PLUS": false,
        "TNP TEPC CALC": false,
        "TNP CORTC CALC": false,
        "APFF ACCESS": false,
        "TDRC": false,
        "FPC": false,
        "FPP": false,
        "TAXHYPERION NLTR": false,
        "WCO ACCESS": false,
        "BLOCKMYSTARTPAGELINK": false,
        "TNP CEC CALC": false,
        "TNPNATLANG": false,
        "TAXNEWSCATEGORIES": false,
        "TNPDIGMCMECHAN": false,
        "TNPDIGBROWN": false,
        "TNPDIGNIKOLAKAKIS": false,
        "TNPDIGHAYHOETAXATION": false,
        "TNPDIGKERZNER": false,
        "TNPDIGSCHWARTZ": false,
        "TNPDIGINNES": false,
        "TNPDIGARON": false,
        "TNPDIGCARR": false,
        "TNPDIGGAMBLE": false,
        "TNPDIGTAXATIONOFREALESTATE": false,
        "TNPDIGBROOKS": false,
        "TNPDIGMUNRO": false,
        "TNPDIGTHAW": false,
        "TNPDIGVINER": false,
        "TNPDIGFRIEDLANDER": false,
        "TNPDIGBUTCHER": false,
        "TNPDIGALEXANDER": false,
        "TNPDIGHAYHOECASELAW": false,
        "TNPDIGHAYHOEFEDPROVLEGIS": false,
        "TNPDIGHAYHOEGOVPUBLICATIONS": false,
        "TNPDIGJOLIN": false,
        "TNPDIGSTILLABOWER": false,
        "TNPDIGCASESINDEXCITATOR": false,
        "TNPDIGSEGUIN": false,
        "TNPDIGWISE": false,
        "TNPDIGBOWEN": false,
        "TNPDIGBISCOTT": false,
        "TNPDIGEDMUNDS": false,
        "TNPDIGMANNGUIDETOREVIEW": false,
        "TNPDIGCOMPILATIONENGAGEMENTS": false,
        "TNPDIGGUIDETOESTATEANDTRUSTS": false,
        "TNPDIGITIZATION": false,
        "TNPLITIGATOR": false,
        "TNPCROSSREFFILTER": false,
        "RESULTLISTEASYEDIT": false,
        "RESULTLISTQDRAFT": false,
        "DISPLAY TEST PREF TAB": false,
        "BlindLog": false,
        "EncryptLog": false,
        "MASS EMAILER": false,
        "ADCVERREDLININGTOGGLE": false,
        "ENVHEALTHSAFETYPRACPG": false,
        "INSURCOMPLIANCEPRACPG": false,
        "BLOCK WLN PATRON": false,
        "DSP INT HEADNOTE INFO": false,
        "PRDCT WLNLINKS": false,
        "GAO LH PDFS OPEN IN LINKS": false,
        "WLNLINKS UK": false,
        "BLOCK WLNLINKS EMBEDDED LINKS": false,
        "BLOCK LICENSE AGREEMENT": false,
        "FIRMSTYLE": false,
        "SMART BREADCRUMB DISPLAY": false,
        "IRS WLN PAGE": false,
        "FORMSAUTOSHAREOFF": false,
        "WLNPLTRACK": false,
        "WLNPL GOVTHOMEPAGE": false,
        "WLNPL CORPHOMEPAGE": false,
        "WLNPL DEFAULTHOMEPAGE": true,
        "ENABLE-LEGI-GOV-LINKS": false,
        "ENABLE BAILII LINKS": false,
        "BLOCK SHARE NOTE LINK": false,
        "BLCCAN ZONE": false,
        "BLCCAN SUBSCRIBER": false,
        "BLOCKBLCCAN": true,
        "BLOCKBLC": false,
        "WM SEARCH RESULTS": false,
        "WMHK SEARCH RESULTS": false,
        "WMAU SEARCH RESULTS": false,
        "TAX PWC USER": false,
        "TAX KPMG USER": false,
        "COPY USER DATA": false,
        "ASSIGNCLIENTFILE": false,
        "RESEARCH REPORT": false,
        "FOLDER ANALYSIS": false,
        "FOLDER ANALYSIS ADDL CONTENT": false,
        "TIME ZONE AUSTRALIA": false,
        "TIME ZONE NEW ZEALAND": false,
        "EY WLN PAGE": false,
        "FOLDER DESCRIPTION": false,
        "ENABLE CONTRACT EXPRESS": false,
        "CONTRACT EXPRESS PL AU": false,
        "CONTRACT EXPRESS PL US": false,
        "ASK-EDITOR": false,
        "BLOCK OPEN WEB": false,
        "PLUK SUBSCRIBER": false,
        "WLUK SUBSCRIBER": false,
        "LIBRARY SUBSCRIBER": false,
        "CHECKPOINTDIRECTLINK": false,
        "BLOCKCHECKPOINTLINKS": false,
        "LINK BUILDER": false,
        "BCICALCULATOR": false,
        "PLUK-ENAB-ALLCONTACTS": false,
        "ALLOW ICLR": true,
        "BLOCK PROVIEW FEDERATED SEARCH": false,
        "DOC ANALYSIS": false,
        "DT DocAnalysis": false,
        "GENERATE WLUK TRANSTOKEN": false,
        "WFB USEMOCKFORMS": false,
        "BLOCKSESSIONPAUSEDISPLAY": false,
        "PWC WLN PAGE": false,
        "KPMG WLN PAGE": false,
        "CROSSBORDER DASHBOARD": false,
        "TR DISCOVER SEARCH": false,
        "VIRTUAL ASSISTANT": false,
        "BLCDEALTRACKALERT": false,
        "BLCDEALTRACKALERT BIWEEKLY": false,
        "BLCDEALTRACKALERT CONTINUOUS": false,
        "BLCDEALTRACKALERT DAILY": false,
        "BLCDEALTRACKALERT MONTHLY": false,
        "BLCDEALTRACKALERT MULTIDAY": false,
        "BLCDEALTRACKALERT WEEKLY": false,
        "EY MIGRATION POP UP": false,
        "KPMG MIGRATION POP UP": false,
        "PWC MIGRATION POP UP": false,
        "IRS MIGRATION POP UP": false,
        "TAX MIGRATE": false,
        "SEARCH TABS": false,
        "JOURNAL PURCHASE FORM": false,
        "WLUK EDITORS PICKS TAB": false,
        "LEGAL LIT ANALYTICS": false,
        "UKMATTERMAPS": false,
        "USMATTERMAPS": false,
        "DISPLAY PL MESSAGE 1": false,
        "DISPLAY PL MESSAGE 2": false,
        "GRADING TOOL": false,
        "MODERN DOC DISPLAY": false,
        "INDIGO SEARCH": false,
        "INDIGO DISPLAY": false,
        "PSEUDO BLOCK INDIGO DISPLAY": true,
        "INDIGO DISPLAY PREF": false,
        "INDIGO HOT DOCS": false,
        "INDIGO RESEARCH REPORT": false,
        "COMPARE BLACKLINING": false,
        "NOTIFICATION CENTER": false,
        "PRIOR USER INTERACTIONS": false,
        "COLD START": false,
        "TOC FOR CASES": false,
        "MATERIAL KEY FACT FILTER": false,
        "PROCEDURAL POSTURE FILTER": false,
        "FAVORITE SEARCHES": false,
        "FOLDER KEYCITE CHANGE": false,
        "FOLDER RECOMMEND CHANGE": false,
        "FOLDER RECOMMEND ALERT": false,
        "RECENT FILTERS": false,
        "SEARCH RESULT CITING REFS": false,
        "SEARCH RESULT NEG HISTORY": false,
        "QUESTIONANSWERING": false,
        "ITDEPENDS": false,
        "ITDEPENDSQUESTIONANSWER": false,
        "WLUK DOC ALERTS": false,
        "WLUK JCL ALERTS": false,
        "PA REGULATIONS STATUS FILTER": false,
        "ALWAYS CLIENT ID PROMPT": false,
        "PL US BANNER": false,
        "ANSWERS FEEDBACK": false,
        "KC IMPLIED OVERRULINGS": false,
        "ENHANCED THEME": false,
        "DOC ANALYZER TOUR": false,
        "LIT ANALYTICS TOUR": false,
        "HOME PAGE TOUR": false,
        "BUSINESS DEVELOPMENT PL US": false,
        "WLNPL SLF HOMEPAGE": false
      },
      "IsUserMigrated": false,
      "SupportedFeatures": [
        "PRACTICALLAW",
        "ALERTS",
        "BROWSE",
        "BROWSEPREVIEW",
        "CASEEVALUATORWLN",
        "CDN",
        "CLIENTID",
        "CONTACTS",
        "CONTENTTYPEDELIVERYLIMIT",
        "COREUI",
        "CUSTOMPAGES",
        "DELIVERY",
        "DOCKETS",
        "DOCUMENTORDERING",
        "DOCUMENTS",
        "DROPBOX",
        "ERRORS",
        "FAVORITESORGANIZER",
        "FINDANDPRINT",
        "FOLDERS",
        "FOLDERSEXTERNALSHARING",
        "GLOSSARY",
        "WAYWO",
        "IOS",
        "IPAD",
        "FACTORANALYSIS",
        "KEYNUMBERSEARCH",
        "KM",
        "LINKIN",
        "LINKOUT",
        "LIVECHAT",
        "MOBILE",
        "MYPLAN",
        "NYOFFICALDIGEST",
        "PRICINGGUIDE",
        "PROMOTIONS",
        "PUBLICATIONFAVORITES",
        "RELATEDINFORMATION",
        "RELATEDTOPICS",
        "REPORTSHARED",
        "REVERSEPROXY",
        "SEARCH",
        "SHAREPOINTSEARCH",
        "SHAREPOINTWIDGETS",
        "SOCIALPLATFORM",
        "SURVEY",
        "USERAGREEMENT",
        "USERDOCUMENTS",
        "USEREMULATION",
        "USERSETTINGS",
        "BANKRUPTCYEXPLORER",
        "BUSINESSINVESTIGATOR",
        "BUSINESSLAWCENTER",
        "CASENOTEBOOK",
        "DUNANDBRADSTREETBUSINESS",
        "EXPERIANBUSINESSCREDIT",
        "EXPERTDUEDILIGENCE",
        "EXPERTEVALUATOR",
        "MATTERBENCHMARKING",
        "RECENTHISTORY",
        "WEB2MASHUP",
        "AUTHORITYCOMPILER",
        "SEARCHTEMPLATEPREVIEW",
        "PEOPLEMAP",
        "PUBLICRECORDS",
        "DOCKETGATEWAY",
        "WEBCONTENT",
        "PROFESSIONAL",
        "SUGGESTEDDOCUMENTS",
        "EMBEDDEDTEXT",
        "PRODUCTVIEW",
        "PRIVATEFILES",
        "STATEQACOMPARE",
        "SOURCELINK",
        "PMDPROTECTEDCONTENT",
        "ROADRUNNER",
        "REDLINE",
        "SUPERBROWSE",
        "TOCREPORTVIEW",
        "DATACOMPARISONREPORT",
        "GRAPHICALFACETS",
        "COPYUSERDATA",
        "SHAREDNOTES",
        "RESEARCHACCELERATOR",
        "WEBINARS",
        "READINGMODE",
        "ANALYTICS",
        "HIDESEARCHTERMHIGHLIGHTINGPREFERENCE",
        "MONETIZATION",
        "SHOWDOCUMENTANALYZEROVERVIEWPREFERENCE",
        "SHOWLITANALYTICSOVERVIEWPREFERENCE",
        "SHOWHOMEPAGEOVERVIEWPREFERENCE",
        "FOUNDATION"
      ],
      "ActiveBrowserPingInitialWaitInMinutes": 3,
      "ActiveBrowserPingFrequencyInMinutes": 3,
      "ShowClientIdToast": false,
      "DataRoomFeatures": [],
      "SocialPlatformProductId": "140",
      "MaxFileUploadSize": 157286400,
      "SnapEngageScriptUrl": "",
      "DeliveryQueueQueried": false,
      "DeliveryQueueTotal": 0,
      "DeliveryQueueInProgress": 0,
      "DeliveryQueueDocketsInProgress": 0,
      "DeliveryQueueInError": 0,
      "DeliveryQueueNotification": 0
    },
    "WidgetDomIds": {
      "FooterDivId": "co_footer",
      "ErrorSummaryWidget": "coid_website_errorsSummaryPlaceHolder",
      "DockWidget": "co_dockContainer",
      "RecentFoldersWidget": "co_recentFoldersContainer",
      "RecentHistoryWidget": "co_recentHistoryContainer",
      "FrequentFavoritesWidget": "co_frequentFavoritesContainer",
      "AlertsCenter": "co_alertsCenterContainer",
      "ClientIdWidget": "co_clientIdContainer",
      "SignOff": "co_signOffContainer",
      "WhatIsNext": "co_whatIsNextContainer",
      "SearchWidget": "coid_website_searchWidget"
    },
    "RedirectError": {
      "Show": false
    },
    "DomStorageHasBeenCleared": false,
    "LiveChat": {
      "Show": false,
      "Options": {
        "QueueNumber": 0
      }
    },
    "WelcomeLightbox": {
      "Show": false
    },
    "SyncInitiated": false,
    "SyncCapable": false,
    "SubscriptionRenewalBanner": {
      "Show": false
    },
    "IsBusinessLawCenter": false
  },
  "TabScripts": {
    "DocSource": "7903d1326e8e42fa91a82e1b8990f8c7",
    "DocGuid": "I8757585ab8fa11e3a341ea44e5e1f25f",
    "NavigationPath": "Search/v1/results/navigation/i0ad6ad3d0000016305665c98a975de34?Nav=CUSTOMDIGEST&fragmentIdentifier=I8757585ab8fa11e3a341ea44e5e1f25f&startIndex=1&contextData=%28sc.CustomDigest%29&transitionType=CustomDigestItem",
    "ListSource": "Search",
    "List": "CUSTOMDIGEST",
    "Rank": 63,
    "DocumentVersionNumber": 0
  }
};


window['Server/KM'] = {
  "SessionId": "",
  "FirmName": "",
  "FirmLogoUri": "",
  "FirmWelcomeUri": "",
  "Protocol": "http"
};


window['Server/Configuration'] = {
  "CompartmentName": "WestlawNext",
  "CookieDomain": "next.westlaw.com",
  "EnableIpad": false,
  "EnableIphone": false,
  "IsIPadAppRenderingMode": false,
  "IsIPhoneAppRenderingMode": false,
  "IOSNativeVersion": "0.0.0",
  "EnableSync": false,
  "EnableDeliveryQueue": true,
  "EnableDeliveryWidget": true,
  "ProductName": "WestlawNext",
  "ProductDisplayName": "Westlaw",
  "ProductDisplayDelimiter": "|",
  "ProductViewName": "none",
  "DailyDeliveryLimit": -1,
  "DailyDeliveryCount": -1,
  "SessionDeliveryLimit": 20,
  "SupportedAlertTypes": [
    "WestClip",
    "KeyCite",
    "DocketAlert",
    "DocketTrack",
    "DealTrack",
    "PublicationAlert",
    "Newsletter",
    "BusinessInvestigator",
    "CourtWire",
    "BusinessLawCenterAlert",
    "PeopleMap",
    "CapitolWatchTrack"
  ],
  "EnableDataRoomAlerts": true,
  "GlobalizationKeyMode": "Default",
  "IsAnonymousSession": false,
  "EnableAccessibleLightbox": true,
  "EnableContactsPaging": true,
  "IsCrawlerSession": false,
  "IsGlobalizationI18NLocaleEnabled": false,
  "IsGlobalizationI18NLibraryLookupEnabled": true,
  "IsProcessCategoryPagesWithDifferentLocalesOn": false,
  "OverrideResultsPerPage": 0,
  "UseExpandableToc": true,
  "Locale": "en-US",
  "IsSmartFoldersEnabled": true,
  "IsFeatureOverlayEnabled": true,
  "IsTRDiscoverEnabled": true,
  "IsVideoTourEnabled": true,
  "IsBestPortionNavigationEnabled": true,
  "UsePageHeaderV2": true,
  "UseTypeAhead": true,
  "UseSnapshots": true,
  "IsBriefAnalyzerEnabled": true,
  "IsChargeableByDefaultForSession": true,
  "IsIssueFinderEnabled": true,
  "IsWestlawAnswersEnabled": true,
  "IsSharedHighlightsEnabled": true,
  "IsRealTimeNotificationEnabled": true,
  "EnableA11YLightboxKeyboardScroll": true,
  "IsA11YRedesignedHeaderEnabled": true,
  "IsA11YPreferencesLightboxEnabled": true,
  "SpeechToTextCustomizationIdOverride": "default",
  "InfrastructureAccessControls": [
    "iac-a11y-asbuilder-tmpl",
    "iac-a11y-header-redesign",
    "iac-accessible-clientid-widget",
    "iac-add-timezone",
    "iac-alert-admin-settings",
    "iac-alert-ny-sct-hourly",
    "iac-alerts-cal",
    "iac-alerts-customerinfo-olc",
    "iac-alerts-cw",
    "iac-alerts-docket-guid",
    "iac-alerts-productaware-history",
    "iac-alerts-standart-email-format",
    "iac-all-citations",
    "iac-allow-robots-indexing-sitemap-wln",
    "iac-analyticsclientidfeaturesenabled",
    "iac-analytics-related-filings",
    "iac-annotation-filtering",
    "iac-anonymous-cdn",
    "iac-appcommand",
    "iac-asm-policy",
    "iac-au-compartments",
    "iac-au-seo",
    "iac-autosuggest-au",
    "iac-batch-getsynopsis",
    "iac-bestlaw-tracking",
    "iac-blc-filersearch",
    "iac-blc-fs-next",
    "iac-blc-redlining",
    "iac-blc-ri-agreementsenh",
    "iac-blc-ri-newpathway",
    "iac-blc-ri-privateequity",
    "iac-blind-encrypted",
    "iac-blind-encrypted-header-enabled",
    "iac-block-uk-westlaw",
    "iac-blt-alertfulltext",
    "iac-blt-alert-type-mna-trans",
    "iac-blt-alert-type-sec-insider",
    "iac-blt-alert-type-sec-noninsider",
    "iac-blt-feature18",
    "iac-blt-feature3",
    "iac-blt-hoovers",
    "iac-blt-incorporationdata",
    "iac-blt-news",
    "iac-blt-oct2014-release",
    "iac-blt-officerlinks",
    "iac-blt-report-advisors",
    "iac-blt-securities",
    "iac-blt-securities-alerts",
    "iac-blt-subsidiaries",
    "iac-blt-table-sections",
    "iac-blt-tagged-sections",
    "iac-blt-tickercik",
    "iac-blt-webkitpdf",
    "iac-blt-xmlmindrtf",
    "iac-businesslawcenter-tdr",
    "iac-canadian-content",
    "iac-casetracking",
    "iac-change-uk-ntz-clientid",
    "iac-cig-addfoldereditem",
    "iac-cig-facet-orphan",
    "iac-cig-group-orphan",
    "iac-cig-orphan",
    "iac-cig-orphan-ind",
    "iac-cig-report-orphan",
    "iac-ci-resultlist",
    "iac-citation-reordering",
    "iac-client-chargeable-by-default",
    "iac-clientid-new-validation",
    "iac-concourselibrary-wln",
    "iac-content-finder",
    "iac-correct-dock-user-property-value",
    "iac-courtexpress",
    "iac-cpet-browseparts-novus",
    "iac-cr-effective-date-display",
    "iac-crossborder-dashboard",
    "iac-crossborder-itg",
    "iac-display-applied-filter-names-on-ssp",
    "iac-display-recent-items",
    "iac-docanalyzer-caselc-atlaslc",
    "iac-docanalyzer-cited-statutes",
    "iac-docanalyzer-filter",
    "iac-docanalyzer-footnotes",
    "iac-docanalyzer-rdintegration",
    "iac-docanalyzer-relevantportion",
    "iac-docanalyzer-secondarysources",
    "iac-docanalyzer-statutes",
    "iac-docanalyzer-ui-march-release",
    "iac-doc-medical-entities-link-out",
    "iac-docversioning-wln",
    "iac-dpa-browse-juris-landing-pg",
    "iac-dpa-curated",
    "iac-dpa-delivery-watson-answer",
    "iac-dpa-enforcementmap",
    "iac-dpa-featured-content",
    "iac-dpa-keyword-newjurs",
    "iac-dpa-keyword-novus",
    "iac-dpa-knowledgegraph",
    "iac-dpa-related-concepts",
    "iac-dpa-usabilla",
    "iac-dpa-watson-v11",
    "iac-dpa-watson-v12",
    "iac-dr-client-missed",
    "iac-dtp-bankruptcy-claims",
    "iac-dtp-dktptynmtbl",
    "iac-dtp-experts",
    "iac-dtp-openweb",
    "iac-dyn-stem-exceptions",
    "iac-enable-news-summary-alerts-delivery",
    "iac-enacted-legislation-link",
    "iac-enhanced-search-term-tooltip",
    "iac-factoranalysis-history",
    "iac-fa-searchbilling",
    "iac-fastdom-standarddocument",
    "iac-feature-overlay",
    "iac-findandprint",
    "iac-firmlibrary-wln",
    "iac-foldering-get-descendants-new",
    "iac-folderingshareacrossorgs",
    "iac-forcesignon-orphansession",
    "iac-gateway-do",
    "iac-get-renewalandtrialdata",
    "iac-grantonlyfacsinsessionbindings",
    "iac-guid-chasing-disable",
    "iac-hide-docket-monthly-frequency",
    "iac-hide-territorial-options",
    "iac-historical-datacorrections",
    "iac-image-module",
    "iac-improved-navigation",
    "iac-indigo-coldstart",
    "iac-indigo-cpet-browseparts",
    "iac-indigo-display-pref",
    "iac-indigo-fav-searches",
    "iac-indigo-folder-kc-change",
    "iac-indigo-folder-recommend-change",
    "iac-indigo-hot-docs",
    "iac-indigo-notification-center",
    "iac-indigo-paymenttype",
    "iac-indigo-pui",
    "iac-indigo-recent-filters",
    "iac-indigo-research-report",
    "iac-indigo-statutes-compare",
    "iac-indigo-typeahead",
    "iac-inlinehtmldelivery-dockettrackalert",
    "iac-internationalfind",
    "iac-ios-newadvancedsearch",
    "iac-ip2-markman",
    "iac-ip-trademark-viennacode-facet",
    "iac-itdepends",
    "iac-itg-tab",
    "iac-kc-alerts-patents",
    "iac-kc-citing-references",
    "iac-kc-citing-refs-enhanced-sw",
    "iac-kc-flags",
    "iac-kc-flags-green-c-by-boolean",
    "iac-kc-judicial-history",
    "iac-kc-negative-treatment",
    "iac-kc-rules-affected-by",
    "iac-kc-statutes-affected-by",
    "iac-kc-table-of-authorities",
    "iac-kc-validity",
    "iac-kc-wave-the-white-flag",
    "iac-keycite-nod-redesign-old-rels",
    "iac-keycite-sort-by-court-level",
    "iac-keynumber-facets",
    "iac-km-aliveserverconnection",
    "iac-km-fiacctprefs",
    "iac-la-case-outcomes",
    "iac-la-case-types",
    "iac-la-courts",
    "iac-la-delivery",
    "iac-la-law-firms",
    "iac-linkbuilder-docandcatpages",
    "iac-linkbuilder-searchresultspages",
    "iac-linkbuilder-topic-search",
    "iac-linkouturl-pubandserial",
    "iac-log-prdct-wlus-deny",
    "iac-lt-dpa-watson-integration",
    "iac-master-page",
    "iac-mattermaps-deliver-image",
    "iac-mattermaps-editmap",
    "iac-matters-by-number-wln",
    "iac-medlit",
    "iac-modal-footnotes",
    "iac-modernization-wln-ios-doc",
    "iac-most-cited-sort",
    "iac-move-menus-down",
    "iac-multipart-pdf",
    "iac-new-newsletter-template",
    "iac-newsroom-images",
    "iac-non-unique-cites",
    "iac-novustimezone",
    "iac-nyofficial-digestlink",
    "iac-oversized-and-error-email-delivery",
    "iac-pa-regulations-status-facets",
    "iac-partytype-checkbox",
    "iac-patron-category-page",
    "iac-pdf-multipart-check",
    "iac-planz-application-enabled",
    "iac-plconnect-tasks-and-synonyms",
    "iac-plconnect-tasks-ux-redesign",
    "iac-plc-rss-feeds",
    "iac-plct-crossclientid",
    "iac-plct-crossproductclientid",
    "iac-plct-globalsearch",
    "iac-plct-linkbuilder",
    "iac-plct-smalllawfirmmgmt",
    "iac-plct-ssrulebooks",
    "iac-plct-startupssmallbus",
    "iac-plct-viewalltasks",
    "iac-plc-viewonlydraftingnotes",
    "iac-plc-waywo",
    "iac-plplus-application-enabled",
    "iac-plplus-calendar",
    "iac-pl-scrollissues",
    "iac-pluk-asset-page-enable-wln-links",
    "iac-pluk-cdn-available-for-ip",
    "iac-plus-clientidinsession",
    "iac-plus-clientidpromptpltowl",
    "iac-plus-documentononepage",
    "iac-plus-feedback",
    "iac-plus-homebanner",
    "iac-plus-knowhowbooleanquery",
    "iac-plus-linkbuilder",
    "iac-plus-notesformating",
    "iac-plus-searchcontext",
    "iac-plus-truncatejurinsearch",
    "iac-plus-unhideannotations",
    "iac-plus-viewmorelessdetails",
    "iac-portalmanager-combined",
    "iac-portalmanager-contentlinks",
    "iac-portalmanager-findbypartyname",
    "iac-portalmanager-search",
    "iac-practical-law-display-changes",
    "iac-practicallaw-itg-dropdown",
    "iac-practical-law-subheadings",
    "iac-practiceareas-asterisknote",
    "iac-practicepoint-smartsearch-onesynonym",
    "iac-practicepoint-smartsearch-synonyms",
    "iac-practicepoint-smartsearch-treatises",
    "iac-practitioner-insights-alerts-no-logo",
    "iac-pr-add-bing",
    "iac-pr-addfoldereditem",
    "iac-pr-entity-extraction",
    "iac-pr-fein-plus3",
    "iac-price-guide-link",
    "iac-pricing-guide-redirect",
    "iac-privacy-policy",
    "iac-pr-polkrpt",
    "iac-pr-qsentrpt",
    "iac-pr-section-delivery",
    "iac-pr-ssn-only-search",
    "iac-pr-use-pipl-v5",
    "iac-public-record-prod-gateway",
    "iac-public-records",
    "iac-public-records-alerts",
    "iac-public-records-firstamerican",
    "iac-public-records-report-excel-delivery",
    "iac-public-records-report-filtering",
    "iac-pubrec-real-time-monitor",
    "iac-qanda",
    "iac-qanda-pinpoint",
    "iac-qanda-typeahead",
    "iac-raise-document-limit",
    "iac-ra-no-rank1docs-cache",
    "iac-remove-nyor-hard-coded-collections",
    "iac-remove-securedatatoken",
    "iac-research-accel",
    "iac-research-accel-synopsis",
    "iac-ri-bill-activity",
    "iac-ri-bill-tracking",
    "iac-ri-capitol-watch",
    "iac-ri-category-delivery",
    "iac-ri-citestyles-endpoint-v2-enable",
    "iac-ri-context-analysis",
    "iac-ri-editorial-materials",
    "iac-ri-filings",
    "iac-ri-fnd-newpathway",
    "iac-ri-form-families",
    "iac-ri-legislative-timeline",
    "iac-ri-no-single-rn-uds-post",
    "iac-ri-notes-of-decisions",
    "iac-ri-opinions",
    "iac-ri-professional-references",
    "iac-ri-reduce-uds-rn-data",
    "iac-ri-topics",
    "iac-ri-versions",
    "iac-sb-list-items-delivery",
    "iac-search-como-group1",
    "iac-search-como-group2",
    "iac-search-como-group3",
    "iac-search-como-group4",
    "iac-search-como-group6",
    "iac-search-como-group7",
    "iac-search-como-group8",
    "iac-search-como-public-records",
    "iac-search-como-recodocs",
    "iac-search-como-reghist",
    "iac-search-custom-nyor-reranking",
    "iac-search-delivery-group1",
    "iac-search-delivery-group2",
    "iac-search-delivery-group3",
    "iac-search-delivery-group4",
    "iac-search-delivery-group5",
    "iac-search-firmcentral",
    "iac-search-knowhowrankoption",
    "iac-search-matterroom",
    "iac-search-nl-thresholding-option",
    "iac-search-pmd-result-types",
    "iac-search-result-duplicate-identifier",
    "iac-search-suggestions",
    "iac-search-within-favourites-plcuk",
    "iac-searchwithin-ios",
    "iac-shared-highlights",
    "iac-share-folders-with-cobalt-contacts",
    "iac-sharing-with-the-same-domain",
    "iac-show50statesurvey-inlineflags",
    "iac-small-law-survey-redirect",
    "iac-smartbreadcrumb-add-navid",
    "iac-smartbreadcrumbs-au",
    "iac-smartfolders-ss",
    "iac-snapshots-state",
    "iac-snowdonia-beta",
    "iac-sortoption-courtlevel-pref",
    "iac-starpages-plcuk",
    "iac-staticqa",
    "iac-staticqa-history",
    "iac-staticqa-searchbilling",
    "iac-statutes-new-ast-pdfs",
    "iac-superbrowse-mult-gradeheads",
    "iac-superbrowse-paging",
    "iac-taxpage-eylogo",
    "iac-term-frequency-sorting",
    "iac-transfer-content",
    "iac-trd-alternate-search",
    "iac-trd-juris-facet",
    "iac-trd-legalanalytics",
    "iac-trd-lpafacet-subsearch",
    "iac-trillium-crsw-doc-enhance",
    "iac-trillium-link",
    "iac-uk-a11y-clientid-lightbox",
    "iac-uk-clientid",
    "iac-uk-compartments",
    "iac-uk-fd-and-fs",
    "iac-uk-keywordfinder",
    "iac-uk-linkbuilder",
    "iac-uk-linkbuilder-copy",
    "iac-uk-nonpltracking",
    "iac-uk-performance-new-static-content-or",
    "iac-unlink-unmigrated",
    "iac-use-new-training-user",
    "iac-userdoclink-wln",
    "iac-us-knowhow-algorithm",
    "iac-v3inapplibrary",
    "iac-validity-highlighting",
    "iac-verify-eaddress-against-existance",
    "iac-webinars",
    "iac-website-throttle",
    "iac-westsearch-cases-keynumberfacet",
    "iac-westsearch-cases-partyfacet",
    "iac-westsearch-cases-synopsis",
    "iac-westsearch-cases-topicfacet",
    "iac-westsearch-enhancements",
    "iac-without-flash-dependencies",
    "iac-wln-cig-linkedreport",
    "iac-wlndoc-sharednotes",
    "iac-wln-global-search-judicial-chambers",
    "iac-wln-historicalheader",
    "iac-wln-ios-display-toa",
    "iac-wln-newfiletype",
    "iac-wlnopenweb-serverbrowsepage",
    "iac-wln-ri-tabs",
    "iac-wln-save-snippet",
    "iac-wln-strong-downgrade-email",
    "iac-wlntax-blue-flag",
    "iac-wln-toc-keyciteflag",
    "iac-wl-startpage",
    "iac-wl-striphash",
    "iac-wordsphrases-snippet-support"
  ],
  "IsTypeAheadNewUiEnabled": true,
  "ContactsPageSize": 300,
  "ShowPrivacyPolicy": true,
  "ShowCookiePolicy": true,
  "ResearchReportDocumentLimit": 1000,
  "IsSaveSnippetEnabled": true,
  "IsHideAnnotationsSharedByInactiveUsersEnabled": true,
  "AllowPauseOnLinkOut": true,
  "IsMaintainDocumentPositionRIEnabled": true,
  "IsFormsEngine2Enabled": false,
  "IsFormsEngine2DownloadEnabled": false,
  "IsIndigoDisplayEnabled": false
};


window['Server/Mobile'] = {
  "IsNativeIPad": false,
  "IsNativeIPhone": false
};


window['Server/Messages'] = {
  "ProductName": "Westlaw",
  "ProductSupportNumber": "1-800-WESTLAW (1-800-937-8529)"
};


window['Server/Net'] = {
  "PageContextData": "(sc.CustomDigest)",
  "CacheScopeList": [
    "^/RelatedInfo/v[3456]/keycite/content/",
    "^/RelatedInfo/v3/content/json/",
    "^/RelatedInfo/v1/wlncCaselawHistory\\\\?",
    "^/RelatedInfo/v1/wlncCitingReferences\\\\?",
    "^/RelatedInfo/v1/wlncCourtDocs\\\\?",
    "^/RelatedInfo/v1/wlncLegalMemos\\\\?",
    "^/RelatedInfo/v1/kcJudicialHistory\\\\?",
    "^/RelatedInfo/v1/kcCitingReferences\\\\?",
    "^/RelatedInfo/v1/riFilings\\\\?",
    "^/RelatedInfo/v1/kcNegativeTreatment\\\\?",
    "^/RelatedInfo/v1/kcTableOfAuthorities\\\\?",
    "^/RelatedInfo/v1/kcBillDrafts\\\\?",
    "^/RelatedInfo/v1/kcLegislativeMaterials\\\\?",
    "^/RelatedInfo/v1/kcRegulatoryHistory\\\\?",
    "^/RelatedInfo/v1/kcValidity\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreements\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLetters\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnSecCommentLettersTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosures\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibits\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingsAndDisclosuresExhibitsTwoStepViaMAAndFD\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitions\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhanced\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsEnhancedTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnMergersAndAcquisitionsRelated\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnRandPTransactionFullTextCategoryTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFilingFullTextCategory\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestments\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsV2\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnFundsInvestmentsTwoStepViaFDAndMA\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnPefundsFundsFirms\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnh\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStep\\\\?",
    "^/RelatedInfo/v1/corporatezone/wlnAgreementsEnhTwoStepViaMA\\\\?",
    "^/RelatedInfo/v1/tnpCases\\\\?",
    "^/RelatedInfo/v1/tnpCommentary\\\\?",
    "^/RelatedInfo/v1/tnpCompliance\\\\?",
    "^/RelatedInfo/v1/tnpGovernmentDocuments\\\\?",
    "^/RelatedInfo/v1/tnpHistory\\\\?",
    "^/RelatedInfo/v1/tnpHistoryAndTreatments\\\\?",
    "^/RelatedInfo/v1/tnpLegislation\\\\?",
    "^/Search/v1/search/external/results",
    "^/Search/v3/search/results",
    "^/Search/v1/results",
    "^/Document/v1/fulltext/",
    "^/Document/v1/list/fulltext/",
    "^/Document/v1/Mobile/FullText/",
    "^/Document/v1/fixedheader/",
    "^/Document/v1/list/fixedheader/",
    "^/Document/v1/list/Mobile/Fulltext/",
    "^/Document/v[12]/MetaInfo/"
  ],
  "SessionScope": "d20233481a5f0dfb615a8630219cd8b243c1c2e74fb3160800e76f7896b305b7",
  "UserScope": "5405685",
  "CacheScope": "1780a50810fd3b91c6b9348a0f53fe77"
};


window['Server/Events'] = {
  "PageEventIdentifier": "ba9ef47f7a754127924ef38cf9400e76",
  "PageName": "Cobalt.Website.ServerPage.Document",
  "ResourceToken": "v1|d4b65c1069dddf3f8794c9b59dc6e63a761c18f88d6caabc37285a09eaa3b4eb"
};

</script>


	
	

<!-- View Path: ~/Document/Views/DocumentTabView.cshtml -->
<script type="text/javascript">
window.__viewName = '~/Document/Views/DocumentTabView.cshtml';
</script>
<script type="text/javascript" crossorigin="anonymous" charset="utf-8" src="https://ja.next.westlaw.com/StaticContent_40.1.1015/webpack/Products/WestlawNext/webpack-loader.js"></script>

	

<div id="co_searchDisableDiv" class="co_screenOverlay co_hideState"></div><div id="co_dragDrop_parent_0"></div></body></html>